                                                                                                                                                                         II




                                                                                                                                               Calendar No. 14
                                                                        113TH CONGRESS
                                                                           1ST SESSION                          H. R. 307
                                                                                    IN THE SENATE OF THE UNITED STATES
                                                                                         JANUARY 23 (legislative day, JANUARY 3), 2013
                                                                            Received; read twice and referred to the Committee on Health, Education,
                                                                                                       Labor, and Pensions

                                                                                                             FEBRUARY 14, 2013
                                                                                                 Reported by Mr. HARKIN, with an amendment
                                                                                     [Strike out all after the enacting clause and insert the part printed in italic]




                                                                                                               AN ACT
                                                                        To reauthorize certain programs under the Public Health
                                                                           Service Act and the Federal Food, Drug, and Cosmetic
                                                                           Act with respect to public health security and all-hazards
                                                                           preparedness and response, and for other purposes.
                                                                          1              Be it enacted by the Senate and House of Representa-
                                                                          2 tives of the United States of America in Congress assembled,
                                                                          3     SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

                                                                          4              (a) SHORT TITLE.—This Act may be cited as the
                                                                          5 ‘‘Pandemic and All-Hazards Preparedness Reauthoriza-
                                      



                                                                          6 tion Act of 2013’’.
                                                                                                                                   2
                                                                          1              (b) TABLE            OF    CONTENTS.—The table of contents of
                                                                          2 this Act is as follows:
                                                                                Sec. 1. Short title; table of contents.

                                                                                      TITLE I—STRENGTHENING NATIONAL PREPAREDNESS AND
                                                                                           RESPONSE FOR PUBLIC HEALTH EMERGENCIES

                                                                                Sec.   101.      National Health Security Strategy.
                                                                                Sec.   102.      Assistant Secretary for Preparedness and Response.
                                                                                Sec.   103.      National Advisory Committee on Children and Disasters.
                                                                                Sec.   104.      Modernization of the National Disaster Medical System.
                                                                                Sec.   105.      Continuing the role of the Department of Veterans Affairs.

                                                                                        TITLE II—OPTIMIZING STATE AND LOCAL ALL-HAZARDS
                                                                                                  PREPAREDNESS AND RESPONSE

                                                                                Sec. 201. Temporary redeployment of federally funded personnel during a pub-
                                                                                                lic health emergency.
                                                                                Sec. 202. Improving State and local public health security.
                                                                                Sec. 203. Hospital preparedness and medical surge capacity.
                                                                                Sec. 204. Enhancing situational awareness and biosurveillance.
                                                                                Sec. 205. Eliminating duplicative Project Bioshield reports.

                                                                                    TITLE III—ENHANCING MEDICAL COUNTERMEASURE REVIEW

                                                                                Sec.   301.      Special protocol assessment.
                                                                                Sec.   302.      Authorization for medical products for use in emergencies.
                                                                                Sec.   303.      Definitions.
                                                                                Sec.   304.      Enhancing medical countermeasure activities.
                                                                                Sec.   305.      Regulatory management plans.
                                                                                Sec.   306.      Report.
                                                                                Sec.   307.      Pediatric medical countermeasures.

                                                                                        TITLE IV—ACCELERATING MEDICAL COUNTERMEASURE
                                                                                             ADVANCED RESEARCH AND DEVELOPMENT

                                                                                Sec.   401.      BioShield.
                                                                                Sec.   402.      Biomedical Advanced Research and Development Authority.
                                                                                Sec.   403.      Strategic National Stockpile.
                                                                                Sec.   404.      National Biodefense Science Board.
                                      




                                                                                    •HR 307 RS

                                                                          1     TITLE I—STRENGTHENING NA-                        3
                                                                          2        TIONAL PREPAREDNESS AND
                                                                          3        RESPONSE   FOR   PUBLIC
                                                                          4        HEALTH EMERGENCIES
                                                                          5     SEC. 101. NATIONAL HEALTH SECURITY STRATEGY.

                                                                          6              (a) IN GENERAL.—Section 2802 of the Public Health
                                                                          7 Service Act (42 U.S.C. 300hh–1) is amended—
                                                                          8                        (1) in subsection (a)(1), by striking ‘‘2009’’ and
                                                                          9              inserting ‘‘2014’’; and
                                                                        10                         (2) in subsection (b)—
                                                                        11                                  (A) in paragraph (1)(A), by inserting ‘‘,
                                                                        12                         including drills and exercises to ensure medical
                                                                        13                         surge capacity for events without notice’’ after
                                                                        14                         ‘‘exercises’’; and
                                                                        15                                  (B) in paragraph (3)—
                                                                        16                                         (i) in the matter preceding subpara-
                                                                        17                                  graph (A)—
                                                                        18                                                   (I) by striking ‘‘facilities), and
                                                                        19                                         trauma care’’ and inserting ‘‘and am-
                                                                        20                                         bulatory care facilities and which may
                                                                        21                                         include dental health facilities), and
                                                                        22                                         trauma care, critical care,’’; and
                                                                        23                                                   (II) by inserting ‘‘(including re-
                                      



                                                                        24                                         lated availability, accessibility, and co-
                                                                                    •HR 307 RS

                                                                                                                                   4
                                                                          1                                        ordination)’’                after        ‘‘public    health
                                                                          2                                        emergencies’’;
                                                                          3                                        (ii) in subparagraph (A), by inserting
                                                                          4                                 ‘‘and trauma’’ after ‘‘medical’’;
                                                                          5                                        (iii) in subparagraph (B), by striking
                                                                          6                                 ‘‘Medical evacuation and fatality manage-
                                                                          7                                 ment’’ and inserting ‘‘Fatality manage-
                                                                          8                                 ment’’;
                                                                          9                                        (iv) by redesignating subparagraphs
                                                                        10                                  (C), (D), and (E) as subparagraphs (D),
                                                                        11                                  (E), and (F), respectively;
                                                                        12                                         (v) by inserting after subparagraph
                                                                        13                                  (B), the following the new subparagraph:
                                                                        14                                  ‘‘(C) Coordinated medical triage and evac-
                                                                        15                         uation to appropriate medical institutions based
                                                                        16                         on patient medical need, taking into account re-
                                                                        17                         gionalized systems of care.’’;
                                                                        18                                         (vi) in subparagraph (E), as redesig-
                                                                        19                                  nated by clause (iv), by inserting ‘‘(which
                                                                        20                                  may include such dental health assets)’’
                                                                        21                                  after ‘‘medical assets’’; and
                                                                        22                                         (vii) by adding at the end the fol-
                                                                        23                                  lowing:
                                      




                                                                        24                                  ‘‘(G) Optimizing a coordinated and flexible
                                                                        25                         approach to the medical surge capacity of hos-


                                                                                    •HR 307 RS

                                                                                                                                   5
                                                                          1                        pitals, other health care facilities, critical care,
                                                                          2                        and trauma care (which may include trauma
                                                                          3                        centers) and emergency medical systems.’’;
                                                                          4                                 (C) in paragraph (4)—
                                                                          5                                        (i) in subparagraph (A), by inserting
                                                                          6                                 ‘‘, including the unique needs and consider-
                                                                          7                                 ations of individuals with disabilities,’’
                                                                          8                                 after ‘‘medical needs of at-risk individ-
                                                                          9                                 uals’’; and
                                                                        10                                         (ii) in subparagraph (B), by inserting
                                                                        11                                  ‘‘the’’ before ‘‘purpose of this section’’; and
                                                                        12                                  (D) by adding at the end the following:
                                                                        13                         ‘‘(7) COUNTERMEASURES.—
                                                                        14                                  ‘‘(A) Promoting strategic initiatives to ad-
                                                                        15                         vance countermeasures to diagnose, mitigate,
                                                                        16                         prevent, or treat harm from any biological
                                                                        17                         agent or toxin, chemical, radiological, or nuclear
                                                                        18                         agent or agents, whether naturally occurring,
                                                                        19                         unintentional, or deliberate.
                                                                        20                                  ‘‘(B) For purposes of this paragraph, the
                                                                        21                         term ‘countermeasures’ has the same meaning
                                                                        22                         as the terms ‘qualified countermeasures’ under
                                                                        23                         section 319F–1, ‘qualified pandemic and epi-
                                      



                                                                        24                         demic products’ under section 319F–3, and ‘se-
                                                                        25                         curity countermeasures’ under section 319F–2.


                                                                                    •HR 307 RS

                                                                          1                        ‘‘(8) MEDICAL               6   AND PUBLIC HEALTH COMMU-
                                                                          2              NITY         RESILIENCY.—Strengthening                               the ability of
                                                                          3              States, local communities, and tribal communities to
                                                                          4              prepare for, respond to, and be resilient in the event
                                                                          5              of public health emergencies, whether naturally oc-
                                                                          6              curring, unintentional, or deliberate by—
                                                                          7                                 ‘‘(A) optimizing alignment and integration
                                                                          8                        of medical and public health preparedness and
                                                                          9                        response planning and capabilities with and into
                                                                        10                         routine daily activities; and
                                                                        11                                  ‘‘(B) promoting familiarity with local med-
                                                                        12                         ical and public health systems.’’.
                                                                        13               (b) AT-RISK INDIVIDUALS.—Section 2814 of the
                                                                        14 Public Health Service Act (42 U.S.C. 300hh–16) is
                                                                        15 amended—
                                                                        16                         (1) by striking paragraphs (5), (7), and (8);
                                                                        17                         (2)         in         paragraph                 (4),          by     striking
                                                                        18               ‘‘2811(b)(3)(B)’’ and inserting ‘‘2802(b)(4)(B)’’;
                                                                        19                         (3) by redesignating paragraphs (1) through
                                                                        20               (4) as paragraphs (2) through (5), respectively;
                                                                        21                         (4) by inserting before paragraph (2) (as so re-
                                                                        22               designated), the following:
                                                                        23                         ‘‘(1) monitor emerging issues and concerns as
                                      



                                                                        24               they relate to medical and public health prepared-
                                                                        25               ness and response for at-risk individuals in the event


                                                                                    •HR 307 RS

                                                                                                                                   7
                                                                          1              of a public health emergency declared by the Sec-
                                                                          2              retary under section 319;’’;
                                                                          3                        (5) by amending paragraph (2) (as so redesig-
                                                                          4              nated) to read as follows:
                                                                          5                        ‘‘(2) oversee the implementation of the pre-
                                                                          6              paredness goals described in section 2802(b) with re-
                                                                          7              spect to the public health and medical needs of at-
                                                                          8              risk individuals in the event of a public health emer-
                                                                          9              gency, as described in section 2802(b)(4);’’; and
                                                                        10                         (6) by inserting after paragraph (6), the fol-
                                                                        11               lowing:
                                                                        12                         ‘‘(7) disseminate and, as appropriate, update
                                                                        13               novel and best practices of outreach to and care of
                                                                        14               at-risk individuals before, during, and following pub-
                                                                        15               lic health emergencies in as timely a manner as is
                                                                        16               practicable, including from the time a public health
                                                                        17               threat is identified; and
                                                                        18                         ‘‘(8) ensure that public health and medical in-
                                                                        19               formation distributed by the Department of Health
                                                                        20               and Human Services during a public health emer-
                                                                        21               gency is delivered in a manner that takes into ac-
                                                                        22               count the range of communication needs of the in-
                                                                        23               tended recipients, including at-risk individuals.’’.
                                      




                                                                                    •HR 307 RS

                                                                          1     SEC. 102. ASSISTANT SECRETARY FOR PREPAREDNESS AND 8
                                                                          2                             RESPONSE.

                                                                          3              (a) IN GENERAL.—Section 2811 of the Public Health
                                                                          4 Service Act (42 U.S.C. 300hh–10) is amended—
                                                                          5                        (1) in subsection (b)—
                                                                          6                                 (A) in paragraph (3), by inserting ‘‘, secu-
                                                                          7                        rity countermeasures (as defined in section
                                                                          8                        319F–2),’’ after ‘‘qualified countermeasures (as
                                                                          9                        defined in section 319F–1)’’;
                                                                        10                                  (B) in paragraph (4), by adding at the end
                                                                        11                         the following:
                                                                        12                                  ‘‘(D) POLICY               COORDINATION AND STRA-
                                                                        13                         TEGIC DIRECTION.—Provide                                integrated policy
                                                                        14                         coordination and strategic direction with re-
                                                                        15                         spect to all matters related to Federal public
                                                                        16                         health and medical preparedness and execution
                                                                        17                         and deployment of the Federal response for
                                                                        18                         public health emergencies and incidents covered
                                                                        19                         by the National Response Plan developed pur-
                                                                        20                         suant to section 504(6) of the Homeland Secu-
                                                                        21                         rity Act of 2002, or any successor plan, before,
                                                                        22                         during, and following public health emergencies.
                                                                        23                                  ‘‘(E) IDENTIFICATION                           OF       INEFFICIEN-
                                                                        24                         CIES.—Identify              and minimize gaps, duplication,
                                      



                                                                        25                         and other inefficiencies in medical and public
                                                                        26                         health preparedness and response activities and
                                                                                    •HR 307 RS

                                                                                                                                   9
                                                                          1                        the actions necessary to overcome these obsta-
                                                                          2                        cles.
                                                                          3                                 ‘‘(F) COORDINATION                          OF        GRANTS    AND
                                                                          4                        AGREEMENTS.—Align                           and coordinate medical
                                                                          5                        and public health grants and cooperative agree-
                                                                          6                        ments as applicable to preparedness and re-
                                                                          7                        sponse activities authorized under this Act, to
                                                                          8                        the extent possible, including program require-
                                                                          9                        ments, timelines, and measurable goals, and in
                                                                        10                         consultation with the Secretary of Homeland
                                                                        11                         Security, to—
                                                                        12                                         ‘‘(i) optimize and streamline medical
                                                                        13                                  and public health preparedness and re-
                                                                        14                                  sponse capabilities and the ability of local
                                                                        15                                  communities to respond to public health
                                                                        16                                  emergencies; and
                                                                        17                                         ‘‘(ii) gather and disseminate best
                                                                        18                                  practices among grant and cooperative
                                                                        19                                  agreement recipients, as appropriate.
                                                                        20                                  ‘‘(G) DRILL                AND         OPERATIONAL             EXER-
                                                                        21                         CISES.—Carry               out drills and operational exer-
                                                                        22                         cises, in consultation with the Department of
                                                                        23                         Homeland Security, the Department of De-
                                      



                                                                        24                         fense, the Department of Veterans Affairs, and
                                                                        25                         other applicable Federal departments and agen-


                                                                                    •HR 307 RS

                                                                                                                               10
                                                                          1                        cies, as necessary and appropriate, to identify,
                                                                          2                        inform, and address gaps in and policies related
                                                                          3                        to all-hazards medical and public health pre-
                                                                          4                        paredness and response, including exercises
                                                                          5                        based on—
                                                                          6                                        ‘‘(i) identified threats for which coun-
                                                                          7                                 termeasures are available and for which no
                                                                          8                                 countermeasures are available; and
                                                                          9                                        ‘‘(ii) unknown threats for which no
                                                                        10                                  countermeasures are available.
                                                                        11                                  ‘‘(H) NATIONAL                 SECURITY PRIORITY.—On
                                                                        12                         a periodic basis consult with, as applicable and
                                                                        13                         appropriate, the Assistant to the President for
                                                                        14                         National Security Affairs, to provide an update
                                                                        15                         on, and discuss, medical and public health pre-
                                                                        16                         paredness and response activities pursuant to
                                                                        17                         this Act and the Federal Food, Drug, and Cos-
                                                                        18                         metic Act, including progress on the develop-
                                                                        19                         ment, approval, clearance, and licensure of
                                                                        20                         medical countermeasures.’’; and
                                                                        21                                  (C) by adding at the end the following:
                                                                        22                         ‘‘(7) COUNTERMEASURES                            BUDGET PLAN.—De-
                                                                        23               velop, and update on an annual basis, a coordinated
                                      



                                                                        24               5-year budget plan based on the medical counter-
                                                                                    •HR 307 RS

                                                                                                                               11
                                                                          1              measure priorities described in subsection (d). Each
                                                                          2              such plan shall—
                                                                          3                                 ‘‘(A) include consideration of the entire
                                                                          4                        medical countermeasures enterprise, includ-
                                                                          5                        ing—
                                                                          6                                        ‘‘(i) basic research and advanced re-
                                                                          7                                 search and development;
                                                                          8                                        ‘‘(ii) approval, clearance, licensure,
                                                                          9                                 and authorized uses of products; and
                                                                        10                                         ‘‘(iii) procurement, stockpiling, main-
                                                                        11                                  tenance, and replenishment of all products
                                                                        12                                  in the Strategic National Stockpile;
                                                                        13                                  ‘‘(B) inform prioritization of resources and
                                                                        14                         include measurable outputs and outcomes to
                                                                        15                         allow for the tracking of the progress made to-
                                                                        16                         ward identified priorities;
                                                                        17                                  ‘‘(C) identify medical countermeasure life-
                                                                        18                         cycle costs to inform planning, budgeting, and
                                                                        19                         anticipated needs within the continuum of the
                                                                        20                         medical countermeasure enterprise consistent
                                                                        21                         with section 319F–2; and
                                                                        22                                  ‘‘(D) be made available to the appropriate
                                                                        23                         committees of Congress upon request.’’;
                                      




                                                                        24                         (2) by striking subsection (c) and inserting the
                                                                        25               following:


                                                                                    •HR 307 RS

                                                                                                                               12
                                                                          1              ‘‘(c) FUNCTIONS.—The Assistant Secretary for Pre-
                                                                          2 paredness and Response shall—
                                                                          3                        ‘‘(1) have lead responsibility within the Depart-
                                                                          4              ment of Health and Human Services for emergency
                                                                          5              preparedness and response policy coordination and
                                                                          6              strategic direction;
                                                                          7                        ‘‘(2) have authority over and responsibility
                                                                          8              for—
                                                                          9                                 ‘‘(A) the National Disaster Medical System
                                                                        10                         pursuant to section 2812;
                                                                        11                                  ‘‘(B) the Hospital Preparedness Coopera-
                                                                        12                         tive Agreement Program pursuant to section
                                                                        13                         319C–2;
                                                                        14                                  ‘‘(C) the Biomedical Advanced Research
                                                                        15                         and Development Authority pursuant to section
                                                                        16                         319L;
                                                                        17                                  ‘‘(D) the Medical Reserve Corps pursuant
                                                                        18                         to section 2813;
                                                                        19                                  ‘‘(E) the Emergency System for Advance
                                                                        20                         Registration of Volunteer Health Professionals
                                                                        21                         pursuant to section 319I; and
                                                                        22                                  ‘‘(F) administering grants and related au-
                                                                        23                         thorities related to trauma care under parts A
                                      



                                                                        24                         through C of title XII, such authority to be
                                                                        25                         transferred by the Secretary from the Adminis-


                                                                                    •HR 307 RS

                                                                                                                               13
                                                                          1                        trator of the Health Resources and Services Ad-
                                                                          2                        ministration to such Assistant Secretary;
                                                                          3                        ‘‘(3) exercise the responsibilities and authorities
                                                                          4              of the Secretary with respect to the coordination
                                                                          5              of—
                                                                          6                                 ‘‘(A) the Public Health Emergency Pre-
                                                                          7                        paredness Cooperative Agreement Program pur-
                                                                          8                        suant to section 319C–1;
                                                                          9                                 ‘‘(B) the Strategic National Stockpile pur-
                                                                        10                         suant to section 319F–2; and
                                                                        11                                  ‘‘(C) the Cities Readiness Initiative; and
                                                                        12                         ‘‘(4) assume other duties as determined appro-
                                                                        13               priate by the Secretary.’’; and
                                                                        14                         (3) by adding at the end the following:
                                                                        15               ‘‘(d) PUBLIC HEALTH EMERGENCY MEDICAL COUN-
                                                                        16      TERMEASURES                  ENTERPRISE STRATEGY                            AND      IMPLEMEN-
                                                                        17      TATION           PLAN.—
                                                                        18                         ‘‘(1) IN        GENERAL.—Not                     later than 180 days
                                                                        19               after the date of enactment of this subsection, and
                                                                        20               every year thereafter, the Assistant Secretary for
                                                                        21               Preparedness and Response shall develop and submit
                                                                        22               to the appropriate committees of Congress a coordi-
                                                                        23               nated strategy and accompanying implementation
                                      



                                                                        24               plan for medical countermeasures to address chem-
                                                                        25               ical, biological, radiological, and nuclear threats. In


                                                                                    •HR 307 RS

                                                                                                                               14
                                                                          1              developing such a plan, the Assistant Secretary for
                                                                          2              Preparedness and Response shall consult with the
                                                                          3              Director of the Biomedical Advanced Research and
                                                                          4              Development Authority, the Director of the National
                                                                          5              Institutes of Health, the Director of the Centers for
                                                                          6              Disease Control and Prevention, and the Commis-
                                                                          7              sioner of Food and Drugs. Such strategy and plan
                                                                          8              shall be known as the ‘Public Health Emergency
                                                                          9              Medical Countermeasures Enterprise Strategy and
                                                                        10               Implementation Plan’.
                                                                        11                         ‘‘(2) REQUIREMENTS.—The plan under para-
                                                                        12               graph (1) shall—
                                                                        13                                  ‘‘(A) describe the chemical, biological, radi-
                                                                        14                         ological, and nuclear agent or agents that may
                                                                        15                         present a threat to the Nation and the cor-
                                                                        16                         responding efforts to develop qualified counter-
                                                                        17                         measures (as defined in section 319F–1), secu-
                                                                        18                         rity countermeasures (as defined in section
                                                                        19                         319F–2), or qualified pandemic or epidemic
                                                                        20                         products (as defined in section 319F–3) for
                                                                        21                         each threat;
                                                                        22                                  ‘‘(B) evaluate the progress of all activities
                                                                        23                         with respect to such countermeasures or prod-
                                      



                                                                        24                         ucts, including research, advanced research, de-
                                                                                    •HR 307 RS

                                                                                                                               15
                                                                          1                        velopment, procurement, stockpiling, deploy-
                                                                          2                        ment, distribution, and utilization;
                                                                          3                                 ‘‘(C) identify and prioritize near-, mid-,
                                                                          4                        and long-term needs with respect to such coun-
                                                                          5                        termeasures or products to address a chemical,
                                                                          6                        biological, radiological, and nuclear threat or
                                                                          7                        threats;
                                                                          8                                 ‘‘(D) identify, with respect to each cat-
                                                                          9                        egory of threat, a summary of all awards and
                                                                        10                         contracts, including advanced research and de-
                                                                        11                         velopment and procurement, that includes—
                                                                        12                                         ‘‘(i)       the       time         elapsed            from   the
                                                                        13                                  issuance of the initial solicitation or re-
                                                                        14                                  quest for a proposal to the adjudication
                                                                        15                                  (such as the award, denial of award, or so-
                                                                        16                                  licitation termination); and
                                                                        17                                         ‘‘(ii) an identification of projected
                                                                        18                                  timelines, anticipated funding allocations,
                                                                        19                                  benchmarks, and milestones for each med-
                                                                        20                                  ical countermeasure priority under sub-
                                                                        21                                  paragraph (C), including projected needs
                                                                        22                                  with regard to replenishment of the Stra-
                                                                        23                                  tegic National Stockpile;
                                      




                                                                                    •HR 307 RS

                                                                                                                               16
                                                                          1                                 ‘‘(E) be informed by the recommendations
                                                                          2                        of the National Biodefense Science Board pur-
                                                                          3                        suant to section 319M;
                                                                          4                                 ‘‘(F) evaluate progress made in meeting
                                                                          5                        timelines, allocations, benchmarks, and mile-
                                                                          6                        stones identified under subparagraph (D)(ii);
                                                                          7                                 ‘‘(G) report on the amount of funds avail-
                                                                          8                        able for procurement in the special reserve fund
                                                                          9                        as defined in section 319F–2(h) and the impact
                                                                        10                         this funding will have on meeting the require-
                                                                        11                         ments under section 319F–2;
                                                                        12                                  ‘‘(H) incorporate input from Federal,
                                                                        13                         State, local, and tribal stakeholders;
                                                                        14                                  ‘‘(I) identify the progress made in meeting
                                                                        15                         the medical countermeasure priorities for at-
                                                                        16                         risk individuals (as defined in 2802(b)(4)(B)),
                                                                        17                         as applicable under subparagraph (C), including
                                                                        18                         with regard to the projected needs for related
                                                                        19                         stockpiling and replenishment of the Strategic
                                                                        20                         National Stockpile, including by addressing the
                                                                        21                         needs of pediatric populations with respect to
                                                                        22                         such countermeasures and products in the Stra-
                                                                        23                         tegic National Stockpile, including—
                                      




                                                                                    •HR 307 RS

                                                                                                                               17
                                                                          1                                        ‘‘(i) a list of such countermeasures
                                                                          2                                 and products necessary to address the
                                                                          3                                 needs of pediatric populations;
                                                                          4                                        ‘‘(ii) a description of measures taken
                                                                          5                                 to coordinate with the Office of Pediatric
                                                                          6                                 Therapeutics of the Food and Drug Ad-
                                                                          7                                 ministration to maximize the labeling, dos-
                                                                          8                                 ages, and formulations of such counter-
                                                                          9                                 measures and products for pediatric popu-
                                                                        10                                  lations;
                                                                        11                                         ‘‘(iii) a description of existing gaps in
                                                                        12                                  the Strategic National Stockpile and the
                                                                        13                                  development of such countermeasures and
                                                                        14                                  products to address the needs of pediatric
                                                                        15                                  populations; and
                                                                        16                                         ‘‘(iv) an evaluation of the progress
                                                                        17                                  made in addressing priorities identified
                                                                        18                                  pursuant to subparagraph (C);
                                                                        19                                  ‘‘(J) identify the use of authority and ac-
                                                                        20                         tivities undertaken pursuant to sections 319F–
                                                                        21                         1(b)(1), 319F–1(b)(2), 319F–1(b)(3), 319F–
                                                                        22                         1(c),           319F–1(d),                     319F–1(e),             319F–
                                                                        23                         2(c)(7)(C)(iii), 319F–2(c)(7)(C)(iv), and 319F–
                                      



                                                                        24                         2(c)(7)(C)(v) of this Act, and subsections
                                                                        25                         (a)(1), (b)(1), and (e) of section 564 of the


                                                                                    •HR 307 RS

                                                                                                                               18
                                                                          1                        Federal Food, Drug, and Cosmetic Act, by
                                                                          2                        summarizing—
                                                                          3                                        ‘‘(i) the particular actions that were
                                                                          4                                 taken under the authorities specified, in-
                                                                          5                                 cluding, as applicable, the identification of
                                                                          6                                 the threat agent, emergency, or the bio-
                                                                          7                                 medical countermeasure with respect to
                                                                          8                                 which the authority was used;
                                                                          9                                        ‘‘(ii) the reasons underlying the deci-
                                                                        10                                  sion to use such authorities, including, as
                                                                        11                                  applicable, the options that were consid-
                                                                        12                                  ered and rejected with respect to the use of
                                                                        13                                  such authorities;
                                                                        14                                         ‘‘(iii) the number of, nature of, and
                                                                        15                                  other information concerning the persons
                                                                        16                                  and entities that received a grant, coopera-
                                                                        17                                  tive agreement, or contract pursuant to the
                                                                        18                                  use of such authorities, and the persons
                                                                        19                                  and entities that were considered and re-
                                                                        20                                  jected for such a grant, cooperative agree-
                                                                        21                                  ment, or contract, except that the report
                                                                        22                                  need not disclose the identity of any such
                                                                        23                                  person or entity;
                                      




                                                                        24                                         ‘‘(iv) whether, with respect to each
                                                                        25                                  procurement that is approved by the Presi-


                                                                                    •HR 307 RS

                                                                                                                               19
                                                                          1                                 dent under section 319F–2(c)(6), a con-
                                                                          2                                 tract was entered into within one year
                                                                          3                                 after such approval by the President; and
                                                                          4                                        ‘‘(v) with respect to section 319F–
                                                                          5                                 1(d), for the one-year period for which the
                                                                          6                                 report is submitted, the number of persons
                                                                          7                                 who were paid amounts totaling $100,000
                                                                          8                                 or greater and the number of persons who
                                                                          9                                 were        paid        amounts             totaling         at   least
                                                                        10                                  $50,000 but less than $100,000; and
                                                                        11                                  ‘‘(K) be made publicly available.
                                                                        12                         ‘‘(3) GAO            REPORT.—

                                                                        13                                  ‘‘(A) IN       GENERAL.—Not                    later than 1 year
                                                                        14                         after the date of the submission to the Congress
                                                                        15                         of the first Public Health Emergency Medical
                                                                        16                         Countermeasures Enterprise Strategy and Im-
                                                                        17                         plementation Plan, the Comptroller General of
                                                                        18                         the United States shall conduct an independent
                                                                        19                         evaluation, and submit to the appropriate com-
                                                                        20                         mittees of Congress a report, concerning such
                                                                        21                         Strategy and Implementation Plan.
                                                                        22                                  ‘‘(B) CONTENT.—The report described in
                                                                        23                         subparagraph (A) shall review and assess—
                                      




                                                                        24                                         ‘‘(i) the near-term, mid-term, and
                                                                        25                                  long-term medical countermeasure needs


                                                                                    •HR 307 RS

                                                                                                                               20
                                                                          1                                 and identified priorities of the Federal
                                                                          2                                 Government pursuant to paragraph (2)(C);
                                                                          3                                        ‘‘(ii) the activities of the Department
                                                                          4                                 of Health and Human Services with re-
                                                                          5                                 spect to advanced research and develop-
                                                                          6                                 ment pursuant to section 319L; and
                                                                          7                                        ‘‘(iii) the progress made toward meet-
                                                                          8                                 ing the timelines, allocations, benchmarks,
                                                                          9                                 and milestones identified in the Public
                                                                        10                                  Health           Emergency                 Medical           Counter-
                                                                        11                                  measures Enterprise Strategy and Imple-
                                                                        12                                  mentation Plan under this subsection.
                                                                        13               ‘‘(e) PROTECTION                  OF      NATIONAL SECURITY.—In car-
                                                                        14 rying out subsections (b)(7) and (d), the Secretary shall
                                                                        15 ensure that information and items that could compromise
                                                                        16 national security, contain confidential commercial infor-
                                                                        17 mation, or contain proprietary information are not dis-
                                                                        18 closed.’’.
                                                                        19               (b) INTERAGENCY COORDINATION PLAN.—In the
                                                                        20 first Public Health Emergency Countermeasures Enter-
                                                                        21 prise Strategy and Implementation Plan submitted under
                                                                        22 subsection (d) of section 2811 of the Public Health Service
                                                                        23 Act (42 U.S.C. 300hh–10) (as added by subsection
                                      




                                                                        24 (a)(3)), the Secretary of Health and Human Services, in
                                                                        25 consultation with the Secretary of Defense, shall include


                                                                                    •HR 307 RS

                                                                                                                               21
                                                                          1 a description of the manner in which the Department of
                                                                          2 Health and Human Services is coordinating with the De-
                                                                          3 partment of Defense regarding countermeasure activities
                                                                          4 to address chemical, biological, radiological, and nuclear
                                                                          5 threats. Such report shall include information with respect
                                                                          6 to—
                                                                          7                        (1) the research, advanced research, develop-
                                                                          8              ment, procurement, stockpiling, and distribution of
                                                                          9              countermeasures to meet identified needs; and
                                                                        10                         (2) the coordination of efforts between the De-
                                                                        11               partment of Health and Human Services and the
                                                                        12               Department of Defense to address countermeasure
                                                                        13               needs for various segments of the population.
                                                                        14      SEC. 103. NATIONAL ADVISORY COMMITTEE ON CHILDREN
                                                                        15                              AND DISASTERS.
                                                                        16               Subtitle B of title XXVIII of the Public Health Serv-
                                                                        17 ice Act (42 U.S.C. 300hh et seq.) is amended by inserting
                                                                        18 after section 2811 the following:
                                                                        19      ‘‘SEC. 2811A. NATIONAL ADVISORY COMMITTEE ON CHIL-
                                                                        20                              DREN AND DISASTERS.
                                                                        21               ‘‘(a) ESTABLISHMENT.—The Secretary, in consulta-
                                                                        22 tion with the Secretary of Homeland Security, shall estab-
                                                                        23 lish an advisory committee to be known as the ‘National
                                      



                                                                        24 Advisory Committee on Children and Disasters’ (referred
                                                                        25 to in this section as the ‘Advisory Committee’).


                                                                                    •HR 307 RS

                                                                                                                               22
                                                                          1              ‘‘(b) DUTIES.—The Advisory Committee shall—
                                                                          2                        ‘‘(1) provide advice and consultation with re-
                                                                          3              spect to the activities carried out pursuant to section
                                                                          4              2814, as applicable and appropriate;
                                                                          5                        ‘‘(2) evaluate and provide input with respect to
                                                                          6              the medical and public health needs of children as
                                                                          7              they relate to preparation for, response to, and re-
                                                                          8              covery from all-hazards emergencies; and
                                                                          9                        ‘‘(3) provide advice and consultation with re-
                                                                        10               spect to State emergency preparedness and response
                                                                        11               activities and children, including related drills and
                                                                        12               exercises pursuant to the preparedness goals under
                                                                        13               section 2802(b).
                                                                        14               ‘‘(c) ADDITIONAL DUTIES.—The Advisory Committee
                                                                        15 may provide advice and recommendations to the Secretary
                                                                        16 with respect to children and the medical and public health
                                                                        17 grants and cooperative agreements as applicable to pre-
                                                                        18 paredness and response activities authorized under this
                                                                        19 title and title III.
                                                                        20               ‘‘(d) MEMBERSHIP.—
                                                                        21                         ‘‘(1) IN      GENERAL.—The                     Secretary, in consulta-
                                                                        22               tion with such other Secretaries as may be appro-
                                                                        23               priate, shall appoint not to exceed 15 members to
                                      



                                                                        24               the Advisory Committee. In appointing such mem-
                                                                        25               bers, the Secretary shall ensure that the total mem-


                                                                                    •HR 307 RS

                                                                                                                               23
                                                                          1              bership of the Advisory Committee is an odd num-
                                                                          2              ber.
                                                                          3                        ‘‘(2) REQUIRED                  MEMBERS.—The                    Secretary, in
                                                                          4              consultation with such other Secretaries as may be
                                                                          5              appropriate, may appoint to the Advisory Committee
                                                                          6              under paragraph (1) such individuals as may be ap-
                                                                          7              propriate to perform the duties described in sub-
                                                                          8              sections (b) and (c), which may include—
                                                                          9                                 ‘‘(A) the Assistant Secretary for Prepared-
                                                                        10                         ness and Response;
                                                                        11                                  ‘‘(B) the Director of the Biomedical Ad-
                                                                        12                         vanced Research and Development Authority;
                                                                        13                                  ‘‘(C) the Director of the Centers for Dis-
                                                                        14                         ease Control and Prevention;
                                                                        15                                  ‘‘(D) the Commissioner of Food and
                                                                        16                         Drugs;
                                                                        17                                  ‘‘(E) the Director of the National Insti-
                                                                        18                         tutes of Health;
                                                                        19                                  ‘‘(F) the Assistant Secretary of the Admin-
                                                                        20                         istration for Children and Families;
                                                                        21                                  ‘‘(G) the Administrator of the Federal
                                                                        22                         Emergency Management Agency;
                                                                        23                                  ‘‘(H) at least two non-Federal health care
                                      



                                                                        24                         professionals with expertise in pediatric medical
                                                                                    •HR 307 RS

                                                                                                                               24
                                                                          1                        disaster planning, preparedness, response, or
                                                                          2                        recovery;
                                                                          3                                 ‘‘(I) at least two representatives from
                                                                          4                        State, local, territorial, or tribal agencies with
                                                                          5                        expertise in pediatric disaster planning, pre-
                                                                          6                        paredness, response, or recovery; and
                                                                          7                                 ‘‘(J) representatives from such Federal
                                                                          8                        agencies (such as the Department of Education
                                                                          9                        and the Department of Homeland Security) as
                                                                        10                         determined necessary to fulfill the duties of the
                                                                        11                         Advisory Committee, as established under sub-
                                                                        12                         sections (b) and (c).
                                                                        13               ‘‘(e) MEETINGS.—The Advisory Committee shall
                                                                        14 meet not less than biannually.
                                                                        15               ‘‘(f) SUNSET.—The Advisory Committee shall termi-
                                                                        16 nate on the date that is 5 years after the date of enact-
                                                                        17 ment of the Pandemic and All-Hazards Preparedness Re-
                                                                        18 authorization Act of 2013.’’.
                                                                        19      SEC. 104. MODERNIZATION OF THE NATIONAL DISASTER
                                                                        20                              MEDICAL SYSTEM.
                                                                        21               Section 2812 of the Public Health Service Act (42
                                                                        22 U.S.C. 300hh–11) is amended—
                                                                        23                         (1) in subsection (a)(3)—
                                      




                                                                        24                                  (A) in subparagraph (A), in clause (i) by
                                                                        25                         inserting ‘‘, including at-risk individuals as ap-


                                                                                    •HR 307 RS

                                                                                                                               25
                                                                          1                        plicable’’ after ‘‘victims of a public health emer-
                                                                          2                        gency’’;
                                                                          3                                 (B) by redesignating subparagraph (C) as
                                                                          4                        subparagraph (E); and
                                                                          5                                 (C) by inserting after subparagraph (B),
                                                                          6                        the following:
                                                                          7                                 ‘‘(C) CONSIDERATIONS                       FOR AT-RISK POPU-
                                                                          8                        LATIONS.—The                    Secretary shall take steps to
                                                                          9                        ensure that an appropriate specialized and fo-
                                                                        10                         cused range of public health and medical capa-
                                                                        11                         bilities are represented in the National Disaster
                                                                        12                         Medical System, which take into account the
                                                                        13                         needs of at-risk individuals, in the event of a
                                                                        14                         public health emergency.’’.
                                                                        15                                  ‘‘(D)        ADMINISTRATION.—The                             Secretary
                                                                        16                         may determine and pay claims for reimburse-
                                                                        17                         ment for services under subparagraph (A) di-
                                                                        18                         rectly or through contracts that provide for
                                                                        19                         payment in advance or by way of reimburse-
                                                                        20                         ment.’’; and
                                                                        21                         (2) in subsection (g), by striking ‘‘such sums as
                                                                        22               may be necessary for each of the fiscal years 2007
                                                                        23               through 2011’’ and inserting ‘‘$52,700,000 for each
                                      



                                                                        24               of fiscal years 2013 through 2017’’.
                                                                                    •HR 307 RS

                                                                                                                               26
                                                                          1     SEC. 105. CONTINUING THE ROLE OF THE DEPARTMENT OF
                                                                          2                             VETERANS AFFAIRS.
                                                                          3              Section 8117(g) of title 38, United States Code, is
                                                                          4 amended by striking ‘‘such sums as may be necessary to
                                                                          5 carry out this section for each of fiscal years 2007 through
                                                                          6 2011’’ and inserting ‘‘$155,300,000 for each of fiscal
                                                                          7 years 2013 through 2017 to carry out this section’’.
                                                                          8     TITLE II—OPTIMIZING STATE
                                                                          9        AND LOCAL ALL-HAZARDS
                                                                        10         PREPAREDNESS   AND RE-
                                                                        11         SPONSE
                                                                        12      SEC. 201. TEMPORARY REDEPLOYMENT OF FEDERALLY
                                                                        13                              FUNDED             PERSONNEL                 DURING              A   PUBLIC
                                                                        14                              HEALTH EMERGENCY.
                                                                        15               Section 319 of the Public Health Service Act (42
                                                                        16 U.S.C. 247d) is amended by adding at the end the fol-
                                                                        17 lowing:
                                                                        18               ‘‘(e) TEMPORARY REDEPLOYMENT                                        OF     FEDERALLY
                                                                        19 FUNDED PERSONNEL DURING                                        A    PUBLIC HEALTH EMER-
                                                                        20      GENCY.—

                                                                        21                         ‘‘(1) EMERGENCY                    REDEPLOYMENT OF FEDER-
                                                                        22               ALLY FUNDED PERSONNEL.—Notwithstanding                                                 any
                                                                        23               other provision of law, and subject to paragraph (2),
                                                                        24               upon request by the Governor of a State or the chief
                                      



                                                                        25               of a tribe or such Governor or chief’s designee, the
                                                                        26               Secretary may authorize the requesting State or
                                                                                    •HR 307 RS

                                                                                                                               27
                                                                          1              tribe to temporarily redeploy, for purposes of imme-
                                                                          2              diately addressing a public health emergency in the
                                                                          3              State or tribe, non-Federal personnel funded in
                                                                          4              whole or in part through, as appropriate, programs
                                                                          5              under this Act.
                                                                          6                        ‘‘(2) ACTIVATION                   OF EMERGENCY REDEPLOY-
                                                                          7              MENT.—
                                                                          8                                 ‘‘(A) PUBLIC              HEALTH EMERGENCY.—The
                                                                          9                        Secretary may authorize a temporary redeploy-
                                                                        10                         ment of personnel under paragraph (1) only
                                                                        11                         during the period of a public health emergency
                                                                        12                         determined pursuant to subsection (a).
                                                                        13                                  ‘‘(B) CONTENTS                     OF REQUEST.—To            seek
                                                                        14                         authority for a temporary redeployment of per-
                                                                        15                         sonnel under paragraph (1), the Governor of a
                                                                        16                         State or the chief of a tribe shall submit to the
                                                                        17                         Secretary a request for such authority and shall
                                                                        18                         include in the request each of the following:
                                                                        19                                          ‘‘(i) An assurance that the public
                                                                        20                                  health emergency in the geographic area of
                                                                        21                                  the requesting State or tribe cannot be
                                                                        22                                  adequately and appropriately addressed by
                                                                        23                                  the public health workforce otherwise avail-
                                      



                                                                        24                                  able.
                                                                                    •HR 307 RS

                                                                                                                               28
                                                                          1                                        ‘‘(ii) An assurance that the public
                                                                          2                                 health emergency would be addressed more
                                                                          3                                 efficiently and effectively through the re-
                                                                          4                                 quested temporary redeployment of per-
                                                                          5                                 sonnel.
                                                                          6                                        ‘‘(iii) An assurance that the requested
                                                                          7                                 temporary redeployment of personnel is
                                                                          8                                 consistent with any applicable All-Hazards
                                                                          9                                 Public Health Emergency Preparedness
                                                                        10                                  and Response Plan under section 319C–1.
                                                                        11                                         ‘‘(iv) An identification of—
                                                                        12                                                   ‘‘(I) each Federal program from
                                                                        13                                         which personnel would be temporarily
                                                                        14                                         redeployed pursuant to the requested
                                                                        15                                         authority; and
                                                                        16                                                   ‘‘(II) the number of personnel
                                                                        17                                         who would be so redeployed from each
                                                                        18                                         such program.
                                                                        19                                         ‘‘(v) Such other information and as-
                                                                        20                                  surances as the Secretary may require.
                                                                        21                                  ‘‘(C) CONSIDERATION.—In reviewing a re-
                                                                        22                         quest for temporary redeployment under para-
                                                                        23                         graph (1) of personnel funded through a Fed-
                                      



                                                                        24                         eral program, the Secretary shall consider the
                                                                                    •HR 307 RS

                                                                                                                               29
                                                                          1                        degree to which the program would be adversely
                                                                          2                        affected by the redeployment.
                                                                          3                                 ‘‘(D) TERMINATION                    AND EXTENSION.—

                                                                          4                                        ‘‘(i)           TERMINATION.—A                        State   or
                                                                          5                                 tribe’s authority for a temporary redeploy-
                                                                          6                                 ment of personnel under paragraph (1)
                                                                          7                                 shall terminate upon the earlier of the fol-
                                                                          8                                 lowing:
                                                                          9                                                  ‘‘(I) The Secretary’s determina-
                                                                        10                                         tion that the public health emergency
                                                                        11                                         no longer exists.
                                                                        12                                                   ‘‘(II) Subject to clause (ii), the
                                                                        13                                         expiration of the 30-day period fol-
                                                                        14                                         lowing the date on which the Sec-
                                                                        15                                         retary approved the State or tribe’s
                                                                        16                                         request for such authority.
                                                                        17                                         ‘‘(ii) EXTENSION                      AUTHORITY.—The
                                                                        18                                  Secretary may extend the authority to au-
                                                                        19                                  thorize a temporary redeployment of per-
                                                                        20                                  sonnel under paragraph (1) beyond the
                                                                        21                                  date otherwise applicable under clause
                                                                        22                                  (i)(II) if the public health emergency still
                                                                        23                                  exists as of such date, but only if—
                                      




                                                                        24                                                   ‘‘(I) the State or tribe that sub-
                                                                        25                                         mitted the initial request for authority


                                                                                    •HR 307 RS

                                                                                                                               30
                                                                          1                                        for a temporary redeployment of per-
                                                                          2                                        sonnel submits a request for an exten-
                                                                          3                                        sion of such authority; and
                                                                          4                                                  ‘‘(II) the request for an extension
                                                                          5                                        contains the same type of information
                                                                          6                                        and assurances necessary for the ap-
                                                                          7                                        proval of an initial request for such
                                                                          8                                        authority.
                                                                          9                        ‘‘(3) NOTICE              TO PERSONNEL OF POSSIBILITY
                                                                        10               OF REDEPLOYMENT.—The                                   Secretary shall ensure
                                                                        11               that, if a State or tribe receives Federal funds for
                                                                        12               personnel who are subject to the Secretary’s rede-
                                                                        13               ployment authority under this subsection, the State
                                                                        14               or tribe gives notice to such personnel of the possi-
                                                                        15               bility of redeployment—
                                                                        16                                  ‘‘(A) at the time of hiring; or
                                                                        17                                  ‘‘(B) in the case of personnel hired before
                                                                        18                         the date of the enactment of this subsection, as
                                                                        19                         soon as practicable.
                                                                        20                         ‘‘(4) NOTICE               TO CONGRESS.—The                           Secretary
                                                                        21               shall give notice to the Congress in conjunction with
                                                                        22               the approval under this subsection of—
                                                                        23                                  ‘‘(A) any initial request for authority for a
                                      



                                                                        24                         temporary redeployment of personnel; and
                                                                                    •HR 307 RS

                                                                                                                               31
                                                                          1                                 ‘‘(B) any request for an extension of such
                                                                          2                        authority.
                                                                          3                        ‘‘(5) GUIDANCE.—The Secretary shall—
                                                                          4                                 ‘‘(A) not later than 6 months after the en-
                                                                          5                        actment of this subsection, issue proposed guid-
                                                                          6                        ance on the temporary redeployment of per-
                                                                          7                        sonnel under this subsection; and
                                                                          8                                 ‘‘(B) after providing notice and a 60-day
                                                                          9                        period for public comment, finalize such guid-
                                                                        10                         ance.
                                                                        11                         ‘‘(6) REPORT             TO CONGRESS.—Not                        later than 4
                                                                        12               years after the date of enactment of the Pandemic
                                                                        13               and All-Hazards Preparedness Reauthorization Act
                                                                        14               of 2013, the Comptroller General of the United
                                                                        15               States shall conduct an independent evaluation, and
                                                                        16               submit to the appropriate committees of the Con-
                                                                        17               gress a report, on the Secretary’s authority under
                                                                        18               this subsection, including—
                                                                        19                                  ‘‘(A) a description of how, and under what
                                                                        20                         circumstances, such authority has been used by
                                                                        21                         States and tribes;
                                                                        22                                  ‘‘(B) an analysis of how such authority has
                                                                        23                         assisted States and tribes in responding to pub-
                                      



                                                                        24                         lic health emergencies;
                                                                                    •HR 307 RS

                                                                                                                               32
                                                                          1                                 ‘‘(C) an evaluation of how such authority
                                                                          2                        has improved operational efficiencies in re-
                                                                          3                        sponding to public health emergencies;
                                                                          4                                 ‘‘(D) an analysis of the extent to which, if
                                                                          5                        any, Federal programs from which personnel
                                                                          6                        have been temporarily redeployed pursuant to
                                                                          7                        such authority have been adversely affected by
                                                                          8                        the redeployment; and
                                                                          9                                 ‘‘(E) recommendations on how such au-
                                                                        10                         thority could be improved to further assist in
                                                                        11                         responding to public health emergencies.
                                                                        12                         ‘‘(7) DEFINITION.—In this subsection, the term
                                                                        13               ‘State’ includes, in addition to the entities listed in
                                                                        14               the definition of such term in section 2, the Freely
                                                                        15               Associated States.
                                                                        16                         ‘‘(8) SUNSET.—The authority under this sub-
                                                                        17               section shall terminate on the date that is 5 years
                                                                        18               after the date of enactment of the Pandemic and
                                                                        19               All-Hazards Preparedness Reauthorization Act of
                                                                        20               2013.’’.
                                                                        21      SEC. 202. IMPROVING STATE AND LOCAL PUBLIC HEALTH
                                                                        22                              SECURITY.
                                                                        23               (a) COOPERATIVE AGREEMENTS.—Section 319C–1
                                      



                                                                        24 of the Public Health Service Act (42 U.S.C. 247d–3a) is
                                                                        25 amended—


                                                                                    •HR 307 RS

                                                                                                                               33
                                                                          1                        (1) in subsection (b)(1)(C), by striking ‘‘consor-
                                                                          2              tium of entities described in subparagraph (A)’’ and
                                                                          3              inserting ‘‘consortium of States’’;
                                                                          4                        (2) in subsection (b)(2)—
                                                                          5                                 (A) in subparagraph (A)—
                                                                          6                                        (i) by striking clauses (i) and (ii) and
                                                                          7                                 inserting the following:
                                                                          8                                        ‘‘(i) a description of the activities such
                                                                          9                                 entity will carry out under the agreement
                                                                        10                                  to meet the goals identified under section
                                                                        11                                  2802, including with respect to chemical,
                                                                        12                                  biological, radiological, or nuclear threats,
                                                                        13                                  whether naturally occurring, unintentional,
                                                                        14                                  or deliberate;
                                                                        15                                         ‘‘(ii) a description of the activities
                                                                        16                                  such entity will carry out with respect to
                                                                        17                                  pandemic influenza, as a component of the
                                                                        18                                  activities carried out under clause (i), and
                                                                        19                                  consistent with the requirements of para-
                                                                        20                                  graphs (2) and (5) of subsection (g);’’;
                                                                        21                                         (ii) in clause (iv), by striking ‘‘and’’ at
                                                                        22                                  the end; and
                                                                        23                                         (iii) by adding at the end the fol-
                                      



                                                                        24                                  lowing:
                                                                                    •HR 307 RS

                                                                                                                               34
                                                                          1                                        ‘‘(vi) a description of how, as appro-
                                                                          2                                 priate, the entity may partner with rel-
                                                                          3                                 evant public and private stakeholders in
                                                                          4                                 public health emergency preparedness and
                                                                          5                                 response;
                                                                          6                                        ‘‘(vii) a description of how the entity,
                                                                          7                                 as applicable and appropriate, will coordi-
                                                                          8                                 nate with State emergency preparedness
                                                                          9                                 and response plans in public health emer-
                                                                        10                                  gency preparedness, including State edu-
                                                                        11                                  cational agencies (as defined in section
                                                                        12                                  9101(41) of the Elementary and Sec-
                                                                        13                                  ondary Education Act of 1965) and State
                                                                        14                                  child care lead agencies (designated under
                                                                        15                                  section 658D of the Child Care and Devel-
                                                                        16                                  opment Block Grant Act of 1990);
                                                                        17                                         ‘‘(viii) in the case of entities that op-
                                                                        18                                  erate on the United States-Mexico border
                                                                        19                                  or the United States-Canada border, a de-
                                                                        20                                  scription of the activities such entity will
                                                                        21                                  carry out under the agreement that are
                                                                        22                                  specific to the border area including dis-
                                                                        23                                  ease detection, identification, investigation,
                                      



                                                                        24                                  and preparedness and response activities
                                                                        25                                  related to emerging diseases and infectious


                                                                                    •HR 307 RS

                                                                                                                               35
                                                                          1                                 disease outbreaks whether naturally occur-
                                                                          2                                 ring or due to bioterrorism, consistent with
                                                                          3                                 the requirements of this section; and
                                                                          4                                        ‘‘(ix) a description of any activities
                                                                          5                                 that such entity will use to analyze real-
                                                                          6                                 time clinical specimens for pathogens of
                                                                          7                                 public health or bioterrorism significance,
                                                                          8                                 including any utilization of poison control
                                                                          9                                 centers;’’; and
                                                                        10                                  (B) in subparagraph (C), by inserting ‘‘,
                                                                        11                         including addressing the needs of at-risk indi-
                                                                        12                         viduals,’’ after ‘‘capabilities of such entity’’;
                                                                        13                         (3) in subsection (f)—
                                                                        14                                  (A) in paragraph (2), by adding ‘‘and’’ at
                                                                        15                         the end;
                                                                        16                                  (B) in paragraph (3), by striking ‘‘; and’’
                                                                        17                         and inserting a period; and
                                                                        18                                  (C) by striking paragraph (4);
                                                                        19                         (4) in subsection (g)—
                                                                        20                                  (A) in paragraph (1), by striking subpara-
                                                                        21                         graph (A) and inserting the following:
                                                                        22                                  ‘‘(A) include outcome goals representing
                                                                        23                         operational achievements of the National Pre-
                                      



                                                                        24                         paredness             Goals          developed             under      section
                                                                        25                         2802(b) with respect to all-hazards, including


                                                                                    •HR 307 RS

                                                                                                                               36
                                                                          1                        chemical, biological, radiological, or nuclear
                                                                          2                        threats; and’’; and
                                                                          3                                 (B) in paragraph (2)(A), by adding at the
                                                                          4                        end the following: ‘‘The Secretary shall periodi-
                                                                          5                        cally update, as necessary and appropriate,
                                                                          6                        such pandemic influenza plan criteria and shall
                                                                          7                        require the integration of such criteria into the
                                                                          8                        benchmarks and standards described in para-
                                                                          9                        graph (1).’’;
                                                                        10                         (5) by striking subsection (h);
                                                                        11                         (6) in subsection (i)—
                                                                        12                                  (A) in paragraph (1)—
                                                                        13                                         (i) in subparagraph (A)—
                                                                        14                                                   (I) by striking ‘‘$824,000,000 for
                                                                        15                                         fiscal            year           2007,            of   which
                                                                        16                                         $35,000,000 shall be used to carry
                                                                        17                                         out subsection (h),’’ and inserting
                                                                        18                                         ‘‘$641,900,000 for fiscal year 2013’’;
                                                                        19                                         and
                                                                        20                                                   (II) by striking ‘‘such sums as
                                                                        21                                         may be necessary for each of fiscal
                                                                        22                                         years 2008 through 2011’’ and insert-
                                                                        23                                         ing ‘‘$641,900,000 for each of fiscal
                                      



                                                                        24                                         years 2014 through 2017’’;
                                                                        25                                         (ii) by striking subparagraph (B);


                                                                                    •HR 307 RS

                                                                                                                               37
                                                                          1                                        (iii) by redesignating subparagraphs
                                                                          2                                 (C) and (D) as subparagraphs (B) and
                                                                          3                                 (C), respectively; and
                                                                          4                                        (iv) in subparagraph (C), as so redes-
                                                                          5                                 ignated, by striking ‘‘subparagraph (C)’’
                                                                          6                                 and inserting ‘‘subparagraph (B)’’;
                                                                          7                                 (B) in subparagraphs (C) and (D) of para-
                                                                          8                        graph (3), by striking ‘‘(1)(A)(i)(I)’’ each place
                                                                          9                        it appears and inserting ‘‘(1)(A)’’;
                                                                        10                                  (C) in paragraph (4)(B), by striking ‘‘sub-
                                                                        11                         section (c)’’ and inserting ‘‘subsection (b)’’; and
                                                                        12                                  (D) by adding at the end the following:
                                                                        13                         ‘‘(7) AVAILABILITY                    OF COOPERATIVE AGREE-
                                                                        14               MENT FUNDS.—
                                                                        15                                  ‘‘(A) IN        GENERAL.—Amounts                         provided to
                                                                        16                         an eligible entity under a cooperative agreement
                                                                        17                         under subsection (a) for a fiscal year and re-
                                                                        18                         maining unobligated at the end of such year
                                                                        19                         shall remain available to such entity for the
                                                                        20                         next fiscal year for the purposes for which such
                                                                        21                         funds were provided.
                                                                        22                                  ‘‘(B) FUNDS              CONTINGENT ON ACHIEVING
                                                                        23                         BENCHMARKS.—The                         continued availability of
                                      



                                                                        24                         funds under subparagraph (A) with respect to
                                                                        25                         an entity shall be contingent upon such entity


                                                                                    •HR 307 RS

                                                                                                                               38
                                                                          1                        achieving the benchmarks and submitting the
                                                                          2                        pandemic influenza plan as described in sub-
                                                                          3                        section (g).’’; and
                                                                          4                        (7) in subsection (j), by striking paragraph (3).
                                                                          5              (b) VACCINE TRACKING                            AND       DISTRIBUTION.—Sec-
                                                                          6 tion 319A(e) of the Public Health Service Act (42 U.S.C.
                                                                          7 247d–1(e)) is amended by striking ‘‘such sums for each
                                                                          8 of fiscal years 2007 through 2011’’ and inserting
                                                                          9 ‘‘$30,800,000 for each of fiscal years 2013 through
                                                                        10 2017’’.
                                                                        11      SEC. 203. HOSPITAL PREPAREDNESS AND MEDICAL SURGE
                                                                        12                              CAPACITY.
                                                                        13               (a) ALL-HAZARDS PUBLIC HEALTH                                            AND    MEDICAL
                                                                        14 RESPONSE                         CURRICULA                  AND            TRAINING.—Section
                                                                        15 319F(a)(5)(B) of the Public Health Service Act (42
                                                                        16 U.S.C. 247d–6(a)(5)(B)) is amended by striking ‘‘public
                                                                        17 health or medical’’ and inserting ‘‘public health, medical,
                                                                        18 or dental’’.
                                                                        19               (b) ENCOURAGING HEALTH PROFESSIONAL VOLUN-
                                                                        20      TEERS.—

                                                                        21                         (1) EMERGENCY                    SYSTEM FOR ADVANCE REG-
                                                                        22               ISTRATION                OF        VOLUNTEER                  HEALTH            PROFES-
                                                                        23               SIONALS.—Section                     319I(k) of the Public Health
                                      



                                                                        24               Service Act (42 U.S.C. 247d–7b(k)) is amended by
                                                                        25               striking ‘‘$2,000,000 for fiscal year 2002, and such


                                                                                    •HR 307 RS

                                                                                                                               39
                                                                          1              sums as may be necessary for each of the fiscal
                                                                          2              years          2003            through                2011’’          and       inserting
                                                                          3              ‘‘$5,000,000 for each of fiscal years 2013 through
                                                                          4              2017’’.
                                                                          5                        (2) VOLUNTEERS.—Section 2813 of the Public
                                                                          6              Health Service Act (42 U.S.C. 300hh–15) is amend-
                                                                          7              ed—
                                                                          8                                 (A) in subsection (d)(2), by adding at the
                                                                          9                        end the following: ‘‘Such training exercises
                                                                        10                         shall, as appropriate and applicable, incorporate
                                                                        11                         the needs of at-risk individuals in the event of
                                                                        12                         a public health emergency.’’; and
                                                                        13                                  (B)         in     subsection               (i),       by     striking
                                                                        14                         ‘‘$22,000,000 for fiscal year 2007, and such
                                                                        15                         sums as may be necessary for each of fiscal
                                                                        16                         years 2008 through 2011’’ and inserting
                                                                        17                         ‘‘$11,200,000 for each of fiscal years 2013
                                                                        18                         through 2017’’.
                                                                        19               (c) PARTNERSHIPS                    FOR      STATE         AND      REGIONAL PRE-
                                                                        20      PAREDNESS                   TO IMPROVE SURGE CAPACITY.—Section
                                                                        21 319C–2 of the Public Health Service Act (42 U.S.C.
                                                                        22 247d–3b) is amended—
                                                                        23                         (1) in subsection (a), by inserting ‘‘, including
                                      



                                                                        24               capacity and preparedness to address the needs of
                                                                                    •HR 307 RS

                                                                                                                               40
                                                                          1              pediatric and other at-risk populations’’ before the
                                                                          2              period at the end;
                                                                          3                        (2) in subsection (b)(1)(A)(ii), by striking ‘‘cen-
                                                                          4              ters, primary’’ and inserting ‘‘centers, community
                                                                          5              health centers, primary’’;
                                                                          6                        (3) by striking subsection (c) and inserting the
                                                                          7              following:
                                                                          8              ‘‘(c) USE           OF    FUNDS.—An award under subsection
                                                                          9 (a) shall be expended for activities to achieve the prepared-
                                                                        10 ness goals described under paragraphs (1), (3), (4), (5),
                                                                        11 and (6) of section 2802(b) with respect to all-hazards, in-
                                                                        12 cluding chemical, biological, radiological, or nuclear
                                                                        13 threats.’’;
                                                                        14                         (4) by striking subsection (g) and inserting the
                                                                        15               following:
                                                                        16               ‘‘(g) COORDINATION.—
                                                                        17                         ‘‘(1) LOCAL            RESPONSE CAPABILITIES.—An                      eli-
                                                                        18               gible entity shall, to the extent practicable, ensure
                                                                        19               that activities carried out under an award under
                                                                        20               subsection (a) are coordinated with activities of rel-
                                                                        21               evant local Metropolitan Medical Response Systems,
                                                                        22               local Medical Reserve Corps, the local Cities Readi-
                                                                        23               ness Initiative, and local emergency plans.
                                      




                                                                        24                         ‘‘(2)       NATIONAL                COLLABORATION.—Partner-
                                                                        25               ships consisting of one or more eligible entities
                                                                                    •HR 307 RS

                                                                                                                               41
                                                                          1              under this section may, to the extent practicable,
                                                                          2              collaborate with other partnerships consisting of one
                                                                          3              or more eligible entities under this section for pur-
                                                                          4              poses of national coordination and collaboration with
                                                                          5              respect to activities to achieve the preparedness
                                                                          6              goals described under paragraphs (1), (3), (4), (5),
                                                                          7              and (6) of section 2802(b).’’;
                                                                          8                        (5) in subsection (i)—
                                                                          9                                 (A) by striking ‘‘The requirements of’’ and
                                                                        10                         inserting the following:
                                                                        11                         ‘‘(1) IN       GENERAL.—The                    requirements of’’; and
                                                                        12                                  (B) by adding at the end the following:
                                                                        13                         ‘‘(2) MEETING                   GOALS OF NATIONAL HEALTH
                                                                        14               SECURITY STRATEGY.—The                                  Secretary shall imple-
                                                                        15               ment objective, evidence-based metrics to ensure that
                                                                        16               entities receiving awards under this section are
                                                                        17               meeting, to the extent practicable, the applicable
                                                                        18               goals of the National Health Security Strategy
                                                                        19               under section 2802.’’; and
                                                                        20                         (6) in subsection (j)—
                                                                        21                                  (A) by amending paragraph (1) to read as
                                                                        22                         follows:
                                                                        23                         ‘‘(1) IN        GENERAL.—For                     purposes of carrying
                                      



                                                                        24               out this section, there is authorized to be appro-
                                                                                    •HR 307 RS

                                                                                                                               42
                                                                          1              priated $374,700,000 for each of fiscal years 2013
                                                                          2              through 2017.’’; and
                                                                          3                                 (B) by adding at the end the following:
                                                                          4                        ‘‘(4) AVAILABILITY                    OF COOPERATIVE AGREE-
                                                                          5              MENT FUNDS.—
                                                                          6                                 ‘‘(A) IN        GENERAL.—Amounts                         provided to
                                                                          7                        an eligible entity under a cooperative agreement
                                                                          8                        under subsection (a) for a fiscal year and re-
                                                                          9                        maining unobligated at the end of such year
                                                                        10                         shall remain available to such entity for the
                                                                        11                         next fiscal year for the purposes for which such
                                                                        12                         funds were provided.
                                                                        13                                  ‘‘(B) FUNDS              CONTINGENT ON ACHIEVING
                                                                        14                         BENCHMARKS.—The                         continued availability of
                                                                        15                         funds under subparagraph (A) with respect to
                                                                        16                         an entity shall be contingent upon such entity
                                                                        17                         achieving the benchmarks and submitting the
                                                                        18                         pandemic influenza plan as required under sub-
                                                                        19                         section (i).’’.
                                                                        20      SEC. 204. ENHANCING SITUATIONAL AWARENESS AND BIO-
                                                                        21                              SURVEILLANCE.
                                                                        22               Section 319D of the Public Health Service Act (42
                                                                        23 U.S.C. 247d–4) is amended—
                                      




                                                                        24                         (1) in subsection (b)—




                                                                                    •HR 307 RS

                                                                                                                               43
                                                                          1                                 (A) in paragraph (1)(B), by inserting ‘‘poi-
                                                                          2                        son control centers,’’ after ‘‘hospitals,’’;
                                                                          3                                 (B) in paragraph (2), by inserting before
                                                                          4                        the period at the end the following: ‘‘, allowing
                                                                          5                        for coordination to maximize all-hazards med-
                                                                          6                        ical and public health preparedness and re-
                                                                          7                        sponse and to minimize duplication of effort’’;
                                                                          8                        and
                                                                          9                                 (C) in paragraph (3), by inserting before
                                                                        10                         the period at the end the following: ‘‘and up-
                                                                        11                         date such standards as necessary’’;
                                                                        12                         (2) by striking subsection (c); and
                                                                        13                         (3) in subsection (d)—
                                                                        14                                  (A) in the subsection heading, by striking
                                                                        15                         ‘‘PUBLIC HEALTH SITUATIONAL AWARENESS’’
                                                                        16                         and inserting ‘‘MODERNIZING PUBLIC HEALTH
                                                                        17                         SITUATIONAL AWARENESS                                AND        BIOSURVEIL-
                                                                        18                         LANCE’’;

                                                                        19                                  (B) in paragraph (1)—
                                                                        20                                         (i) by striking ‘‘Pandemic and All-
                                                                        21                                  Hazards Preparedness Act’’ and inserting
                                                                        22                                  ‘‘Pandemic and All-Hazards Preparedness
                                                                        23                                  Reauthorization Act of 2013’’; and
                                      




                                                                        24                                         (ii) by inserting ‘‘, novel emerging
                                                                        25                                  threats,’’ after ‘‘disease outbreaks’’;


                                                                                    •HR 307 RS

                                                                                                                               44
                                                                          1                                 (C) by striking paragraph (2) and insert-
                                                                          2                        ing the following:
                                                                          3                        ‘‘(2)         STRATEGY                  AND            IMPLEMENTATION
                                                                          4              PLAN.—Not               later than 180 days after the date of
                                                                          5              enactment of the Pandemic and All-Hazards Pre-
                                                                          6              paredness Reauthorization Act of 2013, the Sec-
                                                                          7              retary shall submit to the appropriate committees of
                                                                          8              Congress a coordinated strategy and an accom-
                                                                          9              panying implementation plan that identifies and
                                                                        10               demonstrates the measurable steps the Secretary will
                                                                        11               carry out to—
                                                                        12                                  ‘‘(A) develop, implement, and evaluate the
                                                                        13                         network described in paragraph (1), utilizing
                                                                        14                         the elements described in paragraph (3);
                                                                        15                                  ‘‘(B) modernize and enhance biosurveil-
                                                                        16                         lance activities; and
                                                                        17                                  ‘‘(C) improve information sharing, coordi-
                                                                        18                         nation, and communication among disparate
                                                                        19                         biosurveillance systems supported by the De-
                                                                        20                         partment of Health and Human Services.’’;
                                                                        21                                  (D) in paragraph (3)(D), by inserting
                                                                        22                         ‘‘community health centers, health centers’’
                                                                        23                         after ‘‘poison control,’’;
                                      




                                                                        24                                  (E) in paragraph (5), by striking subpara-
                                                                        25                         graph (A) and inserting the following:


                                                                                    •HR 307 RS

                                                                                                                               45
                                                                          1                                 ‘‘(A)       utilize         applicable                interoperability
                                                                          2                        standards as determined by the Secretary, and
                                                                          3                        in consultation with the Office of the National
                                                                          4                        Coordinator for Health Information Tech-
                                                                          5                        nology, through a joint public and private sec-
                                                                          6                        tor process;’’; and
                                                                          7                                 (F) by adding at the end the following:
                                                                          8                        ‘‘(6) CONSULTATION                     WITH THE NATIONAL BIO-
                                                                          9              DEFENSE SCIENCE BOARD.—In                                       carrying out this
                                                                        10               section and consistent with section 319M, the Na-
                                                                        11               tional Biodefense Science Board shall provide expert
                                                                        12               advice and guidance, including recommendations, re-
                                                                        13               garding the measurable steps the Secretary should
                                                                        14               take to modernize and enhance biosurveillance activi-
                                                                        15               ties pursuant to the efforts of the Department of
                                                                        16               Health and Human Services to ensure comprehen-
                                                                        17               sive, real-time, all-hazards biosurveillance capabili-
                                                                        18               ties. In complying with the preceding sentence, the
                                                                        19               National Biodefense Science Board shall—
                                                                        20                                  ‘‘(A) identify the steps necessary to achieve
                                                                        21                         a national biosurveillance system for human
                                                                        22                         health, with international connectivity, where
                                                                        23                         appropriate, that is predicated on State, re-
                                      



                                                                        24                         gional, and community level capabilities and
                                                                        25                         creates a networked system to allow for two-


                                                                                    •HR 307 RS

                                                                                                                               46
                                                                          1                        way information flow between and among Fed-
                                                                          2                        eral, State, and local government public health
                                                                          3                        authorities and clinical health care providers;
                                                                          4                                 ‘‘(B) identify any duplicative surveillance
                                                                          5                        programs under the authority of the Secretary,
                                                                          6                        or changes that are necessary to existing pro-
                                                                          7                        grams, in order to enhance and modernize such
                                                                          8                        activities, minimize duplication, strengthen and
                                                                          9                        streamline such activities under the authority of
                                                                        10                         the Secretary, and achieve real-time and appro-
                                                                        11                         priate data that relate to disease activity, both
                                                                        12                         human and zoonotic; and
                                                                        13                                  ‘‘(C) coordinate with applicable existing
                                                                        14                         advisory committees of the Director of the Cen-
                                                                        15                         ters for Disease Control and Prevention, includ-
                                                                        16                         ing such advisory committees consisting of rep-
                                                                        17                         resentatives from State, local, and tribal public
                                                                        18                         health authorities and appropriate public and
                                                                        19                         private sector health care entities and academic
                                                                        20                         institutions, in order to provide guidance on
                                                                        21                         public health surveillance activities.’’;
                                                                        22                         (4) in subsection (e)(5), by striking ‘‘4 years
                                                                        23               after the date of enactment of the Pandemic and
                                      



                                                                        24               All-Hazards Preparedness Act’’ and inserting ‘‘3
                                                                        25               years after the date of enactment of the Pandemic


                                                                                    •HR 307 RS

                                                                                                                               47
                                                                          1              and All-Hazards Preparedness Reauthorization Act
                                                                          2              of 2013’’;
                                                                          3                        (5) in subsection (g), by striking ‘‘such sums as
                                                                          4              may be necessary in each of fiscal years 2007
                                                                          5              through 2011’’ and inserting ‘‘$138,300,000 for
                                                                          6              each of fiscal years 2013 through 2017’’; and
                                                                          7                        (6) by adding at the end the following:
                                                                          8              ‘‘(h) DEFINITION.—For purposes of this section the
                                                                          9 term ‘biosurveillance’ means the process of gathering near
                                                                        10 real-time biological data that relates to human and
                                                                        11 zoonotic disease activity and threats to human or animal
                                                                        12 health, in order to achieve early warning and identification
                                                                        13 of such health threats, early detection and prompt ongoing
                                                                        14 tracking of health events, and overall situational aware-
                                                                        15 ness of disease activity.’’.
                                                                        16      SEC. 205. ELIMINATING DUPLICATIVE PROJECT BIOSHIELD
                                                                        17                              REPORTS.
                                                                        18               Section 5 of the Project Bioshield Act of 2004 (42
                                                                        19 U.S.C. 247d–6c) is repealed.
                                                                        20      TITLE III—ENHANCING MEDICAL
                                                                        21        COUNTERMEASURE REVIEW
                                                                        22      SEC. 301. SPECIAL PROTOCOL ASSESSMENT.
                                                                        23               Section 505(b)(5)(B) of the Federal Food, Drug, and
                                      



                                                                        24 Cosmetic Act (21 U.S.C. 355(b)(5)(B)) is amended by
                                                                        25 striking ‘‘size of clinical trials intended’’ and all that fol-


                                                                                    •HR 307 RS

                                                                                                                               48
                                                                          1 lows through ‘‘. The sponsor or applicant’’ and inserting
                                                                          2 the following: ‘‘size—
                                                                          3                        ‘‘(i)(I) of clinical trials intended to form the
                                                                          4              primary basis of an effectiveness claim; or
                                                                          5                        ‘‘(II) in the case where human efficacy studies
                                                                          6              are not ethical or feasible, of animal and any associ-
                                                                          7              ated clinical trials which, in combination, are in-
                                                                          8              tended to form the primary basis of an effectiveness
                                                                        109              claim; or ‘‘(ii) with respect to an application for approval
                                                                        11               of a biological product under section 351(k) of the
                                                                        12               Public Health Service Act, of any necessary clinical
                                                                        13               study or studies.
                                                                        14 The sponsor or applicant’’.
                                                                        15      SEC. 302. AUTHORIZATION FOR MEDICAL PRODUCTS FOR
                                                                        16                              USE IN EMERGENCIES.
                                                                        17               (a) IN GENERAL.—Section 564 of the Federal Food,
                                                                        18 Drug, and Cosmetic Act (21 U.S.C. 360bbb–3) is amend-
                                                                        19 ed—
                                                                        20                         (1) in subsection (a)—
                                                                        21                                  (A) in paragraph (1), by striking ‘‘sections
                                                                        22                         505, 510(k), and 515 of this Act’’ and inserting
                                                                        23                         ‘‘any provision of this Act’’;
                                      




                                                                        24                                  (B) in paragraph (2)(A), by striking
                                                                        25                         ‘‘under a provision of law referred to in such


                                                                                    •HR 307 RS

                                                                                                                               49
                                                                          1                        paragraph’’ and inserting ‘‘under section 505,
                                                                          2                        510(k), or 515 of this Act or section 351 of the
                                                                          3                        Public Health Service Act’’; and
                                                                          4                                 (C) in paragraph (3), by striking ‘‘a provi-
                                                                          5                        sion of law referred to in such paragraph’’ and
                                                                          6                        inserting ‘‘a section of this Act or the Public
                                                                          7                        Health Service Act referred to in paragraph
                                                                          8                        (2)(A)’’;
                                                                          9                        (2) in subsection (b)—
                                                                        10                                  (A) in the subsection heading, by striking
                                                                        11                         ‘‘EMERGENCY’’ and inserting ‘‘EMERGENCY                               OR
                                                                        12                         THREAT JUSTIFYING EMERGENCY AUTHOR-
                                                                        13                         IZED      USE’’;
                                                                        14                                  (B) in paragraph (1)—
                                                                        15                                         (i) in the matter preceding subpara-
                                                                        16                                  graph (A), by striking ‘‘may declare an
                                                                        17                                  emergency’’ and inserting ‘‘may make a
                                                                        18                                  declaration that the circumstances exist’’;
                                                                        19                                         (ii) in subparagraph (A), by striking
                                                                        20                                  ‘‘specified’’;
                                                                        21                                         (iii) in subparagraph (B)—
                                                                        22                                                   (I) by striking ‘‘specified’’; and
                                                                        23                                                   (II) by striking ‘‘; or’’ and insert-
                                      



                                                                        24                                         ing a semicolon;
                                                                                    •HR 307 RS

                                                                                                                               50
                                                                          1                                        (iv) by amending subparagraph (C) to
                                                                          2                                 read as follows:
                                                                          3                                 ‘‘(C) a determination by the Secretary that
                                                                          4                        there is a public health emergency, or a signifi-
                                                                          5                        cant potential for a public health emergency,
                                                                          6                        that affects, or has a significant potential to af-
                                                                          7                        fect, national security or the health and security
                                                                          8                        of United States citizens living abroad, and that
                                                                          9                        involves a biological, chemical, radiological, or
                                                                        10                         nuclear agent or agents, or a disease or condi-
                                                                        11                         tion that may be attributable to such agent or
                                                                        12                         agents; or’’; and
                                                                        13                                         (v) by adding at the end the following:
                                                                        14                                  ‘‘(D) the identification of a material threat
                                                                        15                         pursuant to section 319F–2 of the Public
                                                                        16                         Health Service Act sufficient to affect national
                                                                        17                         security or the health and security of United
                                                                        18                         States citizens living abroad.’’;
                                                                        19                                  (C) in paragraph (2)—
                                                                        20                                         (i) in subparagraph (A), by amending
                                                                        21                                  clause (ii) to read as follows:
                                                                        22                                         ‘‘(ii) a change in the approval status
                                                                        23                                  of the product such that the circumstances
                                      



                                                                        24                                  described in subsection (a)(2) have ceased
                                                                        25                                  to exist.’’;


                                                                                    •HR 307 RS

                                                                                                                               51
                                                                          1                                        (ii) by striking subparagraph (B); and
                                                                          2                                        (iii) by redesignating subparagraph
                                                                          3                                 (C) as subparagraph (B);
                                                                          4                                 (D) in paragraph (4), by striking ‘‘advance
                                                                          5                        notice of termination, and renewal under this
                                                                          6                        subsection.’’ and inserting ‘‘, and advance no-
                                                                          7                        tice of termination under this subsection.’’; and
                                                                          8                                 (E) by adding at the end the following:
                                                                          9                        ‘‘(5) EXPLANATION                    BY SECRETARY.—If                 an au-
                                                                        10               thorization under this section with respect to an un-
                                                                        11               approved product or an unapproved use of an ap-
                                                                        12               proved product has been in effect for more than 1
                                                                        13               year, the Secretary shall provide in writing to the
                                                                        14               sponsor of such product an explanation of the sci-
                                                                        15               entific, regulatory, or other obstacles to approval, li-
                                                                        16               censure, or clearance of such product or use, includ-
                                                                        17               ing specific actions to be taken by the Secretary and
                                                                        18               the sponsor to overcome such obstacles.’’;
                                                                        19                         (3) in subsection (c)—
                                                                        20                                  (A) in the matter preceding paragraph
                                                                        21                         (1)—
                                                                        22                                         (i) by inserting ‘‘the Assistant Sec-
                                                                        23                                  retary for Preparedness and Response,’’
                                      



                                                                        24                                  after ‘‘consultation with’’;
                                                                                    •HR 307 RS

                                                                                                                               52
                                                                          1                                        (ii) by striking ‘‘Health and’’ and in-
                                                                          2                                 serting ‘‘Health, and’’; and
                                                                          3                                        (iii) by striking ‘‘circumstances of the
                                                                          4                                 emergency involved’’ and inserting ‘‘appli-
                                                                          5                                 cable circumstances described in subsection
                                                                          6                                 (b)(1)’’;
                                                                          7                                 (B) in paragraph (1), by striking ‘‘speci-
                                                                          8                        fied’’ and inserting ‘‘referred to’’; and
                                                                          9                                 (C) in paragraph (2)(B), by inserting ‘‘,
                                                                        10                         taking into consideration the material threat
                                                                        11                         posed by the agent or agents identified in a dec-
                                                                        12                         laration under subsection (b)(1)(D), if applica-
                                                                        13                         ble’’ after ‘‘risks of the product’’;
                                                                        14                         (4) in subsection (d)(3), by inserting ‘‘, to the
                                                                        15               extent practicable given the circumstances of the
                                                                        16               emergency,’’ after ‘‘including’’;
                                                                        17                         (5) in subsection (e)—
                                                                        18                                  (A) in paragraph (1)(A), by striking ‘‘cir-
                                                                        19                         cumstances of the emergency’’ and inserting
                                                                        20                         ‘‘applicable circumstances described in sub-
                                                                        21                         section (b)(1)’’;
                                                                        22                                  (B) in paragraph (1)(B), by amending
                                                                        23                         clause (iii) to read as follows:
                                      




                                                                        24                                         ‘‘(iii) Appropriate conditions with re-
                                                                        25                                  spect to collection and analysis of informa-


                                                                                    •HR 307 RS

                                                                                                                               53
                                                                          1                                 tion concerning the safety and effectiveness
                                                                          2                                 of the product with respect to the use of
                                                                          3                                 such product during the period when the
                                                                          4                                 authorization is in effect and a reasonable
                                                                          5                                 time following such period.’’;
                                                                          6                                 (C) in paragraph (2)—
                                                                          7                                        (i) in subparagraph (A)—
                                                                          8                                                  (I) by striking ‘‘manufacturer of
                                                                          9                                        the product’’ and inserting ‘‘person’’;
                                                                        10                                                   (II) by striking ‘‘circumstances of
                                                                        11                                         the emergency’’ and inserting ‘‘appli-
                                                                        12                                         cable circumstances described in sub-
                                                                        13                                         section (b)(1)’’; and
                                                                        14                                                   (III) by inserting at the end be-
                                                                        15                                         fore the period ‘‘or in paragraph
                                                                        16                                         (1)(B)’’;
                                                                        17                                         (ii) in subparagraph (B)(i), by insert-
                                                                        18                                  ing before the period at the end ‘‘, except
                                                                        19                                  as provided in section 564A with respect to
                                                                        20                                  authorized changes to the product expira-
                                                                        21                                  tion date’’; and
                                                                        22                                         (iii) by amending subparagraph (C) to
                                                                        23                                  read as follows:
                                      




                                                                        24                                  ‘‘(C) In establishing conditions under this
                                                                        25                         paragraph with respect to the distribution and


                                                                                    •HR 307 RS

                                                                                                                               54
                                                                          1                        administration of the product for the unap-
                                                                          2                        proved use, the Secretary shall not impose con-
                                                                          3                        ditions that would restrict distribution or ad-
                                                                          4                        ministration of the product when distributed or
                                                                          5                        administered for the approved use.’’; and
                                                                          6                                 (D) by amending paragraph (3) to read as
                                                                          7                        follows:
                                                                          8                        ‘‘(3) GOOD             MANUFACTURING PRACTICE; PRE-
                                                                          9              SCRIPTION.—With                    respect to the emergency use of a
                                                                        10               product for which an authorization under this sec-
                                                                        11               tion is issued (whether an unapproved product or an
                                                                        12               unapproved use of an approved product), the Sec-
                                                                        13               retary may waive or limit, to the extent appropriate
                                                                        14               given the applicable circumstances described in sub-
                                                                        15               section (b)(1)—
                                                                        16                                  ‘‘(A) requirements regarding current good
                                                                        17                         manufacturing practice otherwise applicable to
                                                                        18                         the manufacture, processing, packing, or hold-
                                                                        19                         ing of products subject to regulation under this
                                                                        20                         Act, including such requirements established
                                                                        21                         under section 501 or 520(f)(1), and including
                                                                        22                         relevant conditions prescribed with respect to
                                                                        23                         the       product           by       an       order            under   section
                                      



                                                                        24          •HR 307 RS   520(f)(2);                  55
                                                                          1                                 ‘‘(B) requirements established under sec-
                                                                          2                        tion 503(b); and
                                                                          3                                 ‘‘(C) requirements established under sec-
                                                                          4                        tion 520(e).’’;
                                                                          5                        (6) in subsection (g)—
                                                                          6                                 (A) in the subsection heading, by inserting
                                                                          7                        ‘‘REVIEW         AND’’          before ‘‘REVOCATION’’;
                                                                          8                                 (B) in paragraph (1), by inserting after
                                                                          9                        the period at the end the following: ‘‘As part of
                                                                        10                         such review, the Secretary shall regularly review
                                                                        11                         the progress made with respect to the approval,
                                                                        12                         licensure, or clearance of—
                                                                        13                                  ‘‘(A) an unapproved product for which an
                                                                        14                         authorization was issued under this section; or
                                                                        15                                  ‘‘(B) an unapproved use of an approved
                                                                        16                         product for which an authorization was issued
                                                                        17                         under this section.’’; and
                                                                        18                                  (C) by amending paragraph (2) to read as
                                                                        19                         follows:
                                                                        20                         ‘‘(2) REVISION                  AND REVOCATION.—The                    Sec-
                                                                        21               retary may revise or revoke an authorization under
                                                                        22               this section if—
                                                                        23                                  ‘‘(A) the circumstances described under
                                      



                                                                        24                         subsection (b)(1) no longer exist;
                                                                                    •HR 307 RS

                                                                                                                               56
                                                                          1                                 ‘‘(B) the criteria under subsection (c) for
                                                                          2                        issuance of such authorization are no longer
                                                                          3                        met; or
                                                                          4                                 ‘‘(C) other circumstances make such revi-
                                                                          5                        sion or revocation appropriate to protect the
                                                                          6                        public health or safety.’’;
                                                                          7                        (7) in subsection (h)(1), by adding after the pe-
                                                                          8              riod at the end the following: ‘‘The Secretary shall
                                                                          9              make any revisions to an authorization under this
                                                                        10               section available on the Internet Web site of the
                                                                        11               Food and Drug Administration.’’;
                                                                        12                         (8) by adding at the end of subsection (j) the
                                                                        13               following:
                                                                        14                         ‘‘(4) Nothing in this section shall be construed
                                                                        15               as authorizing a delay in the review or other consid-
                                                                        16               eration by the Secretary of any application or sub-
                                                                        17               mission pending before the Food and Drug Adminis-
                                                                        18               tration for a product for which an authorization
                                                                        19               under this section is issued.’’; and
                                                                        20                         (9) by adding at the end the following:
                                                                        21               ‘‘(m) CATEGORIZATION                         OF       LABORATORY TESTS AS-
                                                                        22      SOCIATED              WITH DEVICES SUBJECT                                  TO      AUTHORIZA-
                                                                        23      TION.—
                                                                        24                         ‘‘(1) IN      GENERAL.—In                   issuing an authorization
                                                                        25               under this section with respect to a device, the Sec-


                                                                                    •HR 307 RS

                                                                                                                               57
                                                                          1              retary may, subject to the provisions of this section,
                                                                          2              determine that a laboratory examination or proce-
                                                                          3              dure associated with such device shall be deemed, for
                                                                          4              purposes of section 353 of the Public Health Service
                                                                          5              Act, to be in a particular category of examinations
                                                                          6              and procedures (including the category described by
                                                                          7              subsection (d)(3) of such section) if, based on the to-
                                                                          8              tality of scientific evidence available to the Sec-
                                                                        109              retary—          ‘‘(A) such categorization would be bene-
                                                                        11                         ficial to protecting the public health; and
                                                                        12                                  ‘‘(B) the known and potential benefits of
                                                                        13                         such categorization under the circumstances of
                                                                        14                         the authorization outweigh the known and po-
                                                                        15                         tential risks of the categorization.
                                                                        16                         ‘‘(2) CONDITIONS                     OF DETERMINATION.—The
                                                                        17               Secretary may establish appropriate conditions on
                                                                        18               the performance of the examination or procedure
                                                                        19               pursuant to such determination.
                                                                        20                         ‘‘(3) EFFECTIVE                     PERIOD.—A                  determination
                                                                        21               under this subsection shall be effective for purposes
                                                                        22               of section 353 of the Public Health Service Act not-
                                                                        23               withstanding any other provision of that section dur-
                                      



                                                                        24               ing the effective period of the relevant declaration
                                                                        25               under subsection (b).’’.


                                                                                    •HR 307 RS

                                                                          1              (b) EMERGENCY USE                     58     OF       MEDICAL PRODUCTS.—
                                                                          2 Subchapter E of chapter V of the Federal Food, Drug,
                                                                          3 and Cosmetic Act (21 U.S.C. 360bbb et seq.) is amended
                                                                          4 by inserting after section 564 the following:
                                                                          5     ‘‘SEC. 564A. EMERGENCY USE OF MEDICAL PRODUCTS.

                                                                          6              ‘‘(a) DEFINITIONS.—In this section:
                                                                          7                        ‘‘(1) ELIGIBLE                  PRODUCT.—The                   term ‘eligible
                                                                          8              product’ means a product that—
                                                                          9                                 ‘‘(A) is approved or cleared under this
                                                                        10                         chapter or licensed under section 351 of the
                                                                        11                         Public Health Service Act;
                                                                        12                                  ‘‘(B)(i) is intended for use to prevent, di-
                                                                        13                         agnose, or treat a disease or condition involving
                                                                        14                         a biological, chemical, radiological, or nuclear
                                                                        15                         agent or agents; or
                                                                        16                                  ‘‘(ii) is intended for use to prevent, diag-
                                                                        17                         nose, or treat a serious or life-threatening dis-
                                                                        18                         ease or condition caused by a product described
                                                                        19                         in clause (i); and
                                                                        20                                  ‘‘(C) is intended for use during the cir-
                                                                        21                         cumstances under which—
                                                                        22                                         ‘‘(i) a determination described in sub-
                                                                        23                                  paragraph (A), (B), or (C) of section
                                      



                                                                        24                                  564(b)(1) has been made by the Secretary
                                                                                    •HR 307 RS

                                                                                                                               59
                                                                          1                                 of Homeland Security, the Secretary of
                                                                          2                                 Defense, or the Secretary, respectively; or
                                                                          3                                        ‘‘(ii) the identification of a material
                                                                          4                                 threat described in subparagraph (D) of
                                                                          5                                 section 564(b)(1) has been made pursuant
                                                                          6                                 to section 319F–2 of the Public Health
                                                                          7                                 Service Act.
                                                                          8                        ‘‘(2) PRODUCT.—The term ‘product’ means a
                                                                          9              drug, device, or biological product.
                                                                        10               ‘‘(b) EXPIRATION DATING.—
                                                                        11                         ‘‘(1) IN       GENERAL.—The                     Secretary may extend
                                                                        12               the expiration date and authorize the introduction or
                                                                        13               delivery for introduction into interstate commerce of
                                                                        14               an eligible product after the expiration date provided
                                                                        15               by the manufacturer if—
                                                                        16                                  ‘‘(A) the expiration date extension is in-
                                                                        17                         tended to support the United States ability to
                                                                        18                         protect—
                                                                        19                                         ‘‘(i) the public health; or
                                                                        20                                         ‘‘(ii) military preparedness and effec-
                                                                        21                                  tiveness; and
                                                                        22                                  ‘‘(B) the expiration date extension is sup-
                                                                        23                         ported by an appropriate scientific evaluation
                                      



                                                                        24                         that is conducted or accepted by the Secretary.
                                                                                    •HR 307 RS

                                                                                                                               60
                                                                          1                        ‘‘(2) REQUIREMENTS                          AND CONDITIONS.—Any
                                                                          2              extension of an expiration date under paragraph (1)
                                                                          3              shall, as part of the extension, identify—
                                                                          4                                 ‘‘(A) each specific lot, batch, or other unit
                                                                          5                        of the product for which extended expiration is
                                                                          6                        authorized;
                                                                          7                                 ‘‘(B) the duration of the extension; and
                                                                          8                                 ‘‘(C) any other requirements or conditions
                                                                          9                        as the Secretary may deem appropriate for the
                                                                        10                         protection of the public health, which may in-
                                                                        11                         clude requirements for, or conditions on, prod-
                                                                        12                         uct sampling, storage, packaging or repack-
                                                                        13                         aging, transport, labeling, notice to product re-
                                                                        14                         cipients, recordkeeping, periodic testing or re-
                                                                        15                         testing, or product disposition.
                                                                        16                         ‘‘(3) EFFECT.—Notwithstanding any other pro-
                                                                        17               vision of this Act or the Public Health Service Act,
                                                                        18               an eligible product shall not be considered an unap-
                                                                        19               proved product (as defined in section 564(a)(2)(A))
                                                                        20               and shall not be deemed adulterated or misbranded
                                                                        21               under this Act because, with respect to such prod-
                                                                        22               uct, the Secretary has, under paragraph (1), ex-
                                                                        23               tended the expiration date and authorized the intro-
                                      



                                                                        24               duction or delivery for introduction into interstate
                                                                                    •HR 307 RS

                                                                                                                               61
                                                                          1              commerce of such product after the expiration date
                                                                          2              provided by the manufacturer.
                                                                          3                        ‘‘(4) EXPIRATION                  DATE.—For               purposes of this
                                                                          4              subsection, the term ‘expiration date’ means the
                                                                          5              date established through appropriate stability testing
                                                                          6              required by the regulations issued by the Secretary
                                                                          7              to ensure that the product meets applicable stand-
                                                                          8              ards of identity, strength, quality, and purity at the
                                                                          9              time of use.
                                                                        10               ‘‘(c) CURRENT GOOD MANUFACTURING PRACTICE.—
                                                                        11                         ‘‘(1) IN       GENERAL.—The                     Secretary may, when
                                                                        12               the circumstances of a domestic, military, or public
                                                                        13               health emergency or material threat described in
                                                                        14               subsection (a)(1)(C) so warrant, authorize, with re-
                                                                        15               spect to an eligible product, deviations from current
                                                                        16               good manufacturing practice requirements otherwise
                                                                        17               applicable to the manufacture, processing, packing,
                                                                        18               or holding of products subject to regulation under
                                                                        19               this Act, including requirements under section 501
                                                                        20               or 520(f)(1) or applicable conditions prescribed with
                                                                        21               respect to the eligible product by an order under sec-
                                                                        22               tion 520(f)(2).
                                                                        23                         ‘‘(2) EFFECT.—Notwithstanding any other pro-
                                      



                                                                        24               vision of this Act or the Public Health Service Act,
                                                                        25               an eligible product shall not be considered an unap-


                                                                                    •HR 307 RS

                                                                                                                               62
                                                                          1              proved product (as defined in section 564(a)(2)(A))
                                                                          2              and shall not be deemed adulterated or misbranded
                                                                          3              under this Act because, with respect to such prod-
                                                                          4              uct, the Secretary has authorized deviations from
                                                                          5              current good manufacturing practices under para-
                                                                          6              graph (1).
                                                                          7              ‘‘(d) EMERGENCY DISPENSING.—The requirements
                                                                          8 of sections 503(b) and 520(e) shall not apply to an eligible
                                                                          9 product, and the product shall not be considered an unap-
                                                                        10 proved product (as defined in section 564(a)(2)(A)) and
                                                                        11 shall not be deemed adulterated or misbranded under this
                                                                        12 Act because it is dispensed without an individual prescrip-
                                                                        13 tion, if—
                                                                        14                         ‘‘(1) the product is dispensed during the cir-
                                                                        15               cumstances described in subsection (a)(1)(C); and
                                                                        16                         ‘‘(2) such dispensing without an individual pre-
                                                                        17               scription occurs—
                                                                        18                                  ‘‘(A) as permitted under the law of the
                                                                        19                         State in which the product is dispensed; or
                                                                        20                                  ‘‘(B) in accordance with an order issued by
                                                                        21                         the Secretary, for the purposes and duration of
                                                                        22                         the       circumstances                described               in     subsection
                                                                        23                         (a)(1)(C).
                                                                        24               ‘‘(e) EMERGENCY USE INSTRUCTIONS.—




                                                                                    •HR 307 RS

                                                                                                                               63
                                                                          1                        ‘‘(1) IN             GENERAL.—The                     Secretary, acting
                                                                          2              through an appropriate official within the Depart-
                                                                          3              ment of Health and Human Services, may create
                                                                          4              and issue emergency use instructions to inform
                                                                          5              health care providers or individuals to whom an eli-
                                                                          6              gible product is to be administered concerning such
                                                                          7              product’s approved, licensed, or cleared conditions of
                                                                          8              use.
                                                                          9                        ‘‘(2) EFFECT.—Notwithstanding any other pro-
                                                                        10               visions of this Act or the Public Health Service Act,
                                                                        11               a product shall not be considered an unapproved
                                                                        12               product and shall not be deemed adulterated or mis-
                                                                        13               branded under this Act because of the issuance of
                                                                        14               emergency use instructions under paragraph (1)
                                                                        15               with respect to such product or the introduction or
                                                                        16               delivery for introduction of such product into inter-
                                                                        17               state commerce accompanied by such instructions—
                                                                        18                                  ‘‘(A) during an emergency response to an
                                                                        19                         actual emergency that is the basis for a deter-
                                                                        20                         mination described in subsection (a)(1)(C)(i); or
                                                                        21                                  ‘‘(B) by a government entity (including a
                                                                        22                         Federal, State, local, or tribal government enti-
                                                                        23                         ty), or a person acting on behalf of such a gov-
                                      



                                                                        24                         ernment entity, in preparation for an emer-
                                                                        25                         gency response.’’.


                                                                                    •HR 307 RS

                                                                          1              (c) RISK EVALUATION                   64      AND        MITIGATION STRATE-
                                                                          2     GIES.—Section                 505–1 of the Federal Food, Drug, and
                                                                          3 Cosmetic Act (21 U.S.C. 355–1), is amended—
                                                                          4                        (1) in subsection (f), by striking paragraph (7);
                                                                          5              and
                                                                          6                        (2) by adding at the end the following:
                                                                          7              ‘‘(k) WAIVER              IN    PUBLIC HEALTH EMERGENCIES.—
                                                                          8 The Secretary may waive any requirement of this section
                                                                          9 with respect to a qualified countermeasure (as defined in
                                                                        10 section 319F–1(a)(2) of the Public Health Service Act)
                                                                        11 to which a requirement under this section has been ap-
                                                                        12 plied, if the Secretary determines that such waiver is re-
                                                                        13 quired to mitigate the effects of, or reduce the severity
                                                                        14 of, the circumstances under which—
                                                                        15                         ‘‘(1) a determination described in subparagraph
                                                                        16               (A), (B), or (C) of section 564(b)(1) has been made
                                                                        17               by the Secretary of Homeland Security, the Sec-
                                                                        18               retary of Defense, or the Secretary, respectively; or
                                                                        19                         ‘‘(2) the identification of a material threat de-
                                                                        20               scribed in subparagraph (D) of section 564(b)(1)
                                                                        21               has been made pursuant to section 319F–2 of the
                                                                        22               Public Health Service Act.’’.
                                                                        23               (d) PRODUCTS HELD                          FOR        EMERGENCY USE.—The
                                      



                                                                        24 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301
                                                                                    •HR 307 RS

                                                                                                                               65
                                                                          1 et seq.) is amended by inserting after section 564A, as
                                                                          2 added by subsection (b), the following:
                                                                          3     ‘‘SEC. 564B. PRODUCTS HELD FOR EMERGENCY USE.

                                                                          4              ‘‘It is not a violation of any section of this Act or
                                                                          5 of the Public Health Service Act for a government entity
                                                                          6 (including a Federal, State, local, or tribal government en-
                                                                          7 tity), or a person acting on behalf of such a government
                                                                          8 entity, to introduce into interstate commerce a product (as
                                                                          9 defined in section 564(a)(4)) intended for emergency use,
                                                                        10 if that product—
                                                                        11                         ‘‘(1) is intended to be held and not used; and
                                                                        12                         ‘‘(2) is held and not used, unless and until that
                                                                        13               product—
                                                                        14                                  ‘‘(A) is approved, cleared, or licensed
                                                                        15                         under section 505, 510(k), or 515 of this Act
                                                                        16                         or section 351 of the Public Health Service Act;
                                                                        17                                  ‘‘(B) is authorized for investigational use
                                                                        18                         under section 505 or 520 of this Act or section
                                                                        19                         351 of the Public Health Service Act; or
                                                                        20                                  ‘‘(C) is authorized for use under section
                                                                        21                         564.’’.
                                                                        22      SEC. 303. DEFINITIONS.
                                                                        23               Section 565 of the Federal Food, Drug, and Cosmetic
                                      



                                                                        24 Act (21 U.S.C. 360bbb–4) is amended by striking ‘‘The
                                                                        25 Secretary, in consultation’’ and inserting the following:


                                                                                    •HR 307 RS

                                                                                                                               66
                                                                          1              ‘‘(a) DEFINITIONS.—In this section—
                                                                          2                        ‘‘(1) the term ‘countermeasure’ means a quali-
                                                                          3              fied countermeasure, a security countermeasure, and
                                                                          4              a qualified pandemic or epidemic product;
                                                                          5                        ‘‘(2) the term ‘qualified countermeasure’ has
                                                                          6              the meaning given such term in section 319F–1 of
                                                                          7              the Public Health Service Act;
                                                                          8                        ‘‘(3) the term ‘security countermeasure’ has the
                                                                          9              meaning given such term in section 319F–2 of such
                                                                        10               Act; and
                                                                        11                         ‘‘(4) the term ‘qualified pandemic or epidemic
                                                                        12               product’ means a product that meets the definition
                                                                        13               given such term in section 319F–3 of the Public
                                                                        14               Health Service Act and—
                                                                        15                                  ‘‘(A) that has been identified by the De-
                                                                        16                         partment of Health and Human Services or the
                                                                        17                         Department of Defense as receiving funding di-
                                                                        18                         rectly related to addressing chemical, biological,
                                                                        19                         radiological, or nuclear threats, including pan-
                                                                        20                         demic influenza; or
                                                                        21                                  ‘‘(B) is included under this paragraph pur-
                                                                        22                         suant to a determination by the Secretary.
                                                                        23               ‘‘(b) GENERAL DUTIES.—The Secretary, in consulta-
                                      



                                                                        24 tion’’.
                                                                                    •HR 307 RS

                                                                          1     SEC. 304. ENHANCING MEDICAL COUNTERMEASURE AC- 67
                                                                          2                             TIVITIES.
                                                                          3              Section 565 of the Federal Food, Drug, and Cosmetic
                                                                          4 Act (21 U.S.C. 360bbb–4), as amended by section 303,
                                                                          5 is further amended—
                                                                          6                        (1) in the section heading, by striking ‘‘TECH-
                                                                          7              NICAL ASSISTANCE’’                            and inserting ‘‘COUNTER-
                                                                          8              MEASURE DEVELOPMENT, REVIEW, AND TECH-
                                                                          9              NICAL ASSISTANCE’’;
                                                                        10                         (2) in subsection (b), by striking the subsection
                                                                        11               enumerator and all that follows through ‘‘shall es-
                                                                        12               tablish’’ and inserting the following:
                                                                        13               ‘‘(b) GENERAL DUTIES.—In order to accelerate the
                                                                        14 development, stockpiling, approval, licensure, and clear-
                                                                        15 ance of qualified countermeasures, security counter-
                                                                        16 measures, and qualified pandemic or epidemic products,
                                                                        17 the Secretary, in consultation with the Assistant Secretary
                                                                        18 for Preparedness and Response, shall—
                                                                        19                         ‘‘(1) ensure the appropriate involvement of
                                                                        20               Food and Drug Administration personnel in inter-
                                                                        21               agency activities related to countermeasure advanced
                                                                        22               research and development, consistent with sections
                                                                        23               319F, 319F–1, 319F–2, 319F–3, 319L, and 2811
                                                                        24               of the Public Health Service Act;
                                      




                                                                        25                         ‘‘(2) ensure the appropriate involvement and
                                                                        26               consultation of Food and Drug Administration per-
                                                                                    •HR 307 RS

                                                                                                                               68
                                                                          1              sonnel in any flexible manufacturing activities car-
                                                                          2              ried out under section 319L of the Public Health
                                                                          3              Service Act, including with respect to meeting regu-
                                                                          4              latory requirements set forth in this Act;
                                                                          5                        ‘‘(3) promote countermeasure expertise within
                                                                          6              the Food and Drug Administration by—
                                                                          7                                 ‘‘(A) ensuring that Food and Drug Admin-
                                                                          8                        istration personnel involved in reviewing coun-
                                                                          9                        termeasures for approval, licensure, or clear-
                                                                        10                         ance are informed by the Assistant Secretary
                                                                        11                         for Preparedness and Response on the material
                                                                        12                         threat assessment conducted under section
                                                                        13                         319F–2 of the Public Health Service Act for
                                                                        14                         the agent or agents for which the counter-
                                                                        15                         measure under review is intended;
                                                                        16                                  ‘‘(B) training Food and Drug Administra-
                                                                        17                         tion personnel regarding review of counter-
                                                                        18                         measures for approval, licensure, or clearance;
                                                                        19                                  ‘‘(C) holding public meetings at least twice
                                                                        20                         annually to encourage the exchange of scientific
                                                                        21                         ideas; and
                                                                        22                                  ‘‘(D) establishing protocols to ensure that
                                                                        23                         countermeasure reviewers have sufficient train-
                                      



                                                                        24                         ing or experience with countermeasures;
                                                                                    •HR 307 RS

                                                                                                                               69
                                                                          1                        ‘‘(4) maintain teams, composed of Food and
                                                                          2              Drug Administration personnel with expertise on
                                                                          3              countermeasures,                      including                specific         counter-
                                                                          4              measures, populations with special clinical needs (in-
                                                                          5              cluding children and pregnant women that may use
                                                                          6              countermeasures, as applicable and appropriate),
                                                                          7              classes or groups of countermeasures, or other coun-
                                                                          8              termeasure-related technologies and capabilities, that
                                                                        109              shall—           ‘‘(A) consult with countermeasure experts,
                                                                        11                         including countermeasure sponsors and appli-
                                                                        12                         cants, to identify and help resolve scientific
                                                                        13                         issues related to the approval, licensure, or
                                                                        14                         clearance of countermeasures, through work-
                                                                        15                         shops or public meetings; and
                                                                        16                                  ‘‘(B) improve and advance the science re-
                                                                        17                         lating to the development of new tools, stand-
                                                                        18                         ards, and approaches to assessing and evalu-
                                                                        19                         ating countermeasures—
                                                                        20                                         ‘‘(i) in order to inform the process for
                                                                        21                                  countermeasure approval, clearance, and li-
                                                                        22                                  censure; and
                                                                        23                                         ‘‘(ii) with respect to the development
                                      



                                                                        24                                  of countermeasures for populations with
                                                                        25                                  special clinical needs, including children


                                                                                    •HR 307 RS

                                                                                                                               70
                                                                          1                                 and pregnant women, in order to meet the
                                                                          2                                 needs of such populations, as necessary
                                                                          3                                 and appropriate; and
                                                                          4                        ‘‘(5) establish’’; and
                                                                          5                        (3) by adding at the end the following:
                                                                          6              ‘‘(c) FINAL GUIDANCE                         ON       DEVELOPMENT               OF   ANI-
                                                                          7     MAL      MODELS.—
                                                                          8                        ‘‘(1) IN      GENERAL.—Not                    later than 1 year after
                                                                          9              the date of the enactment of the Pandemic and All-
                                                                        10               Hazards Preparedness Reauthorization Act of 2013,
                                                                        11               the Secretary shall provide final guidance to indus-
                                                                        12               try regarding the development of animal models to
                                                                        13               support approval, clearance, or licensure of counter-
                                                                        14               measures referred to in subsection (a) when human
                                                                        15               efficacy studies are not ethical or feasible.
                                                                        16                         ‘‘(2) AUTHORITY                  TO EXTEND DEADLINE.—The
                                                                        17               Secretary may extend the deadline for providing
                                                                        18               final guidance under paragraph (1) by not more
                                                                        19               than 6 months upon submission by the Secretary of
                                                                        20               a report on the status of such guidance to the Com-
                                                                        21               mittee on Energy and Commerce of the House of
                                                                        22               Representatives and the Committee on Health, Edu-
                                                                        23               cation, Labor, and Pensions of the Senate.
                                      




                                                                        24               ‘‘(d) DEVELOPMENT                         AND     ANIMAL MODELING PRO-
                                                                        25      CEDURES.—



                                                                                    •HR 307 RS

                                                                          1                        ‘‘(1) AVAILABILITY      71           OF ANIMAL MODEL MEET-
                                                                          2              INGS.—To              facilitate the timely development of ani-
                                                                          3              mal models and support the development, stock-
                                                                          4              piling, licensure, approval, and clearance of counter-
                                                                          5              measures, the Secretary shall, not later than 180
                                                                          6              days after the enactment of this subsection, establish
                                                                          7              a procedure by which a sponsor or applicant that is
                                                                          8              developing a countermeasure for which human effi-
                                                                          9              cacy studies are not ethical or practicable, and that
                                                                        10               has an approved investigational new drug application
                                                                        11               or investigational device exemption, may request and
                                                                        12               receive—
                                                                        13                                  ‘‘(A) a meeting to discuss proposed animal
                                                                        14                         model development activities; and
                                                                        15                                  ‘‘(B) a meeting prior to initiating pivotal
                                                                        16                         animal studies.
                                                                        17                         ‘‘(2) PEDIATRIC                 MODELS.—To               facilitate the de-
                                                                        18               velopment and selection of animal models that could
                                                                        19               translate to pediatric studies, any meeting conducted
                                                                        20               under paragraph (1) shall include discussion of ani-
                                                                        21               mal models for pediatric populations, as appropriate.
                                                                        22               ‘‘(e)        REVIEW             AND          APPROVAL                OF         COUNTER-
                                                                        23      MEASURES.—
                                                                        24                         ‘‘(1) MATERIAL                  THREAT.—When                   evaluating an
                                                                        25               application or submission for approval, licensure, or


                                                                                    •HR 307 RS

                                                                                                                               72
                                                                          1              clearance of a countermeasure, the Secretary shall
                                                                          2              take into account the material threat posed by the
                                                                          3              chemical, biological, radiological, or nuclear agent or
                                                                          4              agents identified under section 319F–2 of the Public
                                                                          5              Health Service Act for which the countermeasure
                                                                          6              under review is intended.
                                                                          7                        ‘‘(2) REVIEW                EXPERTISE.—When                           practicable
                                                                          8              and appropriate, teams of Food and Drug Adminis-
                                                                          9              tration personnel reviewing applications or submis-
                                                                        10               sions described under paragraph (1) shall include a
                                                                        11               reviewer with sufficient training or experience with
                                                                        12               countermeasures pursuant to the protocols estab-
                                                                        13               lished under subsection (b)(3)(D).’’.
                                                                        14      SEC. 305. REGULATORY MANAGEMENT PLANS.
                                                                        15               Section 565 of the Federal Food, Drug, and Cosmetic
                                                                        16 Act (21 U.S.C. 360bbb–4), as amended by section 304,
                                                                        17 is further amended by adding at the end the following:
                                                                        18               ‘‘(f) REGULATORY MANAGEMENT PLAN.—
                                                                        19                         ‘‘(1) DEFINITION.—In this subsection, the term
                                                                        20               ‘eligible countermeasure’ means—
                                                                        21                                  ‘‘(A) a security countermeasure with re-
                                                                        22                         spect to which the Secretary has entered into a
                                                                        23                         procurement contract under section 319F–2(c)
                                      



                                                                        24                         of the Public Health Service Act; or
                                                                                    •HR 307 RS

                                                                                                                               73
                                                                          1                                 ‘‘(B) a countermeasure with respect to
                                                                          2                        which the Biomedical Advanced Research and
                                                                          3                        Development Authority has provided funding
                                                                          4                        under section 319L of the Public Health Serv-
                                                                          5                        ice Act for advanced research and development.
                                                                          6                        ‘‘(2) REGULATORY                     MANAGEMENT PLAN PROC-
                                                                          7              ESS.—The              Secretary, in consultation with the As-
                                                                          8              sistant Secretary for Preparedness and Response
                                                                          9              and the Director of the Biomedical Advanced Re-
                                                                        10               search and Development Authority, shall establish a
                                                                        11               formal process for obtaining scientific feedback and
                                                                        12               interactions regarding the development and regu-
                                                                        13               latory review of eligible countermeasures by facili-
                                                                        14               tating the development of written regulatory man-
                                                                        15               agement plans in accordance with this subsection.
                                                                        16                         ‘‘(3) SUBMISSION                  OF REQUEST AND PROPOSED
                                                                        17               PLAN BY SPONSOR OR APPLICANT.—
                                                                        18                                  ‘‘(A) IN         GENERAL.—A                  sponsor or appli-
                                                                        19                         cant of an eligible countermeasure may initiate
                                                                        20                         the process described under paragraph (2) upon
                                                                        21                         submission of a written request to the Sec-
                                                                        22                         retary. Such request shall include a proposed
                                                                        23                         regulatory management plan.
                                      




                                                                        24                                  ‘‘(B) TIMING              OF SUBMISSION.—A                   sponsor
                                                                        25                         or applicant may submit a written request


                                                                                    •HR 307 RS

                                                                                                                               74
                                                                          1                        under subparagraph (A) after the eligible coun-
                                                                          2                        termeasure has an investigational new drug or
                                                                          3                        investigational device exemption in effect.
                                                                          4                                 ‘‘(C)       RESPONSE                BY       SECRETARY.—The
                                                                          5                        Secretary shall direct the Food and Drug Ad-
                                                                          6                        ministration, upon submission of a written re-
                                                                          7                        quest by a sponsor or applicant under subpara-
                                                                          8                        graph (A), to work with the sponsor or appli-
                                                                          9                        cant to agree on a regulatory management plan
                                                                        10                         within a reasonable time not to exceed 90 days.
                                                                        11                         If the Secretary determines that no plan can be
                                                                        12                         agreed upon, the Secretary shall provide to the
                                                                        13                         sponsor or applicant, in writing, the scientific
                                                                        14                         or regulatory rationale why such agreement
                                                                        15                         cannot be reached.
                                                                        16                         ‘‘(4) PLAN.—The content of a regulatory man-
                                                                        17               agement plan agreed to by the Secretary and a spon-
                                                                        18               sor or applicant shall include—
                                                                        19                                  ‘‘(A) an agreement between the Secretary
                                                                        20                         and the sponsor or applicant regarding develop-
                                                                        21                         mental milestones that will trigger responses by
                                                                        22                         the Secretary as described in subparagraph (B);
                                                                        23                                  ‘‘(B) performance targets and goals for
                                      



                                                                        24                         timely and appropriate responses by the Sec-
                                                                        25                         retary to the triggers described under subpara-


                                                                                    •HR 307 RS

                                                                                                                               75
                                                                          1                        graph (A), including meetings between the Sec-
                                                                          2                        retary and the sponsor or applicant, written
                                                                          3                        feedback, decisions by the Secretary, and other
                                                                          4                        activities carried out as part of the development
                                                                          5                        and review process; and
                                                                          6                                 ‘‘(C) an agreement on how the plan shall
                                                                          7                        be modified, if needed.
                                                                          8                        ‘‘(5) MILESTONES                      AND        PERFORMANCE          TAR-
                                                                          9              GETS.—The                developmental milestones described in
                                                                        10               paragraph (4)(A) and the performance targets and
                                                                        11               goals described in paragraph (4)(B) shall include—
                                                                        12                                  ‘‘(A) feedback from the Secretary regard-
                                                                        13                         ing the data required to support the approval,
                                                                        14                         clearance, or licensure of the eligible counter-
                                                                        15                         measure involved;
                                                                        16                                  ‘‘(B) feedback from the Secretary regard-
                                                                        17                         ing the data necessary to inform any authoriza-
                                                                        18                         tion under section 564;
                                                                        19                                  ‘‘(C) feedback from the Secretary regard-
                                                                        20                         ing the data necessary to support the posi-
                                                                        21                         tioning and delivery of the eligible counter-
                                                                        22                         measure, including to the Strategic National
                                                                        23                         Stockpile;
                                      




                                                                        24                                  ‘‘(D) feedback from the Secretary regard-
                                                                        25                         ing the data necessary to support the submis-


                                                                                    •HR 307 RS

                                                                                                                               76
                                                                          1                        sion of protocols for review under section
                                                                          2                        505(b)(5)(B);
                                                                          3                                 ‘‘(E) feedback from the Secretary regard-
                                                                          4                        ing any gaps in scientific knowledge that will
                                                                          5                        need resolution prior to approval, licensure, or
                                                                          6                        clearance of the eligible countermeasure and
                                                                          7                        plans for conducting the necessary scientific re-
                                                                          8                        search;
                                                                          9                                 ‘‘(F) identification of the population for
                                                                        10                         which the countermeasure sponsor or applicant
                                                                        11                         seeks approval, licensure, or clearance and the
                                                                        12                         population for which desired labeling would not
                                                                        13                         be appropriate, if known; and
                                                                        14                                  ‘‘(G) as necessary and appropriate, and to
                                                                        15                         the extent practicable, a plan for demonstrating
                                                                        16                         safety and effectiveness in pediatric popu-
                                                                        17                         lations, and for developing pediatric dosing, for-
                                                                        18                         mulation, and administration with respect to
                                                                        19                         the eligible countermeasure, provided that such
                                                                        20                         plan would not delay authorization under sec-
                                                                        21                         tion 564, approval, licensure, or clearance for
                                                                        22                         adults.
                                                                        23                         ‘‘(6) PRIORITIZATION.—
                                                                        24                                  ‘‘(A) PLANS                FOR         SECURITY              COUNTER-
                                                                        25                         MEASURES.—The                    Secretary shall establish reg-
                                                                                    •HR 307 RS

                                                                                                                               77
                                                                          1                        ulatory management plans for all security coun-
                                                                          2                        termeasures for which a request is submitted
                                                                          3                        under paragraph (3)(A).
                                                                          4                                 ‘‘(B) PLANS             FOR OTHER ELIGIBLE COUN-
                                                                          5                        TERMEASURES.—The                        Secretary shall determine
                                                                          6                        whether resources are available to establish reg-
                                                                          7                        ulatory management plans for eligible counter-
                                                                          8                        measures             that        are        not       security        counter-
                                                                          9                        measures. If resources are available to establish
                                                                        10                         regulatory management plans for eligible coun-
                                                                        11                         termeasures that are not security counter-
                                                                        12                         measures, and if resources are not available to
                                                                        13                         establish regulatory management plans for all
                                                                        14                         eligible countermeasures for which requests
                                                                        15                         have been submitted, the Director of the Bio-
                                                                        16                         medical Advanced Research and Development
                                                                        17                         Authority, in consultation with the Commis-
                                                                        18                         sioner, shall prioritize which eligible counter-
                                                                        19                         measures may receive regulatory management
                                                                        20                         plans.’’.
                                                                        21      SEC. 306. REPORT.
                                                                        22               Section 565 of the Federal Food, Drug, and Cosmetic
                                                                        23 Act (21 U.S.C. 360bbb–4), as amended by section 305,
                                      



                                                                        24 is further amended by adding at the end the following:
                                                                                    •HR 307 RS

                                                                                                                               78
                                                                          1              ‘‘(g) ANNUAL REPORT.—Not later than 180 days
                                                                          2 after the date of enactment of this subsection, and annu-
                                                                          3 ally thereafter, the Secretary shall make publicly available
                                                                          4 on the Web site of the Food and Drug Administration a
                                                                          5 report that details the countermeasure development and
                                                                          6 review activities of the Food and Drug Administration, in-
                                                                          7 cluding—
                                                                          8                        ‘‘(1) with respect to the development of new
                                                                          9              tools, standards, and approaches to assess and
                                                                        10               evaluate countermeasures—
                                                                        11                                  ‘‘(A) the identification of the priorities of
                                                                        12                         the Food and Drug Administration and the
                                                                        13                         progress made on such priorities; and
                                                                        14                                  ‘‘(B) the identification of scientific gaps
                                                                        15                         that impede the development, approval, licen-
                                                                        16                         sure, or clearance of countermeasures for popu-
                                                                        17                         lations with special clinical needs, including
                                                                        18                         children and pregnant women, and the progress
                                                                        19                         made on resolving these challenges;
                                                                        20                         ‘‘(2) with respect to countermeasures for which
                                                                        21               a regulatory management plan has been agreed upon
                                                                        22               under subsection (f), the extent to which the per-
                                                                        23               formance targets and goals set forth in subsection
                                      




                                                                        24               (f)(4)(B) and the regulatory management plan have
                                                                        25               been met, including, for each such countermeasure—


                                                                                    •HR 307 RS

                                                                                                                               79
                                                                          1                                 ‘‘(A) whether the regulatory management
                                                                          2                        plan was completed within the required time-
                                                                          3                        frame, and the length of time taken to complete
                                                                          4                        such plan;
                                                                          5                                 ‘‘(B) whether the Secretary adhered to the
                                                                          6                        timely and appropriate response times set forth
                                                                          7                        in such plan; and
                                                                          8                                 ‘‘(C) explanations for any failure to meet
                                                                          9                        such performance targets and goals;
                                                                        10                         ‘‘(3) the number of regulatory teams estab-
                                                                        11               lished pursuant to subsection (b)(4), the number of
                                                                        12               products, classes of products, or technologies as-
                                                                        13               signed to each such team, and the number of, type
                                                                        14               of, and any progress made as a result of consulta-
                                                                        15               tions carried out under subsection (b)(4)(A);
                                                                        16                         ‘‘(4) an estimate of resources obligated to coun-
                                                                        17               termeasure development and regulatory assessment,
                                                                        18               including—
                                                                        19                                  ‘‘(A) Center-specific objectives and accom-
                                                                        20                         plishments; and
                                                                        21                                  ‘‘(B) the number of full-time equivalent
                                                                        22                         employees of the Food and Drug Administra-
                                                                        23                         tion who directly support the review of counter-
                                      



                                                                        24                         measures;
                                                                                    •HR 307 RS

                                                                                                                               80
                                                                          1                        ‘‘(5) the number of countermeasure applications
                                                                          2              and submissions submitted, the number of counter-
                                                                          3              measures approved, licensed, or cleared, the status
                                                                          4              of remaining submitted applications and submis-
                                                                          5              sions, and the number of each type of authorization
                                                                          6              issued pursuant to section 564;
                                                                          7                        ‘‘(6) the number of written requests for a regu-
                                                                          8              latory management plan submitted under subsection
                                                                          9              (f)(3)(A), the number of regulatory management
                                                                        10               plans developed, and the number of such plans de-
                                                                        11               veloped for security countermeasures; and
                                                                        12                         ‘‘(7) the number, type, and frequency of meet-
                                                                        13               ings between the Food and Drug Administration
                                                                        14               and—
                                                                        15                                  ‘‘(A) sponsors of a countermeasure as de-
                                                                        16                         fined in subsection (a); or
                                                                        17                                  ‘‘(B) another agency engaged in develop-
                                                                        18                         ment or management of portfolios for such
                                                                        19                         countermeasures, including the Centers for Dis-
                                                                        20                         ease Control and Prevention, the Biomedical
                                                                        21                         Advanced Research and Development Authority,
                                                                        22                         the National Institutes of Health, and the ap-
                                                                        23                         propriate agencies of the Department of De-
                                      



                                                                        24                         fense.’’.
                                                                                    •HR 307 RS

                                                                          1     SEC. 307. PEDIATRIC MEDICAL COUNTERMEASURES.   81
                                                                          2              (a) PEDIATRIC STUDIES                           OF     DRUGS.—Section 505A
                                                                          3 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
                                                                          4 355a) is amended—
                                                                          5                        (1) in subsection (d), by adding at the end the
                                                                          6              following:
                                                                          7                        ‘‘(5) CONSULTATION.—With respect to a drug
                                                                          8              that is a qualified countermeasure (as defined in sec-
                                                                          9              tion 319F–1 of the Public Health Service Act), a se-
                                                                        10               curity countermeasure (as defined in section 319F–
                                                                        11               2 of the Public Health Service Act), or a qualified
                                                                        12               pandemic or epidemic product (as defined in section
                                                                        13               319F–3 of the Public Health Service Act), the Sec-
                                                                        14               retary shall solicit input from the Assistant Sec-
                                                                        15               retary for Preparedness and Response regarding the
                                                                        16               need for and, from the Director of the Biomedical
                                                                        17               Advanced Research and Development Authority re-
                                                                        18               garding the conduct of, pediatric studies under this
                                                                        19               section.’’; and
                                                                        20                         (2) in subsection (n)(1), by adding at the end
                                                                        21               the following:
                                                                        22                                  ‘‘(C) For a drug that is a qualified coun-
                                                                        23                         termeasure (as defined in section 319F–1 of the
                                                                        24                         Public Health Service Act), a security counter-
                                      



                                                                        25                         measure (as defined in section 319F–2 of the
                                                                        26                         Public Health Service Act), or a qualified pan-
                                                                                    •HR 307 RS

                                                                                                                               82
                                                                          1                        demic or epidemic product (as defined in sec-
                                                                          2                        tion 319F–3 of such Act), in addition to any
                                                                          3                        action with respect to such drug under subpara-
                                                                          4                        graph (A) or (B), the Secretary shall notify the
                                                                          5                        Assistant Secretary for Preparedness and Re-
                                                                          6                        sponse and the Director of the Biomedical Ad-
                                                                          7                        vanced Research and Development Authority of
                                                                          8                        all pediatric studies in the written request
                                                                          9                        issued by the Commissioner of Food and
                                                                        10                         Drugs.’’.
                                                                        11               (b)       ADDITION               TO        PRIORITY             LIST            CONSIDER-
                                                                        12      ATIONS.—Section                   409I of the Public Health Service Act
                                                                        13 (42 U.S.C. 284m) is amended—
                                                                        14                         (1) by striking subsection (a)(2) and inserting
                                                                        15               the following:
                                                                        16                         ‘‘(2) CONSIDERATION                         OF AVAILABLE INFORMA-
                                                                        17               TION.—In             developing and prioritizing the list under
                                                                        18               paragraph (1), the Secretary—
                                                                        19                                  ‘‘(A) shall consider—
                                                                        20                                         ‘‘(i) therapeutic gaps in pediatrics
                                                                        21                                  that may include developmental pharma-
                                                                        22                                  cology, pharmacogenetic determinants of
                                                                        23                                  drug response, metabolism of drugs and
                                      



                                                                        24                                  biologics in children, and pediatric clinical
                                                                        25                                  trials;


                                                                                    •HR 307 RS

                                                                                                                               83
                                                                          1                                        ‘‘(ii) particular pediatric diseases, dis-
                                                                          2                                 orders or conditions where more complete
                                                                          3                                 knowledge and testing of therapeutics, in-
                                                                          4                                 cluding drugs and biologics, may be bene-
                                                                          5                                 ficial in pediatric populations; and
                                                                          6                                        ‘‘(iii) the adequacy of necessary infra-
                                                                          7                                 structure to conduct pediatric pharma-
                                                                          8                                 cological research, including research net-
                                                                          9                                 works and trained pediatric investigators;
                                                                        10                                  and
                                                                        11                                  ‘‘(B) may consider the availability of quali-
                                                                        12                         fied countermeasures (as defined in section
                                                                        13                         319F–1), security countermeasures (as defined
                                                                        14                         in section 319F–2), and qualified pandemic or
                                                                        15                         epidemic products (as defined in section 319F–
                                                                        16                         3) to address the needs of pediatric populations,
                                                                        17                         in consultation with the Assistant Secretary for
                                                                        18                         Preparedness and Response, consistent with the
                                                                        19                         purposes of this section.’’; and
                                                                        20                         (2) in subsection (b), by striking ‘‘subsection
                                                                        21               (a)’’ and inserting ‘‘paragraphs (1) and (2)(A) of
                                                                        22               subsection (a)’’.
                                                                        23               (c) ADVICE             AND      RECOMMENDATIONS                          OF THE   PEDI-
                                                                        24      ATRIC            ADVISORY COMMITTEE REGARDING COUNTER-
                                                                        25      MEASURES FOR                     PEDIATRIC POPULATIONS.—Subsection


                                                                                    •HR 307 RS

                                                                                                                               84
                                                                          1 (b)(2) of section 14 of the Best Pharmaceuticals for Chil-
                                                                          2 dren Act (42 U.S.C. 284m note) is amended—
                                                                          3                        (1) in subparagraph (C), by striking the period
                                                                          4              and inserting ‘‘; and’’; and
                                                                          5                        (2) by adding at the end the following:
                                                                          6                                 ‘‘(D) the development of countermeasures
                                                                          7                        (as defined in section 565(a) of the Federal
                                                                          8                        Food, Drug, and Cosmetic Act) for pediatric
                                                                          9                        populations.’’.
                                                                        10      TITLE IV—ACCELERATING MED-
                                                                        11         ICAL COUNTERMEASURE AD-
                                                                        12         VANCED RESEARCH AND DE-
                                                                        13         VELOPMENT
                                                                        14      SEC. 401. BIOSHIELD.

                                                                        15               (a) PROCUREMENT                           OF   COUNTERMEASURES.—Sec-
                                                                        16 tion 319F–2(c) of the Public Health Service Act (42
                                                                        17 U.S.C. 247d–6b(c)) is amended—
                                                                        18                         (1) in paragraph (1)(B)(i)(III)(bb), by striking
                                                                        19               ‘‘eight years’’ and inserting ‘‘10 years’’;
                                                                        20                         (2) in paragraph (2)(C), by striking ‘‘the des-
                                                                        21               ignated congressional committees (as defined in
                                                                        22               paragraph (10))’’ and inserting ‘‘the appropriate
                                                                        23               committees of Congress’’;
                                      




                                                                        24                         (3) in paragraph (5)(B)(ii), by striking ‘‘eight
                                                                        25               years’’ and inserting ‘‘10 years’’;


                                                                                    •HR 307 RS

                                                                                                                               85
                                                                          1                        (4) in subparagraph (C) of paragraph (6)—
                                                                          2                                 (A) in the subparagraph heading, by strik-
                                                                          3                        ing ‘‘DESIGNATED                      CONGRESSIONAL                    COMMIT-
                                                                          4                        TEES’’       and inserting ‘‘APPROPRIATE                              CONGRES-
                                                                          5                        SIONAL COMMITTEES’’;                        and
                                                                          6                                 (B) by striking ‘‘the designated congres-
                                                                          7                        sional committees’’ and inserting ‘‘the appro-
                                                                          8                        priate congressional committees’’; and
                                                                          9                        (5) in paragraph (7)(C)—
                                                                        10                                  (A) in clause (i)(I), by inserting ‘‘including
                                                                        11                         advanced research and development,’’ after ‘‘as
                                                                        12                         may reasonably be required,’’;
                                                                        13                                  (B) in clause (ii)—
                                                                        14                                         (i) in subclause (III), by striking
                                                                        15                                  ‘‘eight years’’ and inserting ‘‘10 years’’;
                                                                        16                                  and
                                                                        17                                         (ii) by striking subclause (IX) and in-
                                                                        18                                  serting the following:
                                                                        19                                                   ‘‘(IX) CONTRACT                      TERMS.—The
                                                                        20                                         Secretary, in any contract for procure-
                                                                        21                                         ment under this section—
                                                                        22                                                            ‘‘(aa) may specify—
                                                                        23                                                                     ‘‘(AA) the dosing and
                                      



                                                                        24                                                            administration requirements
                                                                                    •HR 307 RS

                                                                                                                               86
                                                                          1                                                           for the countermeasure to be
                                                                          2                                                           developed and procured;
                                                                          3                                                                    ‘‘(BB) the amount of
                                                                          4                                                           funding that will be dedi-
                                                                          5                                                           cated by the Secretary for
                                                                          6                                                           advanced research, develop-
                                                                          7                                                           ment, and procurement of
                                                                          8                                                           the countermeasure; and
                                                                          9                                                                    ‘‘(CC) the specifications
                                                                        10                                                            the        countermeasure          must
                                                                        11                                                            meet to qualify for procure-
                                                                        12                                                            ment under a contract under
                                                                        13                                                            this section; and
                                                                        14                                                            ‘‘(bb) shall provide a clear
                                                                        15                                                   statement of defined Government
                                                                        16                                                   purpose limited to uses related to
                                                                        17                                                   a security countermeasure, as de-
                                                                        18                                                   fined in paragraph (1)(B).’’; and
                                                                        19                                  (C) by adding at the end the following:
                                                                        20                                         ‘‘(viii) FLEXIBILITY.—In carrying out
                                                                        21                                  this section, the Secretary may, consistent
                                                                        22                                  with the applicable provisions of this sec-
                                                                        23                                  tion, enter into contracts and other agree-
                                      



                                                                        24                                  ments that are in the best interest of the
                                                                        25                                  Government in meeting identified security


                                                                                    •HR 307 RS

                                                                                                                               87
                                                                          1                                 countermeasure needs, including with re-
                                                                          2                                 spect to reimbursement of the cost of ad-
                                                                          3                                 vanced research and development as a rea-
                                                                          4                                 sonable, allowable, and allocable direct cost
                                                                          5                                 of the contract involved.’’.
                                                                          6              (b) REAUTHORIZATION                           OF THE           SPECIAL RESERVE
                                                                          7 FUND.—Section 319F–2 of the Public Health Service Act
                                                                          8 (42 U.S.C. 247d–6b) is amended—
                                                                          9                        (1) in subsection (c)—
                                                                        10                                  (A) by striking ‘‘special reserve fund under
                                                                        11                         paragraph (10)’’ each place it appears and in-
                                                                        12                         serting ‘‘special reserve fund as defined in sub-
                                                                        13                         section (h)’’; and
                                                                        14                                  (B) by striking paragraphs (9) and (10);
                                                                        15                         and
                                                                        16                         (2) by adding at the end the following:
                                                                        17               ‘‘(g) SPECIAL RESERVE FUND.—
                                                                        18                         ‘‘(1) AUTHORIZATION                     OF APPROPRIATIONS.—In
                                                                        19               addition to amounts appropriated to the special re-
                                                                        20               serve fund prior to the date of the enactment of this
                                                                        21               subsection, there is authorized to be appropriated,
                                                                        22               for the procurement of security countermeasures
                                                                        23               under subsection (c) and for carrying out section
                                      



                                                                        24               319L (relating to the Biomedical Advanced Research
                                                                        25               and Development Authority), $2,800,000,000 for the


                                                                                    •HR 307 RS

                                                                                                                               88
                                                                          1              period of fiscal years 2014 through 2018. Amounts
                                                                          2              appropriated pursuant to the preceding sentence are
                                                                          3              authorized to remain available until September 30,
                                                                          4              2019.
                                                                          5                        ‘‘(2) USE            OF SPECIAL RESERVE FUND FOR AD-
                                                                          6              VANCED RESEARCH AND DEVELOPMENT.—The                                                Sec-
                                                                          7              retary may utilize not more than 50 percent of the
                                                                          8              amounts authorized to be appropriated under para-
                                                                          9              graph (1) to carry out section 319L (related to the
                                                                        10               Biomedical Advanced Research and Development
                                                                        11               Authority). Amounts authorized to be appropriated
                                                                        12               under this subsection to carry out section 319L are
                                                                        13               in addition to amounts otherwise authorized to be
                                                                        14               appropriated to carry out such section.
                                                                        15                         ‘‘(3) RESTRICTIONS                          ON    USE          OF     FUNDS.—
                                                                        16               Amounts in the special reserve fund shall not be
                                                                        17               used to pay costs other than payments made by the
                                                                        18               Secretary to a vendor for advanced development
                                                                        19               (under section 319L) or for procurement of a secu-
                                                                        20               rity countermeasure under subsection (c)(7).
                                                                        21                         ‘‘(4) REPORT.—Not later than 30 days after
                                                                        22               any date on which the Secretary determines that the
                                                                        23               amount of funds in the special reserve fund available
                                      



                                                                        24               for procurement is less than $1,500,000,000, the
                                                                        25               Secretary shall submit to the appropriate committees


                                                                                    •HR 307 RS

                                                                                                                               89
                                                                          1              of Congress a report detailing the amount of such
                                                                          2              funds available for procurement and the impact such
                                                                          3              reduction in funding will have—
                                                                          4                                 ‘‘(A) in meeting the security counter-
                                                                          5                        measure needs identified under this section; and
                                                                          6                                 ‘‘(B) on the annual Public Health Emer-
                                                                          7                        gency Medical Countermeasures Enterprise and
                                                                          8                        Strategy Implementation Plan (pursuant to sec-
                                                                          9                        tion 2811(d)).
                                                                        10               ‘‘(h) DEFINITIONS.—In this section:
                                                                        11                         ‘‘(1) The term ‘advanced research and develop-
                                                                        12               ment’ has the meaning given such term in section
                                                                        13               319L(a).
                                                                        14                         ‘‘(2) The term ‘special reserve fund’ means the
                                                                        15               ‘Biodefense Countermeasures’ appropriations ac-
                                                                        16               count, any appropriation made available pursuant to
                                                                        17               section 521(a) of the Homeland Security Act of
                                                                        18               2002, and any appropriation made available pursu-
                                                                        19               ant to subsection (g)(1).’’.
                                                                        20      SEC. 402. BIOMEDICAL ADVANCED RESEARCH AND DEVEL-
                                                                        21                              OPMENT AUTHORITY.
                                                                        22               (a) DUTIES.—Section 319L(c)(4) of the Public
                                                                        23 Health Service Act (42 U.S.C. 247d–7e(c)(4)) is amend-
                                      



                                                                        24 ed—
                                                                                    •HR 307 RS

                                                                                                                               90
                                                                          1                        (1) in subparagraph (B)(iii), by inserting
                                                                          2              ‘‘(which may include advanced research and develop-
                                                                          3              ment for purposes of fulfilling requirements under
                                                                          4              the Federal Food, Drug, and Cosmetic Act or sec-
                                                                          5              tion 351 of this Act)’’ after ‘‘development’’; and
                                                                          6                        (2) in subparagraph (D)(iii), by striking ‘‘and
                                                                          7              vaccine manufacturing technologies’’ and inserting
                                                                          8              ‘‘vaccine-manufacturing technologies, dose-sparing
                                                                          9              technologies, efficacy-increasing technologies, and
                                                                        10               platform technologies’’.
                                                                        11               (b)                TRANSACTION                        AUTHORITIES.—Section
                                                                        12 319L(c)(5) of the Public Health Service Act (42 U.S.C.
                                                                        13 247d–7e(c)(5)) is amended by adding at the end the fol-
                                                                        14 lowing:
                                                                        15                                  ‘‘(G) GOVERNMENT                      PURPOSE.—In            award-
                                                                        16                         ing contracts, grants, and cooperative agree-
                                                                        17                         ments under this section, the Secretary shall
                                                                        18                         provide a clear statement of defined Govern-
                                                                        19                         ment purpose related to activities included in
                                                                        20                         subsection (a)(6)(B) for a qualified counter-
                                                                        21                         measure or qualified pandemic or epidemic
                                                                        22                         product.’’.
                                                                        23               (c) FUND.—Paragraph (2) of section 319L(d) of the
                                      



                                                                        24 Public Health Service Act (42 U.S.C. 247d–7e(d)(2)) is
                                                                        25 amended to read as follows:


                                                                                    •HR 307 RS

                                                                                                                               91
                                                                          1                        ‘‘(2) FUNDING.—To carry out the purposes of
                                                                          2              this section, there is authorized to be appropriated
                                                                          3              to the Fund $415,000,000 for each of fiscal years
                                                                          4              2013 through 2017, such amounts to remain avail-
                                                                          5              able until expended.’’.
                                                                          6              (d) CONTINUED INAPPLICABILITY                                   OF       CERTAIN PRO-
                                                                          7     VISIONS.—Section                    319L(e)(1)(C) of the Public Health
                                                                          8 Service Act (42 U.S.C. 247d–7e(e)(1)(C)) is amended by
                                                                          9 striking ‘‘7 years’’ and inserting ‘‘11 years’’.
                                                                        10               (e) EXTENSION                    OF       LIMITED ANTITRUST EXEMP-
                                                                        11      TION.—

                                                                        12                         (1) IN       GENERAL.—Section                       405(b) of the Pan-
                                                                        13               demic and All-Hazards Preparedness Act (42 U.S.C.
                                                                        14               247d–6a note) is amended by striking ‘‘6-year’’ and
                                                                        15               inserting ‘‘11-year’’.
                                                                        16                         (2) EFFECTIVE                   DATE.—This                subsection shall
                                                                        17               take effect as if enacted on December 17, 2012.
                                                                        18               (f) INDEPENDENT EVALUATION.—Section 319L of
                                                                        19 the Public Health Service Act (42 U.S.C. 247d–7e) is
                                                                        20 amended by adding at the end the following:
                                                                        21               ‘‘(f) INDEPENDENT EVALUATION.—
                                                                        22                         ‘‘(1) IN        GENERAL.—Not                     later than 180 days
                                                                        23               after the date of enactment of this subsection, the
                                      



                                                                        24               Comptroller General of the United States shall con-
                                                                        25               duct an independent evaluation of the activities car-


                                                                                    •HR 307 RS

                                                                                                                               92
                                                                          1              ried out to facilitate flexible manufacturing capacity
                                                                          2              pursuant to this section.
                                                                          3                        ‘‘(2) REPORT.—Not later than 1 year after the
                                                                          4              date of enactment of this subsection, the Comp-
                                                                          5              troller General of the United States shall submit to
                                                                          6              the appropriate committees of Congress a report
                                                                          7              concerning the results of the evaluation conducted
                                                                          8              under paragraph (1). Such report shall review and
                                                                        109              assess—          ‘‘(A) the extent to which flexible manufac-
                                                                        11                         turing capacity under this section is dedicated
                                                                        12                         to chemical, biological, radiological, and nuclear
                                                                        13                         threats;
                                                                        14                                  ‘‘(B) the activities supported by flexible
                                                                        15                         manufacturing initiatives; and
                                                                        16                                  ‘‘(C) the ability of flexible manufacturing
                                                                        17                         activities carried out under this section to—
                                                                        18                                         ‘‘(i) secure and leverage leading tech-
                                                                        19                                  nical expertise with respect to counter-
                                                                        20                                  measure advanced research, development,
                                                                        21                                  and manufacturing processes; and
                                                                        22                                         ‘‘(ii) meet the surge manufacturing
                                                                        23                                  capacity needs presented by novel and
                                      



                                                                        24                                  emerging threats, including chemical, bio-
                                                                        25                                  logical, radiological, and nuclear agents.’’.


                                                                                    •HR 307 RS

                                                                          1              (g) DEFINITIONS.—                   93
                                                                          2                        (1)      QUALIFIED                COUNTERMEASURE.—Section
                                                                          3              319F–1(a)(2)(A) of the Public Health Service Act
                                                                          4              (42 U.S.C. 247d–6a(a)(2)(A)) is amended—
                                                                          5                                 (A) in the matter preceding clause (i), by
                                                                          6                        striking ‘‘to—’’ and inserting ‘‘—’’;
                                                                          7                                 (B) in clause (i)—
                                                                          8                                        (i) by striking ‘‘diagnose’’ and insert-
                                                                          9                                 ing ‘‘to diagnose’’; and
                                                                        10                                         (ii) by striking ‘‘; or’’ and inserting a
                                                                        11                                  semicolon;
                                                                        12                                  (C) in clause (ii)—
                                                                        13                                         (i) by striking ‘‘diagnose’’ and insert-
                                                                        14                                  ing ‘‘to diagnose’’; and
                                                                        15                                         (ii) by striking the period at the end
                                                                        16                                  and inserting ‘‘; or’’; and
                                                                        17                                  (D) by adding at the end the following:
                                                                        18                                         ‘‘(iii) is a product or technology in-
                                                                        19                                  tended to enhance the use or effect of a
                                                                        20                                  drug, biological product, or device de-
                                                                        21                                  scribed in clause (i) or (ii).’’.
                                                                        22                         (2) QUALIFIED                   PANDEMIC OR EPIDEMIC PROD-
                                                                        23               UCT.—Section               319F–3(i)(7)(A) of the Public Health
                                      



                                                                        24               Service Act (42 U.S.C. 247d–6d(i)(7)(A)) is amend-
                                                                        25               ed—


                                                                                    •HR 307 RS

                                                                                                                               94
                                                                          1                                 (A) in clause (i)(II), by striking ‘‘; or’’ and
                                                                          2                        inserting ‘‘;’’;
                                                                          3                                 (B) in clause (ii), by striking ‘‘; and’’ and
                                                                          4                        inserting ‘‘; or’’; and
                                                                          5                                 (C) by adding at the end the following:
                                                                          6                                        ‘‘(iii) a product or technology intended
                                                                          7                                 to enhance the use or effect of a drug, bio-
                                                                          8                                 logical product, or device described in
                                                                          9                                 clause (i) or (ii); and’’.
                                                                        10                         (3) TECHNICAL                   AMENDMENTS.—Section                   319F–
                                                                        11               3(i) of the Public Health Service Act (42 U.S.C.
                                                                        12               247d–6d(i)) is amended—
                                                                        13                                  (A) in paragraph (1)(C), by inserting ‘‘,
                                                                        14                         564A, or 564B’’ after ‘‘564’’; and
                                                                        15                                  (B) in paragraph (7)(B)(iii), by inserting
                                                                        16                         ‘‘, 564A, or 564B’’ after ‘‘564’’.
                                                                        17      SEC. 403. STRATEGIC NATIONAL STOCKPILE.
                                                                        18               Section 319F–2 of the Public Health Service Act (42
                                                                        19 U.S.C. 247d–6b) is amended—
                                                                        20                         (1) in subsection (a)—
                                                                        21                                  (A) in paragraph (1)—
                                                                        22                                         (i) by inserting ‘‘consistent with sec-
                                                                        23                                  tion 2811’’ before ‘‘by the Secretary to be
                                      



                                                                        24                                  appropriate’’; and
                                                                                    •HR 307 RS

                                                                                                                               95
                                                                          1                                        (ii) by inserting before the period at
                                                                          2                                 the end of the second sentence the fol-
                                                                          3                                 lowing: ‘‘and shall submit such review an-
                                                                          4                                 nually to the appropriate congressional
                                                                          5                                 committees of jurisdiction to the extent
                                                                          6                                 that disclosure of such information does
                                                                          7                                 not compromise national security’’; and
                                                                          8                                 (B) in paragraph (2)(D), by inserting be-
                                                                          9                        fore the semicolon at the end the following:
                                                                        10                         ‘‘and that the potential depletion of counter-
                                                                        11                         measures currently in the stockpile is identified
                                                                        12                         and appropriately addressed, including through
                                                                        13                         necessary replenishment’’; and
                                                                        14                         (2)        in        subsection               (f)(1),          by     striking
                                                                        15               ‘‘$640,000,000 for fiscal year 2002, and such sums
                                                                        16               as may be necessary for each of fiscal years 2003
                                                                        17               through 2006. Such authorization is in addition to
                                                                        18               amounts in the special reserve fund referred to in
                                                                        19               subsection (c)(10)(A).’’ and inserting ‘‘$533,800,000
                                                                        20               for each of fiscal years 2013 through 2017. Such
                                                                        21               authorization is in addition to amounts in the special
                                                                        22               reserve fund referred to in subsection (h).’’.
                                                                        23      SEC. 404. NATIONAL BIODEFENSE SCIENCE BOARD.
                                                                        24               Section 319M(a) of the Public Health Service Act (42
                                                                        25 U.S.C. 247d–f(a)) is amended—


                                                                                    •HR 307 RS

                                                                                                                               96
                                                                          1                        (1) in paragraph (2)—
                                                                          2                                 (A) in subparagraph (D)—
                                                                          3                                        (i) in clause (i), by striking ‘‘and’’ at
                                                                          4                                 the end;
                                                                          5                                        (ii) in clause (ii), by striking the pe-
                                                                          6                                 riod and inserting a semicolon; and
                                                                          7                                        (iii) by adding at the end the fol-
                                                                          8                                 lowing:
                                                                          9                                        ‘‘(iii) one such member shall be an in-
                                                                        10                                  dividual with pediatric subject matter ex-
                                                                        11                                  pertise; and
                                                                        12                                         ‘‘(iv) one such member shall be a
                                                                        13                                  State, tribal, territorial, or local public
                                                                        14                                  health official.’’; and
                                                                        15                                  (B) by adding at the end the following
                                                                        16                         flush sentence:
                                                                        17               ‘‘Nothing in this paragraph shall preclude a member
                                                                        18               of the Board from satisfying two or more of the re-
                                                                        19               quirements described in subparagraph (D).’’; and
                                                                        20                         (2) in paragraph (5)—
                                                                        21                                  (A) in subparagraph (B), by striking
                                                                        22                         ‘‘and’’ at the end;
                                                                        23                                  (B) in subparagraph (C), by striking the
                                      



                                                                        24                         period and inserting ‘‘; and’’; and
                                                                        25                                  (C) by adding at the end the following:


                                                                                    •HR 307 RS

                                                                                                                                97
                                                                          1                                  ‘‘(D) provide any recommendation, finding,
                                                                          2                         or report provided to the Secretary under this
                                                                          3                         paragraph to the appropriate committees of
                                                                          4                         Congress.’’.
                                                                          5     SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

                                                                          6              (a) SHORT TITLE.—This Act may be cited as the
                                                                          7 ‘‘Pandemic and All-Hazards Preparedness Reauthorization
                                                                          8 Act of 2013’’.
                                                                          9              (b) TABLE OF CONTENTS.—The table of contents of this
                                                                        10 Act is as follows:
                                                                                Sec. 1. Short title; table of contents.

                                                                                       TITLE I—STRENGTHENING NATIONAL PREPAREDNESS AND
                                                                                            RESPONSE FOR PUBLIC HEALTH EMERGENCIES

                                                                                Sec.   101.      National Health Security Strategy.
                                                                                Sec.   102.      Assistant Secretary for Preparedness and Response.
                                                                                Sec.   103.      National Advisory Committee on Children and Disasters.
                                                                                Sec.   104.      Modernization of the National Disaster Medical System.
                                                                                Sec.   105.      Continuing the role of the Department of Veterans Affairs.

                                                                                         TITLE II—OPTIMIZING STATE AND LOCAL ALL-HAZARDS
                                                                                                   PREPAREDNESS AND RESPONSE

                                                                                Sec. 201. Temporary reassignment of State and local personnel during a public
                                                                                                health emergency.
                                                                                Sec. 202. Improving State and local public health security.
                                                                                Sec. 203. Hospital preparedness and medical surge capacity.
                                                                                Sec. 204. Enhancing situational awareness and biosurveillance.
                                                                                Sec. 205. Eliminating duplicative Project Bioshield reports.

                                                                                       TITLE III—ENHANCING MEDICAL COUNTERMEASURE REVIEW

                                                                                Sec.   301.      Special protocol assessment.
                                                                                Sec.   302.      Authorization for medical products for use in emergencies.
                                                                                Sec.   303.      Definitions.
                                                                                Sec.   304.      Enhancing medical countermeasure activities.
                                                                                Sec.   305.      Regulatory management plans.
                                                                                Sec.   306.      Report.
                                                                                Sec.   307.      Pediatric medical countermeasures.
                                      




                                                                                TITLE IV—ACCELERATING MEDICAL COUNTERMEASURE ADVANCED
                                                                                               RESEARCH AND DEVELOPMENT

                                                                                Sec. 401. BioShield.


                                                                                    •HR 307 RS

                                                                                                                               98
                                                                                Sec. 402. Biomedical Advanced Research and Development Authority.
                                                                                Sec. 403. Strategic National Stockpile.
                                                                                Sec. 404. National Biodefense Science Board.
                                                                          1     TITLE I—STRENGTHENING NA-
                                                                          2        TIONAL PREPAREDNESS AND
                                                                          3        RESPONSE   FOR   PUBLIC
                                                                          4        HEALTH EMERGENCIES
                                                                          5     SEC. 101. NATIONAL HEALTH SECURITY STRATEGY.

                                                                          6              (a) IN GENERAL.—Section 2802 of the Public Health
                                                                          7 Service Act (42 U.S.C. 300hh–1) is amended—
                                                                          8                        (1) in subsection (a)(1), by striking ‘‘2009’’ and
                                                                          9              inserting ‘‘2014’’; and
                                                                        10                         (2) in subsection (b)—
                                                                        11                                  (A) in paragraph (1)(A), by inserting ‘‘, in-
                                                                        12                         cluding drills and exercises to ensure medical
                                                                        13                         surge capacity for events without notice’’ after
                                                                        14                         ‘‘exercises’’; and
                                                                        15                                  (B) in paragraph (3)—
                                                                        16                                         (i) in the matter preceding subpara-
                                                                        17                                  graph (A)—
                                                                        18                                                   (I) by striking ‘‘facilities), and
                                                                        19                                         trauma care’’ and inserting ‘‘and am-
                                                                        20                                         bulatory care facilities and which may
                                                                        21                                         include dental health facilities), and
                                                                        22                                         trauma care, critical care,’’; and
                                      




                                                                        23                                                   (II) by inserting ‘‘(including re-
                                                                        24                                         lated availability, accessibility, and co-
                                                                                    •HR 307 RS

                                                                                                                               99
                                                                          1                                        ordination)’’ after ‘‘public health emer-
                                                                          2                                        gencies’’;
                                                                          3                                        (ii) in subparagraph (A), by inserting
                                                                          4                                 ‘‘and trauma’’ after ‘‘medical’’;
                                                                          5                                        (iii) in subparagraph (B), by striking
                                                                          6                                 ‘‘Medical evacuation and fatality manage-
                                                                          7                                 ment’’ and inserting ‘‘Fatality manage-
                                                                          8                                 ment’’;
                                                                          9                                        (iv) by redesignating subparagraphs
                                                                        10                                  (C), (D), and (E) as subparagraphs (D),
                                                                        11                                  (E), and (F), respectively;
                                                                        12                                         (v) by inserting after subparagraph
                                                                        13                                  (B), the following the new subparagraph:
                                                                        14                                  ‘‘(C) Coordinated medical triage and evacu-
                                                                        15                         ation to appropriate medical institutions based
                                                                        16                         on patient medical need, taking into account re-
                                                                        17                         gionalized systems of care.’’;
                                                                        18                                         (vi) in subparagraph (E), as redesig-
                                                                        19                                  nated by clause (iv), by inserting ‘‘(which
                                                                        20                                  may include such dental health assets)’’
                                                                        21                                  after ‘‘medical assets’’; and
                                                                        22                                         (vii) by adding at the end the fol-
                                                                        23                                  lowing:
                                      




                                                                        24                                  ‘‘(G) Optimizing a coordinated and flexible
                                                                        25                         approach to the medical surge capacity of hos-


                                                                                    •HR 307 RS

                                                                                                                              100
                                                                          1                        pitals, other health care facilities, critical care,
                                                                          2                        trauma care (which may include trauma cen-
                                                                          3                        ters), and emergency medical systems.’’;
                                                                          4                                 (C) in paragraph (4)—
                                                                          5                                        (i) in subparagraph (A), by inserting
                                                                          6                                 ‘‘, including the unique needs and consider-
                                                                          7                                 ations of individuals with disabilities,’’
                                                                          8                                 after ‘‘medical needs of at-risk individuals’’;
                                                                        109                                 and    (ii) in subparagraph (B), by inserting
                                                                        11                                  ‘‘the’’ before ‘‘purpose of this section’’; and
                                                                        12                                  (D) by adding at the end the following:
                                                                        13                         ‘‘(7) COUNTERMEASURES.—
                                                                        14                                  ‘‘(A) Promoting strategic initiatives to ad-
                                                                        15                         vance countermeasures to diagnose, mitigate,
                                                                        16                         prevent, or treat harm from any biological agent
                                                                        17                         or toxin, chemical, radiological, or nuclear agent
                                                                        18                         or agents, whether naturally occurring, uninten-
                                                                        19                         tional, or deliberate.
                                                                        20                                  ‘‘(B) For purposes of this paragraph, the
                                                                        21                         term ‘countermeasures’ has the same meaning as
                                                                        22                         the terms ‘qualified countermeasures’ under sec-
                                                                        23                         tion 319F–1, ‘qualified pandemic and epidemic
                                      



                                                                        24                         products’ under section 319F–3, and ‘security
                                                                        25                         countermeasures’ under section 319F–2.


                                                                                    •HR 307 RS

                                                                          1                        ‘‘(8) MEDICAL          101AND PUBLIC HEALTH COMMUNITY
                                                                          2              RESILIENCY.—Strengthening                               the ability of States,
                                                                          3              local communities, and tribal communities to prepare
                                                                          4              for, respond to, and be resilient in the event of public
                                                                          5              health emergencies, whether naturally occurring, un-
                                                                          6              intentional, or deliberate by—
                                                                          7                                 ‘‘(A) optimizing alignment and integration
                                                                          8                        of medical and public health preparedness and
                                                                          9                        response planning and capabilities with and
                                                                        10                         into routine daily activities; and
                                                                        11                                  ‘‘(B) promoting familiarity with local med-
                                                                        12                         ical and public health systems.’’.
                                                                        13               (b) AT-RISK INDIVIDUALS.—Section 2814 of the Public
                                                                        14 Health Service Act (42 U.S.C. 300hh–16) is amended—
                                                                        15                         (1) by striking paragraphs (5), (7), and (8);
                                                                        16                         (2)         in         paragraph                 (4),          by     striking
                                                                        17               ‘‘2811(b)(3)(B)’’ and inserting ‘‘2802(b)(4)(B)’’;
                                                                        18                         (3) by redesignating paragraphs (1) through (4)
                                                                        19               as paragraphs (2) through (5), respectively;
                                                                        20                         (4) by inserting before paragraph (2) (as so re-
                                                                        21               designated), the following:
                                                                        22                         ‘‘(1) monitor emerging issues and concerns as
                                                                        23               they relate to medical and public health preparedness
                                      



                                                                        24               and response for at-risk individuals in the event of a
                                                                                    •HR 307 RS

                                                                                                                              102
                                                                          1              public health emergency declared by the Secretary
                                                                          2              under section 319;’’;
                                                                          3                        (5) by amending paragraph (2) (as so redesig-
                                                                          4              nated) to read as follows:
                                                                          5                        ‘‘(2) oversee the implementation of the prepared-
                                                                          6              ness goals described in section 2802(b) with respect to
                                                                          7              the public health and medical needs of at-risk indi-
                                                                          8              viduals in the event of a public health emergency, as
                                                                          9              described in section 2802(b)(4);’’; and
                                                                        10                         (6) by inserting after paragraph (6), the fol-
                                                                        11               lowing:
                                                                        12                         ‘‘(7) disseminate and, as appropriate, update
                                                                        13               novel and best practices of outreach to and care of at-
                                                                        14               risk individuals before, during, and following public
                                                                        15               health emergencies in as timely a manner as is prac-
                                                                        16               ticable, including from the time a public health threat
                                                                        17               is identified; and
                                                                        18                         ‘‘(8) ensure that public health and medical infor-
                                                                        19               mation distributed by the Department of Health and
                                                                        20               Human Services during a public health emergency is
                                                                        21               delivered in a manner that takes into account the
                                                                        22               range of communication needs of the intended recipi-
                                                                        23               ents, including at-risk individuals.’’.
                                      




                                                                                    •HR 307 RS

                                                                                                                              103
                                                                          1     SEC. 102. ASSISTANT SECRETARY FOR PREPAREDNESS AND
                                                                          2                             RESPONSE.
                                                                          3              (a) IN GENERAL.—Section 2811 of the Public Health
                                                                          4 Service Act (42 U.S.C. 300hh–10) is amended—
                                                                          5                        (1) in subsection (b)—
                                                                          6                                 (A) in paragraph (3), by inserting ‘‘, secu-
                                                                          7                        rity countermeasures (as defined in section
                                                                          8                        319F–2),’’ after ‘‘qualified countermeasures (as
                                                                          9                        defined in section 319F–1)’’;
                                                                        10                                  (B) in paragraph (4), by adding at the end
                                                                        11                         the following:
                                                                        12                                  ‘‘(D) POLICY                COORDINATION                 AND   STRA-
                                                                        13                         TEGIC DIRECTION.—Provide                           integrated policy co-
                                                                        14                         ordination and strategic direction with respect to
                                                                        15                         all matters related to Federal public health and
                                                                        16                         medical preparedness and execution and deploy-
                                                                        17                         ment of the Federal response for public health
                                                                        18                         emergencies and incidents covered by the Na-
                                                                        19                         tional Response Plan developed pursuant to sec-
                                                                        20                         tion 504(6) of the Homeland Security Act of
                                                                        21                         2002, or any successor plan, before, during, and
                                                                        22                         following public health emergencies.
                                                                        23                                  ‘‘(E)        IDENTIFICATION                    OF        INEFFICIEN-
                                                                        24                         CIES.—Identify              and minimize gaps, duplication,
                                      



                                                                        25                         and other inefficiencies in medical and public
                                                                                    •HR 307 RS

                                                                                                                              104
                                                                          1                        health preparedness and response activities and
                                                                          2                        the actions necessary to overcome these obstacles.
                                                                          3                                 ‘‘(F)       COORDINATION                    OF        GRANTS    AND
                                                                          4                        AGREEMENTS.—Align                           and coordinate medical
                                                                          5                        and public health grants and cooperative agree-
                                                                          6                        ments as applicable to preparedness and re-
                                                                          7                        sponse activities authorized under this Act, to the
                                                                          8                        extent possible, including program requirements,
                                                                          9                        timelines, and measurable goals, and in con-
                                                                        10                         sultation with the Secretary of Homeland Secu-
                                                                        11                         rity, to—
                                                                        12                                          ‘‘(i) optimize and streamline medical
                                                                        13                                  and public health preparedness and re-
                                                                        14                                  sponse capabilities and the ability of local
                                                                        15                                  communities to respond to public health
                                                                        16                                  emergencies; and
                                                                        17                                          ‘‘(ii) gather and disseminate best prac-
                                                                        18                                  tices among grant and cooperative agree-
                                                                        19                                  ment recipients, as appropriate.
                                                                        20                                  ‘‘(G)       DRILL           AND        OPERATIONAL             EXER-
                                                                        21                         CISES.—Carry               out drills and operational exer-
                                                                        22                         cises, in consultation with the Department of
                                                                        23                         Homeland Security, the Department of Defense,
                                      



                                                                        24                         the Department of Veterans Affairs, and other
                                                                        25                         applicable Federal departments and agencies, as


                                                                                    •HR 307 RS

                                                                                                                              105
                                                                          1                        necessary and appropriate, to identify, inform,
                                                                          2                        and address gaps in and policies related to all-
                                                                          3                        hazards medical and public health preparedness
                                                                          4                        and response, including exercises based on—
                                                                          5                                        ‘‘(i) identified threats for which coun-
                                                                          6                                 termeasures are available and for which no
                                                                          7                                 countermeasures are available; and
                                                                          8                                        ‘‘(ii) unknown threats for which no
                                                                          9                                 countermeasures are available.
                                                                        10                                  ‘‘(H) NATIONAL               SECURITY PRIORITY.—On           a
                                                                        11                         periodic basis consult with, as applicable and
                                                                        12                         appropriate, the Assistant to the President for
                                                                        13                         National Security Affairs, to provide an update
                                                                        14                         on, and discuss, medical and public health pre-
                                                                        15                         paredness and response activities pursuant to
                                                                        16                         this Act and the Federal Food, Drug, and Cos-
                                                                        17                         metic Act, including progress on the develop-
                                                                        18                         ment, approval, clearance, and licensure of med-
                                                                        19                         ical countermeasures.’’; and
                                                                        20                                  (C) by adding at the end the following:
                                                                        21                         ‘‘(7) COUNTERMEASURES                             BUDGET PLAN.—De-
                                                                        22               velop, and update on an annual basis, a coordinated
                                                                        23               5-year budget plan based on the medical counter-
                                      



                                                                        24               measure priorities described in subsection (d). Each
                                                                        25               such plan shall—


                                                                                    •HR 307 RS

                                                                                                                              106
                                                                          1                                 ‘‘(A) include consideration of the entire
                                                                          2                        medical countermeasures enterprise, including—
                                                                          3                                        ‘‘(i) basic research and advanced re-
                                                                          4                                 search and development;
                                                                          5                                        ‘‘(ii) approval, clearance, licensure,
                                                                          6                                 and authorized uses of products; and
                                                                          7                                        ‘‘(iii) procurement, stockpiling, main-
                                                                          8                                 tenance, and replenishment of all products
                                                                          9                                 in the Strategic National Stockpile;
                                                                        10                                  ‘‘(B) inform prioritization of resources and
                                                                        11                         include measurable outputs and outcomes to
                                                                        12                         allow for the tracking of the progress made to-
                                                                        13                         ward identified priorities;
                                                                        14                                  ‘‘(C) identify medical countermeasure life-
                                                                        15                         cycle costs to inform planning, budgeting, and
                                                                        16                         anticipated needs within the continuum of the
                                                                        17                         medical countermeasure enterprise consistent
                                                                        18                         with section 319F–2; and
                                                                        19                                  ‘‘(D) be made available to the appropriate
                                                                        20                         committees of Congress upon request.’’;
                                                                        21                         (2) by striking subsection (c) and inserting the
                                                                        22               following:
                                                                        23               ‘‘(c) FUNCTIONS.—The Assistant Secretary for Pre-
                                      



                                                                        24 paredness and Response shall—
                                                                                    •HR 307 RS

                                                                                                                              107
                                                                          1                        ‘‘(1) have lead responsibility within the Depart-
                                                                          2              ment of Health and Human Services for emergency
                                                                          3              preparedness and response policy coordination and
                                                                          4              strategic direction;
                                                                          5                        ‘‘(2) have authority over and responsibility for—
                                                                          6                                 ‘‘(A) the National Disaster Medical System
                                                                          7                        pursuant to section 2812;
                                                                          8                                 ‘‘(B) the Hospital Preparedness Cooperative
                                                                          9                        Agreement Program pursuant to section 319C–2;
                                                                        10                                  ‘‘(C) the Biomedical Advanced Research
                                                                        11                         and Development Authority pursuant to section
                                                                        12                         319L;
                                                                        13                                  ‘‘(D) the Medical Reserve Corps pursuant to
                                                                        14                         section 2813;
                                                                        15                                  ‘‘(E) the Emergency System for Advance
                                                                        16                         Registration of Volunteer Health Professionals
                                                                        17                         pursuant to section 319I; and
                                                                        18                                  ‘‘(F) administering grants and related au-
                                                                        19                         thorities related to trauma care under parts A
                                                                        20                         through C of title XII, such authority to be
                                                                        21                         transferred by the Secretary from the Adminis-
                                                                        22                         trator of the Health Resources and Services Ad-
                                                                        23                         ministration to such Assistant Secretary;
                                      




                                                                        24                         ‘‘(3) exercise the responsibilities and authorities
                                                                        25               of the Secretary with respect to the coordination of—


                                                                                    •HR 307 RS

                                                                                                                              108
                                                                          1                                 ‘‘(A) the Public Health Emergency Pre-
                                                                          2                        paredness Cooperative Agreement Program pur-
                                                                          3                        suant to section 319C–1;
                                                                          4                                 ‘‘(B) the Strategic National Stockpile pur-
                                                                          5                        suant to section 319F–2; and
                                                                          6                                 ‘‘(C) the Cities Readiness Initiative; and
                                                                          7                        ‘‘(4) assume other duties as determined appro-
                                                                          8              priate by the Secretary.’’; and
                                                                          9                        (3) by adding at the end the following:
                                                                        10               ‘‘(d) PUBLIC HEALTH EMERGENCY MEDICAL COUN-
                                                                        11      TERMEASURES                 ENTERPRISE STRATEGY                          AND      IMPLEMENTA-
                                                                        12      TION      PLAN.—
                                                                        13                         ‘‘(1) IN        GENERAL.—Not                    later than 180 days
                                                                        14               after the date of enactment of this subsection, and
                                                                        15               every year thereafter, the Assistant Secretary for Pre-
                                                                        16               paredness and Response shall develop and submit to
                                                                        17               the appropriate committees of Congress a coordinated
                                                                        18               strategy and accompanying implementation plan for
                                                                        19               medical countermeasures to address chemical, biologi-
                                                                        20               cal, radiological, and nuclear threats. In developing
                                                                        21               such a plan, the Assistant Secretary for Preparedness
                                                                        22               and Response shall consult with the Director of the
                                                                        23               Biomedical Advanced Research and Development Au-
                                      



                                                                        24               thority, the Director of the National Institutes of
                                                                        25               Health, the Director of the Centers for Disease Control


                                                                                    •HR 307 RS

                                                                                                                              109
                                                                          1              and Prevention, and the Commissioner of Food and
                                                                          2              Drugs. Such strategy and plan shall be known as the
                                                                          3              ‘Public Health Emergency Medical Countermeasures
                                                                          4              Enterprise Strategy and Implementation Plan’.
                                                                          5                        ‘‘(2) REQUIREMENTS.—The plan under para-
                                                                          6              graph (1) shall—
                                                                          7                                 ‘‘(A) describe the chemical, biological, radio-
                                                                          8                        logical, and nuclear agent or agents that may
                                                                          9                        present a threat to the Nation and the cor-
                                                                        10                         responding efforts to develop qualified counter-
                                                                        11                         measures (as defined in section 319F–1), secu-
                                                                        12                         rity countermeasures (as defined in section
                                                                        13                         319F–2), or qualified pandemic or epidemic
                                                                        14                         products (as defined in section 319F–3) for each
                                                                        15                         threat;
                                                                        16                                  ‘‘(B) evaluate the progress of all activities
                                                                        17                         with respect to such countermeasures or prod-
                                                                        18                         ucts, including research, advanced research, de-
                                                                        19                         velopment, procurement, stockpiling, deployment,
                                                                        20                         distribution, and utilization;
                                                                        21                                  ‘‘(C) identify and prioritize near-, mid-,
                                                                        22                         and long-term needs with respect to such coun-
                                                                        23                         termeasures or products to address a chemical,
                                      



                                                                        24                         biological, radiological, and nuclear threat or
                                                                        25                         threats;


                                                                                    •HR 307 RS

                                                                                                                              110
                                                                          1                                 ‘‘(D) identify, with respect to each category
                                                                          2                        of threat, a summary of all awards and con-
                                                                          3                        tracts, including advanced research and develop-
                                                                          4                        ment and procurement, that includes—
                                                                          5                                        ‘‘(i) the time elapsed from the issuance
                                                                          6                                 of the initial solicitation or request for a
                                                                          7                                 proposal to the adjudication (such as the
                                                                          8                                 award, denial of award, or solicitation ter-
                                                                          9                                 mination); and
                                                                        10                                         ‘‘(ii) an identification of projected
                                                                        11                                  timelines, anticipated funding allocations,
                                                                        12                                  benchmarks, and milestones for each med-
                                                                        13                                  ical countermeasure priority under sub-
                                                                        14                                  paragraph (C), including projected needs
                                                                        15                                  with regard to replenishment of the Stra-
                                                                        16                                  tegic National Stockpile;
                                                                        17                                  ‘‘(E) be informed by the recommendations of
                                                                        18                         the National Biodefense Science Board pursuant
                                                                        19                         to section 319M;
                                                                        20                                  ‘‘(F) evaluate progress made in meeting
                                                                        21                         timelines, allocations, benchmarks, and mile-
                                                                        22                         stones identified under subparagraph (D)(ii);
                                                                        23                                  ‘‘(G) report on the amount of funds avail-
                                      



                                                                        24                         able for procurement in the special reserve fund
                                                                        25                         as defined in section 319F–2(h) and the impact


                                                                                    •HR 307 RS

                                                                                                                              111
                                                                          1                        this funding will have on meeting the require-
                                                                          2                        ments under section 319F–2;
                                                                          3                                 ‘‘(H) incorporate input from Federal, State,
                                                                          4                        local, and tribal stakeholders;
                                                                          5                                 ‘‘(I) identify the progress made in meeting
                                                                          6                        the medical countermeasure priorities for at-risk
                                                                          7                        individuals (as defined in 2802(b)(4)(B)), as ap-
                                                                          8                        plicable under subparagraph (C), including with
                                                                          9                        regard to the projected needs for related stock-
                                                                        10                         piling and replenishment of the Strategic Na-
                                                                        11                         tional Stockpile, including by addressing the
                                                                        12                         needs of pediatric populations with respect to
                                                                        13                         such countermeasures and products in the Stra-
                                                                        14                         tegic National Stockpile, including—
                                                                        15                                         ‘‘(i) a list of such countermeasures and
                                                                        16                                  products necessary to address the needs of
                                                                        17                                  pediatric populations;
                                                                        18                                         ‘‘(ii) a description of measures taken to
                                                                        19                                  coordinate with the Office of Pediatric
                                                                        20                                  Therapeutics of the Food and Drug Admin-
                                                                        21                                  istration to maximize the labeling, dosages,
                                                                        22                                  and formulations of such countermeasures
                                                                        23                                  and products for pediatric populations;
                                      




                                                                        24                                         ‘‘(iii) a description of existing gaps in
                                                                        25                                  the Strategic National Stockpile and the de-


                                                                                    •HR 307 RS

                                                                                                                              112
                                                                          1                                 velopment of such countermeasures and
                                                                          2                                 products to address the needs of pediatric
                                                                          3                                 populations; and
                                                                          4                                        ‘‘(iv) an evaluation of the progress
                                                                          5                                 made in addressing priorities identified
                                                                          6                                 pursuant to subparagraph (C);
                                                                          7                                 ‘‘(J) identify the use of authority and ac-
                                                                          8                        tivities undertaken pursuant to sections 319F–
                                                                          9                        1(b)(1), 319F–1(b)(2), 319F–1(b)(3), 319F–1(c),
                                                                        10                         319F–1(d),               319F–1(e),               319F–2(c)(7)(C)(iii),
                                                                        11                         319F–2(c)(7)(C)(iv), and 319F–2(c)(7)(C)(v) of
                                                                        12                         this Act, and subsections (a)(1), (b)(1), and (e)
                                                                        13                         of section 564 of the Federal Food, Drug, and
                                                                        14                         Cosmetic Act, by summarizing—
                                                                        15                                         ‘‘(i) the particular actions that were
                                                                        16                                  taken under the authorities specified, in-
                                                                        17                                  cluding, as applicable, the identification of
                                                                        18                                  the threat agent, emergency, or the bio-
                                                                        19                                  medical countermeasure with respect to
                                                                        20                                  which the authority was used;
                                                                        21                                         ‘‘(ii) the reasons underlying the deci-
                                                                        22                                  sion to use such authorities, including, as
                                                                        23                                  applicable, the options that were considered
                                      



                                                                        24                                  and rejected with respect to the use of such
                                                                        25                                  authorities;


                                                                                    •HR 307 RS

                                                                                                                              113
                                                                          1                                         ‘‘(iii) the number of, nature of, and
                                                                          2                                 other information concerning the persons
                                                                          3                                 and entities that received a grant, coopera-
                                                                          4                                 tive agreement, or contract pursuant to the
                                                                          5                                 use of such authorities, and the persons and
                                                                          6                                 entities that were considered and rejected
                                                                          7                                 for such a grant, cooperative agreement, or
                                                                          8                                 contract, except that the report need not dis-
                                                                          9                                 close the identity of any such person or en-
                                                                        10                                  tity;
                                                                        11                                          ‘‘(iv) whether, with respect to each pro-
                                                                        12                                  curement that is approved by the President
                                                                        13                                  under section 319F–2(c)(6), a contract was
                                                                        14                                  entered into within one year after such ap-
                                                                        15                                  proval by the President; and
                                                                        16                                          ‘‘(v) with respect to section 319F–1(d),
                                                                        17                                  for the one-year period for which the report
                                                                        18                                  is submitted, the number of persons who
                                                                        19                                  were paid amounts totaling $100,000 or
                                                                        20                                  greater and the number of persons who were
                                                                        21                                  paid amounts totaling at least $50,000 but
                                                                        22                                  less than $100,000; and
                                                                        23                                  ‘‘(K) be made publicly available.
                                      




                                                                        24                         ‘‘(3) GAO            REPORT.—




                                                                                    •HR 307 RS

                                                                                                                              114
                                                                          1                                 ‘‘(A) IN       GENERAL.—Not                   later than 1 year
                                                                          2                        after the date of the submission to the Congress
                                                                          3                        of the first Public Health Emergency Medical
                                                                          4                        Countermeasures Enterprise Strategy and Imple-
                                                                          5                        mentation Plan, the Comptroller General of the
                                                                          6                        United States shall conduct an independent eval-
                                                                          7                        uation, and submit to the appropriate commit-
                                                                          8                        tees of Congress a report, concerning such Strat-
                                                                          9                        egy and Implementation Plan.
                                                                        10                                  ‘‘(B) CONTENT.—The report described in
                                                                        11                         subparagraph (A) shall review and assess—
                                                                        12                                         ‘‘(i) the near-term, mid-term, and
                                                                        13                                  long-term medical countermeasure needs
                                                                        14                                  and identified priorities of the Federal Gov-
                                                                        15                                  ernment pursuant to paragraph (2)(C);
                                                                        16                                         ‘‘(ii) the activities of the Department of
                                                                        17                                  Health and Human Services with respect to
                                                                        18                                  advanced research and development pursu-
                                                                        19                                  ant to section 319L; and
                                                                        20                                         ‘‘(iii) the progress made toward meet-
                                                                        21                                  ing the timelines, allocations, benchmarks,
                                                                        22                                  and milestones identified in the Public
                                                                        23                                  Health           Emergency                 Medical           Counter-
                                      



                                                                        24                                  measures Enterprise Strategy and Imple-
                                                                        25                                  mentation Plan under this subsection.


                                                                                    •HR 307 RS

                                                                                                                              115
                                                                          1              ‘‘(e) PROTECTION                  OF      NATIONAL SECURITY.—In car-
                                                                          2 rying out subsections (b)(7) and (d), the Secretary shall en-
                                                                          3 sure that information and items that could compromise na-
                                                                          4 tional security, contain confidential commercial informa-
                                                                          5 tion, or contain proprietary information are not dis-
                                                                          6 closed.’’.
                                                                          7              (b) INTERAGENCY COORDINATION PLAN.—In the first
                                                                          8 Public Health Emergency Countermeasures Enterprise
                                                                          9 Strategy and Implementation Plan submitted under sub-
                                                                        10 section (d) of section 2811 of the Public Health Service Act
                                                                        11 (42 U.S.C. 300hh–10) (as added by subsection (a)(3)), the
                                                                        12 Secretary of Health and Human Services, in consultation
                                                                        13 with the Secretary of Defense, shall include a description
                                                                        14 of the manner in which the Department of Health and
                                                                        15 Human Services is coordinating with the Department of
                                                                        16 Defense regarding countermeasure activities to address
                                                                        17 chemical, biological, radiological, and nuclear threats. Such
                                                                        18 report shall include information with respect to—
                                                                        19                         (1) the research, advanced research, development,
                                                                        20               procurement, stockpiling, and distribution of counter-
                                                                        21               measures to meet identified needs; and
                                                                        22                         (2) the coordination of efforts between the De-
                                                                        23               partment of Health and Human Services and the De-
                                      



                                                                        24               partment of Defense to address countermeasure needs
                                                                        25               for various segments of the population.


                                                                                    •HR 307 RS

                                                                                                                              116
                                                                          1     SEC. 103. NATIONAL ADVISORY COMMITTEE ON CHILDREN
                                                                          2                             AND DISASTERS.
                                                                          3              Subtitle B of title XXVIII of the Public Health Service
                                                                          4 Act (42 U.S.C. 300hh et seq.) is amended by inserting after
                                                                          5 section 2811 the following:
                                                                          6     ‘‘SEC. 2811A. NATIONAL ADVISORY COMMITTEE ON CHIL-
                                                                          7                             DREN AND DISASTERS.
                                                                          8              ‘‘(a) ESTABLISHMENT.—The Secretary, in consulta-
                                                                          9 tion with the Secretary of Homeland Security, shall estab-
                                                                        10 lish an advisory committee to be known as the ‘National
                                                                        11 Advisory Committee on Children and Disasters’ (referred
                                                                        12 to in this section as the ‘Advisory Committee’).
                                                                        13               ‘‘(b) DUTIES.—The Advisory Committee shall—
                                                                        14                         ‘‘(1) provide advice and consultation with re-
                                                                        15               spect to the activities carried out pursuant to section
                                                                        16               2814, as applicable and appropriate;
                                                                        17                         ‘‘(2) evaluate and provide input with respect to
                                                                        18               the medical and public health needs of children as
                                                                        19               they relate to preparation for, response to, and recov-
                                                                        20               ery from all-hazards emergencies; and
                                                                        21                         ‘‘(3) provide advice and consultation with re-
                                                                        22               spect to State emergency preparedness and response
                                                                        23               activities and children, including related drills and
                                                                        24               exercises pursuant to the preparedness goals under
                                      



                                                                        25               section 2802(b).
                                                                                    •HR 307 RS

                                                                                                                              117
                                                                          1              ‘‘(c) ADDITIONAL DUTIES.—The Advisory Committee
                                                                          2 may provide advice and recommendations to the Secretary
                                                                          3 with respect to children and the medical and public health
                                                                          4 grants and cooperative agreements as applicable to pre-
                                                                          5 paredness and response activities authorized under this title
                                                                          6 and title III.
                                                                          7              ‘‘(d) MEMBERSHIP.—
                                                                          8                        ‘‘(1) IN       GENERAL.—The                   Secretary, in consulta-
                                                                          9              tion with such other Secretaries as may be appro-
                                                                        10               priate, shall appoint not to exceed 15 members to the
                                                                        11               Advisory Committee. In appointing such members,
                                                                        12               the Secretary shall ensure that the total membership
                                                                        13               of the Advisory Committee is an odd number.
                                                                        14                         ‘‘(2) REQUIRED                  MEMBERS.—The                   Secretary, in
                                                                        15               consultation with such other Secretaries as may be
                                                                        16               appropriate, may appoint to the Advisory Committee
                                                                        17               under paragraph (1) such individuals as may be ap-
                                                                        18               propriate to perform the duties described in sub-
                                                                        19               sections (b) and (c), which may include—
                                                                        20                                  ‘‘(A) the Assistant Secretary for Prepared-
                                                                        21                         ness and Response;
                                                                        22                                  ‘‘(B) the Director of the Biomedical Ad-
                                                                        23                         vanced Research and Development Authority;
                                      




                                                                        24                                  ‘‘(C) the Director of the Centers for Disease
                                                                        25                         Control and Prevention;


                                                                                    •HR 307 RS

                                                                                                                              118
                                                                          1                                 ‘‘(D) the Commissioner of Food and Drugs;
                                                                          2                                 ‘‘(E) the Director of the National Institutes
                                                                          3                        of Health;
                                                                          4                                 ‘‘(F) the Assistant Secretary of the Admin-
                                                                          5                        istration for Children and Families;
                                                                          6                                 ‘‘(G) the Administrator of the Federal
                                                                          7                        Emergency Management Agency;
                                                                          8                                 ‘‘(H) at least two non-Federal health care
                                                                          9                        professionals with expertise in pediatric medical
                                                                        10                         disaster planning, preparedness, response, or re-
                                                                        11                         covery;
                                                                        12                                  ‘‘(I) at least two representatives from State,
                                                                        13                         local, territorial, or tribal agencies with expertise
                                                                        14                         in pediatric disaster planning, preparedness, re-
                                                                        15                         sponse, or recovery; and
                                                                        16                                  ‘‘(J) representatives from such Federal
                                                                        17                         agencies (such as the Department of Education
                                                                        18                         and the Department of Homeland Security) as
                                                                        19                         determined necessary to fulfill the duties of the
                                                                        20                         Advisory Committee, as established under sub-
                                                                        21                         sections (b) and (c).
                                                                        22               ‘‘(e) MEETINGS.—The Advisory Committee shall meet
                                                                        23 not less than biannually.
                                      




                                                                        24               ‘‘(f) SUNSET.—The Advisory Committee shall termi-
                                                                        25 nate on September 30, 2018.’’.


                                                                                    •HR 307 RS

                                                                                                                              119
                                                                          1     SEC. 104. MODERNIZATION OF THE NATIONAL DISASTER
                                                                          2                             MEDICAL SYSTEM.
                                                                          3              Section 2812 of the Public Health Service Act (42
                                                                          4 U.S.C. 300hh–11) is amended—
                                                                          5                        (1) in subsection (a)(3)—
                                                                          6                                 (A) in subparagraph (A), in clause (i) by
                                                                          7                        inserting ‘‘, including at-risk individuals as ap-
                                                                          8                        plicable’’ after ‘‘victims of a public health emer-
                                                                          9                        gency’’;
                                                                        10                                  (B) by redesignating subparagraph (C) as
                                                                        11                         subparagraph (E); and
                                                                        12                                  (C) by inserting after subparagraph (B),
                                                                        13                         the following:
                                                                        14                                  ‘‘(C) CONSIDERATIONS                       FOR AT-RISK POPU-
                                                                        15                         LATIONS.—The                Secretary shall take steps to en-
                                                                        16                         sure that an appropriate specialized and focused
                                                                        17                         range of public health and medical capabilities
                                                                        18                         are represented in the National Disaster Medical
                                                                        19                         System, which take into account the needs of at-
                                                                        20                         risk individuals, in the event of a public health
                                                                        21                         emergency.’’.
                                                                        22                                  ‘‘(D)        ADMINISTRATION.—The                             Secretary
                                                                        23                         may determine and pay claims for reimburse-
                                                                        24                         ment for services under subparagraph (A) di-
                                      



                                                                        25                         rectly or through contracts that provide for pay-
                                                                                    •HR 307 RS

                                                                                                                              120
                                                                          1                        ment in advance or by way of reimbursement.’’;
                                                                          2                        and
                                                                          3                        (2) in subsection (g), by striking ‘‘such sums as
                                                                          4              may be necessary for each of the fiscal years 2007
                                                                          5              through 2011’’ and inserting ‘‘$52,700,000 for each of
                                                                          6              fiscal years 2014 through 2018’’.
                                                                          7     SEC. 105. CONTINUING THE ROLE OF THE DEPARTMENT OF
                                                                          8                             VETERANS AFFAIRS.
                                                                          9              Section 8117(g) of title 38, United States Code, is
                                                                        10 amended by striking ‘‘such sums as may be necessary to
                                                                        11 carry out this section for each of fiscal years 2007 through
                                                                        12 2011’’ and inserting ‘‘$155,300,000 for each of fiscal years
                                                                        13 2014 through 2018 to carry out this section’’.
                                                                        14      TITLE II—OPTIMIZING STATE
                                                                        15         AND  LOCAL   ALL-HAZARDS
                                                                        16         PREPAREDNESS   AND    RE-
                                                                        17         SPONSE
                                                                        18      SEC. 201. TEMPORARY REASSIGNMENT OF STATE AND
                                                                        19                              LOCAL            PERSONNEL                  DURING               A   PUBLIC
                                                                        20                              HEALTH EMERGENCY.
                                                                        21               Section 319 of the Public Health Service Act (42
                                                                        22 U.S.C. 247d) is amended by adding at the end the fol-
                                                                        23 lowing:
                                      




                                                                                    •HR 307 RS

                                                                          1              ‘‘(e) TEMPORARY REASSIGNMENT     121                               OF      STATE      AND
                                                                          2 LOCAL PERSONNEL DURING                                      A      PUBLIC HEALTH EMER-
                                                                          3     GENCY.—

                                                                          4                        ‘‘(1) EMERGENCY                 REASSIGNMENT OF FEDERALLY
                                                                          5              FUNDED             PERSONNEL.—Notwithstanding                                   any other
                                                                          6              provision of law, and subject to paragraph (2), upon
                                                                          7              request by the Governor of a State or a tribal organi-
                                                                          8              zation or such Governor or tribal organization’s des-
                                                                          9              ignee, the Secretary may authorize the requesting
                                                                        10               State or Indian tribe to temporarily reassign, for
                                                                        11               purposes of immediately addressing a public health
                                                                        12               emergency in the State or Indian tribe, State and
                                                                        13               local public health department or agency personnel
                                                                        14               funded in whole or in part through programs author-
                                                                        15               ized under this Act, as appropriate.
                                                                        16                         ‘‘(2) ACTIVATION                   OF       EMERGENCY                 REASSIGN-
                                                                        17               MENT.—
                                                                        18                                  ‘‘(A) PUBLIC               HEALTH EMERGENCY.—The
                                                                        19                         Secretary may authorize a temporary reassign-
                                                                        20                         ment of personnel under paragraph (1) only dur-
                                                                        21                         ing the period of a public health emergency de-
                                                                        22                         termined pursuant to subsection (a).
                                                                        23                                  ‘‘(B) CONTENTS                OF REQUEST.—To                   seek au-
                                      



                                                                        24                         thority for a temporary reassignment of per-
                                                                        25                         sonnel under paragraph (1), the Governor of a


                                                                                    •HR 307 RS

                                                                                                                              122
                                                                          1                        State or a tribal organization shall submit to the
                                                                          2                        Secretary a request for such reassignment flexi-
                                                                          3                        bility and shall include in the request each of the
                                                                          4                        following:
                                                                          5                                        ‘‘(i) An assurance that the public
                                                                          6                                 health emergency in the geographic area of
                                                                          7                                 the requesting State or Indian tribe cannot
                                                                          8                                 be adequately and appropriately addressed
                                                                          9                                 by the public health workforce otherwise
                                                                        10                                  available.
                                                                        11                                         ‘‘(ii) An assurance that the public
                                                                        12                                  health emergency would be addressed more
                                                                        13                                  efficiently and effectively through the re-
                                                                        14                                  quested temporary reassignment of State
                                                                        15                                  and local personnel described in paragraph
                                                                        16                                  (1).
                                                                        17                                         ‘‘(iii) An assurance that the requested
                                                                        18                                  temporary reassignment of personnel is con-
                                                                        19                                  sistent with any applicable All-Hazards
                                                                        20                                  Public Health Emergency Preparedness and
                                                                        21                                  Response Plan under section 319C–1.
                                                                        22                                         ‘‘(iv) An identification of—
                                                                        23                                                   ‘‘(I) each Federal program from
                                      



                                                                        24                                         which personnel would be temporarily
                                                                                    •HR 307 RS

                                                                                                                              123
                                                                          1                                        reassigned pursuant to the requested
                                                                          2                                        authority; and
                                                                          3                                                  ‘‘(II) the number of personnel who
                                                                          4                                        would be so reassigned from each such
                                                                          5                                        program.
                                                                          6                                        ‘‘(v) Such other information and as-
                                                                          7                                 surances upon which the Secretary and
                                                                          8                                 Governor of a State or tribal organization
                                                                          9                                 agree.
                                                                        10                                  ‘‘(C) CONSIDERATION.—In reviewing a re-
                                                                        11                         quest for temporary reassignment under para-
                                                                        12                         graph (1), the Secretary shall consider the degree
                                                                        13                         to which the program or programs funded in
                                                                        14                         whole or in part by programs authorized under
                                                                        15                         this Act would be adversely affected by the reas-
                                                                        16                         signment.
                                                                        17                                  ‘‘(D) TERMINATION                   AND EXTENSION.—

                                                                        18                                         ‘‘(i) TERMINATION.—A State or Indian
                                                                        19                                  tribe’s temporary reassignment of personnel
                                                                        20                                  under paragraph (1) shall terminate upon
                                                                        21                                  the earlier of the following:
                                                                        22                                                   ‘‘(I) The Secretary’s determina-
                                                                        23                                         tion that the public health emergency
                                      



                                                                        24                                         no longer exists.
                                                                                    •HR 307 RS

                                                                                                                              124
                                                                          1                                                  ‘‘(II) Subject to clause (ii), the ex-
                                                                          2                                        piration of the 30-day period following
                                                                          3                                        the date on which the Secretary ap-
                                                                          4                                        proved the State or Indian tribe’s re-
                                                                          5                                        quest for such reassignment flexibility.
                                                                          6                                        ‘‘(ii) EXTENSION                     OF        REASSIGNMENT
                                                                          7                                 FLEXIBILITY.—The                     Secretary may extend
                                                                          8                                 reassignment flexibility of personnel under
                                                                          9                                 paragraph (1) beyond the date otherwise
                                                                        10                                  applicable under clause (i)(II) if the public
                                                                        11                                  health emergency still exists as of such date,
                                                                        12                                  but only if—
                                                                        13                                                   ‘‘(I) the State or Indian tribe that
                                                                        14                                         submitted the initial request for a tem-
                                                                        15                                         porary reassignment of personnel sub-
                                                                        16                                         mits a request for an extension of such
                                                                        17                                         temporary reassignment; and
                                                                        18                                                   ‘‘(II) the request for an extension
                                                                        19                                         contains the same information and as-
                                                                        20                                         surances necessary for the approval of
                                                                        21                                         an initial request for such temporary
                                                                        22                                         reassignment pursuant to subpara-
                                                                        23                                         graph (B).
                                      




                                                                        24                         ‘‘(3) VOLUNTARY                 NATURE OF TEMPORARY REAS-
                                                                        25               SIGNMENT OF STATE AND LOCAL PERSONNEL.—
                                                                                    •HR 307 RS

                                                                                                                              125
                                                                          1                                 ‘‘(A) IN        GENERAL.—Unless                       otherwise pro-
                                                                          2                        vided under the law or regulation of the State or
                                                                          3                        Indian tribe that receives authorization for tem-
                                                                          4                        porary reassignment of personnel under para-
                                                                          5                        graph (1), personnel eligible for reassignment
                                                                          6                        pursuant to such authorization—
                                                                          7                                        ‘‘(i) shall have the opportunity to vol-
                                                                          8                                 unteer for temporary reassignment; and
                                                                          9                                        ‘‘(ii) shall not be required to agree to
                                                                        10                                  a temporary reassignment.
                                                                        11                                  ‘‘(B) PROHIBITION                   ON CONDITIONING FED-
                                                                        12                         ERAL AWARDS.—The                       Secretary may not condi-
                                                                        13                         tion the award of a grant, contract, or coopera-
                                                                        14                         tive agreement under this Act on the requirement
                                                                        15                         that a State or Indian tribe require that per-
                                                                        16                         sonnel eligible for reassignment pursuant to an
                                                                        17                         authorization under paragraph (1) agree to such
                                                                        18                         reassignment.
                                                                        19                         ‘‘(4) NOTICE           TO CONGRESS.—The                        Secretary shall
                                                                        20               give notice to the Congress in conjunction with the
                                                                        21               approval under this subsection of—
                                                                        22                                  ‘‘(A) any initial request for temporary reas-
                                                                        23                         signment of personnel; and
                                      




                                                                        24                                  ‘‘(B) any request for an extension of such
                                                                        25                         temporary reassignment.


                                                                                    •HR 307 RS

                                                                                                                              126
                                                                          1                        ‘‘(5) GUIDANCE.—The Secretary shall—
                                                                          2                                 ‘‘(A) not later than 6 months after the en-
                                                                          3                        actment of this subsection, issue proposed guid-
                                                                          4                        ance on the temporary reassignment of personnel
                                                                          5                        under this subsection; and
                                                                          6                                 ‘‘(B) after providing notice and a 60-day
                                                                          7                        period for public comment, finalize such guid-
                                                                          8                        ance.
                                                                          9                        ‘‘(6) REPORT             TO CONGRESS.—Not                        later than 4
                                                                        10               years after the date of enactment of the Pandemic and
                                                                        11               All-Hazards Preparedness Reauthorization Act of
                                                                        12               2013, the Comptroller General of the United States
                                                                        13               shall conduct an independent evaluation, and submit
                                                                        14               to the appropriate committees of the Congress a re-
                                                                        15               port, on temporary reassignment under this sub-
                                                                        16               section, including—
                                                                        17                                  ‘‘(A) a description of how, and under what
                                                                        18                         circumstances, such temporary reassignment has
                                                                        19                         been used by States and Indian tribes;
                                                                        20                                  ‘‘(B) an analysis of how such temporary re-
                                                                        21                         assignment has assisted States and Indian tribes
                                                                        22                         in responding to public health emergencies;
                                                                        23                                  ‘‘(C) an evaluation of how such temporary
                                      



                                                                        24                         reassignment has improved operational effi-
                                                                                    •HR 307 RS

                                                                                                                              127
                                                                          1                        ciencies in responding to public health emer-
                                                                          2                        gencies;
                                                                          3                                 ‘‘(D) an analysis of the extent to which, if
                                                                          4                        any, Federal programs from which personnel
                                                                          5                        have been temporarily reassigned have been ad-
                                                                          6                        versely affected by the reassignment; and
                                                                          7                                 ‘‘(E) recommendations on how medical
                                                                          8                        surge capacity could be improved in responding
                                                                          9                        to public health emergencies and the impact of
                                                                        10                         the reassignment flexibility under this section on
                                                                        11                         such surge capacity.
                                                                        12                         ‘‘(7) DEFINITIONS.—In this subsection—
                                                                        13                                  ‘‘(A) the terms ‘Indian tribe’ and ‘tribal or-
                                                                        14                         ganization’ have the meanings given such terms
                                                                        15                         in section 4 of the Indian Self-Determination
                                                                        16                         and Education Assistance Act; and
                                                                        17                                  ‘‘(B) the term ‘State’ includes, in addition
                                                                        18                         to the entities listed in the definition of such
                                                                        19                         term in section 2, the Freely Associated States.
                                                                        20                         ‘‘(8) SUNSET.—This subsection shall terminate
                                                                        21               on September 30, 2018.’’.
                                      




                                                                                    •HR 307 RS

                                                                                                                              128
                                                                          1     SEC. 202. IMPROVING STATE AND LOCAL PUBLIC HEALTH
                                                                          2                             SECURITY.
                                                                          3              (a) COOPERATIVE AGREEMENTS.—Section 319C–1 of
                                                                          4 the Public Health Service Act (42 U.S.C. 247d–3a) is
                                                                          5 amended—
                                                                          6                        (1) in subsection (b)(1)(C), by striking ‘‘consor-
                                                                          7              tium of entities described in subparagraph (A)’’ and
                                                                          8              inserting ‘‘consortium of States’’;
                                                                          9                        (2) in subsection (b)(2)—
                                                                        10                                  (A) in subparagraph (A)—
                                                                        11                                         (i) by striking clauses (i) and (ii) and
                                                                        12                                  inserting the following:
                                                                        13                                         ‘‘(i) a description of the activities such
                                                                        14                                  entity will carry out under the agreement to
                                                                        15                                  meet the goals identified under section 2802,
                                                                        16                                  including with respect to chemical, biologi-
                                                                        17                                  cal, radiological, or nuclear threats, whether
                                                                        18                                  naturally occurring, unintentional, or delib-
                                                                        19                                  erate;
                                                                        20                                         ‘‘(ii) a description of the activities such
                                                                        21                                  entity will carry out with respect to pan-
                                                                        22                                  demic influenza, as a component of the ac-
                                                                        23                                  tivities carried out under clause (i), and
                                                                        24                                  consistent with the requirements of para-
                                      



                                                                        25                                  graphs (2) and (5) of subsection (g);’’;
                                                                                    •HR 307 RS

                                                                                                                              129
                                                                          1                                        (ii) in clause (iv), by striking ‘‘and’’ at
                                                                          2                                 the end; and
                                                                          3                                        (iii) by adding at the end the fol-
                                                                          4                                 lowing:
                                                                          5                                        ‘‘(vi) a description of how, as appro-
                                                                          6                                 priate, the entity may partner with relevant
                                                                          7                                 public and private stakeholders in public
                                                                          8                                 health emergency preparedness and re-
                                                                        109                                 sponse;‘‘(vii) a description of how the entity,
                                                                        11                                  as applicable and appropriate, will coordi-
                                                                        12                                  nate with State emergency preparedness
                                                                        13                                  and response plans in public health emer-
                                                                        14                                  gency preparedness, including State edu-
                                                                        15                                  cational agencies (as defined in section
                                                                        16                                  9101(41) of the Elementary and Secondary
                                                                        17                                  Education Act of 1965) and State child care
                                                                        18                                  lead agencies (designated under section
                                                                        19                                  658D of the Child Care and Development
                                                                        20                                  Block Grant Act of 1990);
                                                                        21                                         ‘‘(viii) in the case of entities that oper-
                                                                        22                                  ate on the United States-Mexico border or
                                                                        23                                  the United States-Canada border, a descrip-
                                      



                                                                        24                                  tion of the activities such entity will carry
                                                                        25                                  out under the agreement that are specific to


                                                                                    •HR 307 RS

                                                                                                                              130
                                                                          1                                 the border area including disease detection,
                                                                          2                                 identification, investigation, and prepared-
                                                                          3                                 ness and response activities related to
                                                                          4                                 emerging diseases and infectious disease
                                                                          5                                 outbreaks whether naturally occurring or
                                                                          6                                 due to bioterrorism, consistent with the re-
                                                                          7                                 quirements of this section; and
                                                                          8                                        ‘‘(ix) a description of any activities
                                                                          9                                 that such entity will use to analyze real-
                                                                        10                                  time clinical specimens for pathogens of
                                                                        11                                  public health or bioterrorism significance,
                                                                        12                                  including any utilization of poison control
                                                                        13                                  centers;’’; and
                                                                        14                                  (B) in subparagraph (C), by inserting ‘‘,
                                                                        15                         including addressing the needs of at-risk individ-
                                                                        16                         uals,’’ after ‘‘capabilities of such entity’’;
                                                                        17                         (3) in subsection (f)—
                                                                        18                                  (A) in paragraph (2), by adding ‘‘and’’ at
                                                                        19                         the end;
                                                                        20                                  (B) in paragraph (3), by striking ‘‘; and’’
                                                                        21                         and inserting a period; and
                                                                        22                                  (C) by striking paragraph (4);
                                                                        23                         (4) in subsection (g)—
                                      




                                                                        24                                  (A) in paragraph (1), by striking subpara-
                                                                        25                         graph (A) and inserting the following:


                                                                                    •HR 307 RS

                                                                                                                              131
                                                                          1                                 ‘‘(A) include outcome goals representing
                                                                          2                        operational achievements of the National Pre-
                                                                          3                        paredness Goals developed under section 2802(b)
                                                                          4                        with respect to all-hazards, including chemical,
                                                                          5                        biological, radiological, or nuclear threats; and’’;
                                                                          6                        and
                                                                          7                                 (B) in paragraph (2)(A), by adding at the
                                                                          8                        end the following: ‘‘The Secretary shall periodi-
                                                                          9                        cally update, as necessary and appropriate, such
                                                                        10                         pandemic influenza plan criteria and shall re-
                                                                        11                         quire the integration of such criteria into the
                                                                        12                         benchmarks and standards described in para-
                                                                        13                         graph (1).’’;
                                                                        14                         (5) by striking subsection (h);
                                                                        15                         (6) by redesignating subsections (i), (j), and (k)
                                                                        16               as subsections (h), (i), and (j), respectively;
                                                                        17                         (7) in subsection (h), as so redesignated—
                                                                        18                                  (A) in paragraph (1)—
                                                                        19                                         (i) in subparagraph (A)—
                                                                        20                                                   (I) by striking ‘‘$824,000,000 for
                                                                        21                                         fiscal year 2007, of which $35,000,000
                                                                        22                                         shall be used to carry out subsection
                                                                        23                                         (h),’’ and inserting ‘‘$641,900,000 for
                                      



                                                                        24                                         fiscal year 2014’’; and
                                                                                    •HR 307 RS

                                                                                                                              132
                                                                          1                                                  (II) by striking ‘‘such sums as
                                                                          2                                        may be necessary for each of fiscal
                                                                          3                                        years 2008 through 2011’’ and insert-
                                                                          4                                        ing ‘‘$641,900,000 for each of fiscal
                                                                          5                                        years 2015 through 2018’’;
                                                                          6                                        (ii) by striking subparagraph (B);
                                                                          7                                        (iii) by redesignating subparagraphs
                                                                          8                                 (C) and (D) as subparagraphs (B) and (C),
                                                                          9                                 respectively; and
                                                                        10                                         (iv) in subparagraph (C), as so redes-
                                                                        11                                  ignated, by striking ‘‘subparagraph (C)’’
                                                                        12                                  and inserting ‘‘subparagraph (B)’’;
                                                                        13                                  (B) in subparagraphs (C) and (D) of para-
                                                                        14                         graph (3), by striking ‘‘(1)(A)(i)(I)’’ each place
                                                                        15                         it appears and inserting ‘‘(1)(A)’’;
                                                                        16                                  (C) in paragraph (4)(B), by striking ‘‘sub-
                                                                        17                         section (c)’’ and inserting ‘‘subsection (b)’’; and
                                                                        18                                  (D) by adding at the end the following:
                                                                        19                         ‘‘(7) AVAILABILITY                OF COOPERATIVE AGREEMENT
                                                                        20               FUNDS.—
                                                                        21                                  ‘‘(A) IN         GENERAL.—Amounts                        provided to
                                                                        22                         an eligible entity under a cooperative agreement
                                                                        23                         under subsection (a) for a fiscal year and re-
                                      



                                                                        24                         maining unobligated at the end of such year
                                                                        25                         shall remain available to such entity for the next


                                                                                    •HR 307 RS

                                                                                                                              133
                                                                          1                        fiscal year for the purposes for which such funds
                                                                          2                        were provided.
                                                                          3                                 ‘‘(B) FUNDS               CONTINGENT ON ACHIEVING
                                                                          4                        BENCHMARKS.—The                        continued availability of
                                                                          5                        funds under subparagraph (A) with respect to an
                                                                          6                        entity shall be contingent upon such entity
                                                                          7                        achieving the benchmarks and submitting the
                                                                          8                        pandemic influenza plan as described in sub-
                                                                          9                        section (g).’’; and
                                                                        10                         (8) in subsection (i), as so redesignated—
                                                                        11                                  (A) in paragraph (1)(E), by striking ‘‘sub-
                                                                        12                         section (k)’’ and inserting ‘‘subsection (j)’’;
                                                                        13                                  (B) by striking paragraph (3).
                                                                        14               (b) VACCINE TRACKING                         AND      DISTRIBUTION.—Section
                                                                        15 319A(e) of the Public Health Service Act (42 U.S.C. 247d–
                                                                        16 1(e)) is amended by striking ‘‘such sums for each of fiscal
                                                                        17 years 2007 through 2011’’ and inserting ‘‘$30,800,000 for
                                                                        18 each of fiscal years 2014 through 2018’’.
                                                                        19               (c) TECHNICAL AND CONFORMING AMENDMENTS.—
                                                                        20                         (1) Section 319C–1(b)(1)(B) of the Public Health
                                                                        21               Service Act (42 U.S.C. 247d–3a(b)(1)(B)) is amended
                                                                        22               by striking ‘‘subsection (i)(4)’’ and inserting ‘‘sub-
                                                                        23               section (h)(4)’’.
                                      




                                                                        24                         (2) Section 319C–2 of the Public Health Service
                                                                        25               Act (42 U.S.C. 247d–3b) is amended—


                                                                                    •HR 307 RS

                                                                                                                              134
                                                                          1                                 (A) in subsection (i), by striking ‘‘(j), and
                                                                          2                        (k)’’ and inserting ‘‘(i), and (j)’’; and
                                                                          3                                 (B) in subsection (j)(3), by striking ‘‘319C–
                                                                          4                        1(i)’’ and inserting ‘‘319C–1(h)’’.
                                                                          5     SEC. 203. HOSPITAL PREPAREDNESS AND MEDICAL SURGE
                                                                          6                             CAPACITY.
                                                                          7              (a) ALL-HAZARDS PUBLIC HEALTH                                            AND    MEDICAL
                                                                          8 RESPONSE                        CURRICULA                   AND            TRAINING.—Section
                                                                          9 319F(a)(5)(B) of the Public Health Service Act (42 U.S.C.
                                                                        10 247d–6(a)(5)(B)) is amended by striking ‘‘public health or
                                                                        11 medical’’ and inserting ‘‘public health, medical, or dental’’.
                                                                        12               (b) ENCOURAGING HEALTH PROFESSIONAL VOLUN-
                                                                        13      TEERS.—

                                                                        14                         (1) EMERGENCY                    SYSTEM FOR ADVANCE REG-
                                                                        15               ISTRATION                OF        VOLUNTEER                  HEALTH            PROFES-
                                                                        16               SIONALS.—Section                   319I(k) of the Public Health Serv-
                                                                        17               ice Act (42 U.S.C. 247d–7b(k)) is amended by strik-
                                                                        18               ing ‘‘$2,000,000 for fiscal year 2002, and such sums
                                                                        19               as may be necessary for each of the fiscal years 2003
                                                                        20               through 2011’’ and inserting ‘‘$5,000,000 for each of
                                                                        21               fiscal years 2014 through 2018’’.
                                                                        22                         (2) VOLUNTEERS.—Section 2813 of the Public
                                                                        23               Health Service Act (42 U.S.C. 300hh–15) is amend-
                                      



                                                                        24               ed—
                                                                                    •HR 307 RS

                                                                                                                              135
                                                                          1                                 (A) in subsection (d)(2), by adding at the
                                                                          2                        end the following: ‘‘Such training exercises shall,
                                                                          3                        as appropriate and applicable, incorporate the
                                                                          4                        needs of at-risk individuals in the event of a
                                                                          5                        public health emergency.’’; and
                                                                          6                                 (B)         in         subsection            (i),       by    striking
                                                                          7                        ‘‘$22,000,000 for fiscal year 2007, and such sums
                                                                          8                        as may be necessary for each of fiscal years 2008
                                                                          9                        through 2011’’ and inserting ‘‘$11,200,000 for
                                                                        10                         each of fiscal years 2014 through 2018’’.
                                                                        11               (c) PARTNERSHIPS                    FOR        STATE         AND       REGIONAL PRE-
                                                                        12      PAREDNESS                   TO IMPROVE SURGE CAPACITY.—Section
                                                                        13 319C–2 of the Public Health Service Act (42 U.S.C. 247d–
                                                                        14 3b) is amended—
                                                                        15                         (1) in subsection (a), by inserting ‘‘, including,
                                                                        16               as appropriate, capacity and preparedness to address
                                                                        17               the needs of children and other at-risk individuals’’
                                                                        18               before the period at the end;
                                                                        19                         (2) in subsection (b)(1)(A)(ii), by striking ‘‘cen-
                                                                        20               ters, primary’’ and inserting ‘‘centers, community
                                                                        21               health centers, primary’’;
                                                                        22                         (3) by striking subsection (c) and inserting the
                                                                        23               following:
                                      




                                                                        24               ‘‘(c) USE          OF    FUNDS.—An award under subsection (a)
                                                                        25 shall be expended for activities to achieve the preparedness


                                                                                    •HR 307 RS

                                                                                                                              136
                                                                          1 goals described under paragraphs (1), (3), (4), (5), and (6)
                                                                          2 of section 2802(b) with respect to all-hazards, including
                                                                          3 chemical, biological, radiological, or nuclear threats.’’;
                                                                          4                        (4) by striking subsection (g) and inserting the
                                                                          5              following:
                                                                          6              ‘‘(g) COORDINATION.—
                                                                          7                        ‘‘(1) LOCAL           RESPONSE CAPABILITIES.—An                       eligi-
                                                                          8              ble entity shall, to the extent practicable, ensure that
                                                                          9              activities carried out under an award under sub-
                                                                        10               section (a) are coordinated with activities of relevant
                                                                        11               local Metropolitan Medical Response Systems, local
                                                                        12               Medical Reserve Corps, the local Cities Readiness Ini-
                                                                        13               tiative, and local emergency plans.
                                                                        14                         ‘‘(2) NATIONAL                  COLLABORATION.—Partnerships
                                                                        15               consisting of one or more eligible entities under this
                                                                        16               section may, to the extent practicable, collaborate
                                                                        17               with other partnerships consisting of one or more eli-
                                                                        18               gible entities under this section for purposes of na-
                                                                        19               tional coordination and collaboration with respect to
                                                                        20               activities to achieve the preparedness goals described
                                                                        21               under paragraphs (1), (3), (4), (5), and (6) of section
                                                                        22               2802(b).’’;
                                                                        23                         (5) in subsection (i)—
                                      




                                                                        24                                  (A) by striking ‘‘The requirements of’’ and
                                                                        25                         inserting the following:


                                                                                    •HR 307 RS

                                                                                                                              137
                                                                          1                        ‘‘(1) IN     GENERAL.—The                   requirements of’’; and
                                                                          2                                 (B) by adding at the end the following:
                                                                          3                        ‘‘(2) MEETING             GOALS OF NATIONAL HEALTH SE-
                                                                          4              CURITY STRATEGY.—The                            Secretary shall implement
                                                                          5              objective, evidence-based metrics to ensure that enti-
                                                                          6              ties receiving awards under this section are meeting,
                                                                          7              to the extent practicable, the applicable goals of the
                                                                          8              National Health Security Strategy under section
                                                                          9              2802.’’; and
                                                                        10                         (6) in subsection (j)—
                                                                        11                                  (A) by amending paragraph (1) to read as
                                                                        12                         follows:
                                                                        13                         ‘‘(1) IN      GENERAL.—For                  purposes of carrying out
                                                                        14               this section, there is authorized to be appropriated
                                                                        15               $374,700,000 for each of fiscal years 2014 through
                                                                        16               2018.’’; and
                                                                        17                                  (B) by adding at the end the following:
                                                                        18                         ‘‘(4) AVAILABILITY                OF COOPERATIVE AGREEMENT
                                                                        19               FUNDS.—
                                                                        20                                  ‘‘(A) IN         GENERAL.—Amounts                        provided to
                                                                        21                         an eligible entity under a cooperative agreement
                                                                        22                         under subsection (a) for a fiscal year and re-
                                                                        23                         maining unobligated at the end of such year
                                      



                                                                        24                         shall remain available to such entity for the next
                                                                                    •HR 307 RS

                                                                                                                              138
                                                                          1                        fiscal year for the purposes for which such funds
                                                                          2                        were provided.
                                                                          3                                 ‘‘(B) FUNDS               CONTINGENT ON ACHIEVING
                                                                          4                        BENCHMARKS.—The                        continued availability of
                                                                          5                        funds under subparagraph (A) with respect to an
                                                                          6                        entity shall be contingent upon such entity
                                                                          7                        achieving the benchmarks and submitting the
                                                                          8                        pandemic influenza plan as required under sub-
                                                                          9                        section (i).’’.
                                                                        10      SEC. 204. ENHANCING SITUATIONAL AWARENESS AND BIO-
                                                                        11                              SURVEILLANCE.
                                                                        12               (a) IN GENERAL.—Section 319D of the Public Health
                                                                        13 Service Act (42 U.S.C. 247d–4) is amended—
                                                                        14                         (1) in subsection (b)—
                                                                        15                                  (A) in paragraph (1)(B), by inserting ‘‘poi-
                                                                        16                         son control centers,’’ after ‘‘hospitals,’’;
                                                                        17                                  (B) in paragraph (2), by inserting before
                                                                        18                         the period at the end the following: ‘‘, allowing
                                                                        19                         for coordination to maximize all-hazards medical
                                                                        20                         and public health preparedness and response and
                                                                        21                         to minimize duplication of effort’’; and
                                                                        22                                  (C) in paragraph (3), by inserting before
                                                                        23                         the period at the end the following: ‘‘and update
                                      



                                                                        24                         such standards as necessary’’;
                                                                        25                         (2) by striking subsection (c);


                                                                                    •HR 307 RS

                                                                                                                              139
                                                                          1                        (3) by redesignating subsections (d) through (g)
                                                                          2              as subsections (c) through (f), respectively;
                                                                          3                        (4) in subsection (c), as so redesignated—
                                                                          4                                 (A) in the subsection heading, by striking
                                                                          5                        ‘‘PUBLIC HEALTH SITUATIONAL AWARENESS’’
                                                                          6                        and inserting ‘‘MODERNIZING PUBLIC HEALTH
                                                                          7                        SITUATIONAL AWARENESS                                AND         BIOSURVEIL-
                                                                          8                        LANCE’’;

                                                                          9                                 (B) in paragraph (1)—
                                                                        10                                         (i) by striking ‘‘Pandemic and All-
                                                                        11                                  Hazards Preparedness Act’’ and inserting
                                                                        12                                  ‘‘Pandemic and All-Hazards Preparedness
                                                                        13                                  Reauthorization Act of 2013’’; and
                                                                        14                                         (ii) by inserting ‘‘, novel emerging
                                                                        15                                  threats,’’ after ‘‘disease outbreaks’’;
                                                                        16                                  (C) by striking paragraph (2) and inserting
                                                                        17                         the following:
                                                                        18                         ‘‘(2) STRATEGY                  AND IMPLEMENTATION PLAN.—
                                                                        19               Not later than 180 days after the date of enactment
                                                                        20               of the Pandemic and All-Hazards Preparedness Reau-
                                                                        21               thorization Act of 2013, the Secretary shall submit to
                                                                        22               the appropriate committees of Congress a coordinated
                                                                        23               strategy and an accompanying implementation plan
                                      



                                                                        24               that identifies and demonstrates the measurable steps
                                                                        25               the Secretary will carry out to—


                                                                                    •HR 307 RS

                                                                                                                              140
                                                                          1                                 ‘‘(A) develop, implement, and evaluate the
                                                                          2                        network described in paragraph (1), utilizing the
                                                                          3                        elements described in paragraph (3);
                                                                          4                                 ‘‘(B) modernize and enhance biosurveillance
                                                                          5                        activities; and
                                                                          6                                 ‘‘(C) improve information sharing, coordi-
                                                                          7                        nation, and communication among disparate
                                                                          8                        biosurveillance systems supported by the Depart-
                                                                          9                        ment of Health and Human Services.’’;
                                                                        10                                  (D) in paragraph (3)(D), by inserting
                                                                        11                         ‘‘community health centers, health centers’’ after
                                                                        12                         ‘‘poison control,’’;
                                                                        13                                  (E) in paragraph (5), by striking subpara-
                                                                        14                         graph (A) and inserting the following:
                                                                        15                                  ‘‘(A)       utilize         applicable            interoperability
                                                                        16                         standards as determined by the Secretary, and
                                                                        17                         in consultation with the Office of the National
                                                                        18                         Coordinator for Health Information Technology,
                                                                        19                         through a joint public and private sector proc-
                                                                        20                         ess;’’; and
                                                                        21                                  (F) by adding at the end the following:
                                                                        22                         ‘‘(6) CONSULTATION                     WITH THE NATIONAL BIO-
                                                                        23               DEFENSE SCIENCE BOARD.—In                                  carrying out this sec-
                                      



                                                                        24               tion and consistent with section 319M, the National
                                                                        25               Biodefense Science Board shall provide expert advice


                                                                                    •HR 307 RS

                                                                                                                              141
                                                                          1              and guidance, including recommendations, regarding
                                                                          2              the measurable steps the Secretary should take to
                                                                          3              modernize and enhance biosurveillance activities pur-
                                                                          4              suant to the efforts of the Department of Health and
                                                                          5              Human Services to ensure comprehensive, real-time,
                                                                          6              all-hazards biosurveillance capabilities. In complying
                                                                          7              with the preceding sentence, the National Biodefense
                                                                          8              Science Board shall—
                                                                          9                                 ‘‘(A) identify the steps necessary to achieve
                                                                        10                         a national biosurveillance system for human
                                                                        11                         health, with international connectivity, where
                                                                        12                         appropriate, that is predicated on State, re-
                                                                        13                         gional, and community level capabilities and
                                                                        14                         creates a networked system to allow for two-way
                                                                        15                         information flow between and among Federal,
                                                                        16                         State, and local government public health au-
                                                                        17                         thorities and clinical health care providers;
                                                                        18                                  ‘‘(B) identify any duplicative surveillance
                                                                        19                         programs under the authority of the Secretary,
                                                                        20                         or changes that are necessary to existing pro-
                                                                        21                         grams, in order to enhance and modernize such
                                                                        22                         activities, minimize duplication, strengthen and
                                                                        23                         streamline such activities under the authority of
                                      



                                                                        24                         the Secretary, and achieve real-time and appro-
                                                                                    •HR 307 RS

                                                                                                                              142
                                                                          1                        priate data that relate to disease activity, both
                                                                          2                        human and zoonotic; and
                                                                          3                                 ‘‘(C) coordinate with applicable existing ad-
                                                                          4                        visory committees of the Director of the Centers
                                                                          5                        for Disease Control and Prevention, including
                                                                          6                        such advisory committees consisting of represent-
                                                                          7                        atives from State, local, and tribal public health
                                                                          8                        authorities and appropriate public and private
                                                                          9                        sector health care entities and academic institu-
                                                                        10                         tions, in order to provide guidance on public
                                                                        11                         health surveillance activities.’’;
                                                                        12                         (5) in subsection (d), as so redesignated—
                                                                        13                                  (A) in paragraph (1), by striking ‘‘sub-
                                                                        14                         section (d)’’ and inserting ‘‘subsection (c)’’;
                                                                        15                                  (B) in paragraph (4)(B), by striking ‘‘sub-
                                                                        16                         section (d)’’ and inserting ‘‘subsection (c)’’; and
                                                                        17                                  (C) in paragraph (5)—
                                                                        18                                         (i) by striking ‘‘4 years after the date
                                                                        19                                  of enactment of the Pandemic and All-Haz-
                                                                        20                                  ards Preparedness Act’’ and inserting ‘‘3
                                                                        21                                  years after the date of enactment of the
                                                                        22                                  Pandemic and All-Hazards Preparedness
                                                                        23                                  Reauthorization Act of 2013’’; and
                                      




                                                                        24                                         (ii) by striking ‘‘subsection (d)’’ and
                                                                        25                                  inserting ‘‘subsection (c)’’;


                                                                                    •HR 307 RS

                                                                                                                              143
                                                                          1                        (6) in subsection (f), as so redesignated, by strik-
                                                                          2              ing ‘‘such sums as may be necessary in each of fiscal
                                                                          3              years              2007         through               2011’’        and         inserting
                                                                          4              ‘‘$138,300,000 for each of fiscal years 2014 through
                                                                          5              2018’’; and
                                                                          6                        (7) by adding at the end the following:
                                                                          7              ‘‘(g) DEFINITION.—For purposes of this section the
                                                                          8 term ‘biosurveillance’ means the process of gathering near
                                                                          9 real-time biological data that relates to human and zoonotic
                                                                        10 disease activity and threats to human or animal health, in
                                                                        11 order to achieve early warning and identification of such
                                                                        12 health threats, early detection and prompt ongoing tracking
                                                                        13 of health events, and overall situational awareness of disease
                                                                        14 activity.’’.
                                                                        15               (b) TECHNICAL                  AND   CONFORMING AMENDMENT.—Sec-
                                                                        16 tion 319C–1(b)(2)(D) of the Public Health Service Act (42
                                                                        17 U.S.C. 247d–3a(b)(2)(D)) is amended by striking ‘‘section
                                                                        18 319D(d)(3)’’ and inserting ‘‘section 319D(c)(3)’’.
                                                                        19      SEC. 205. ELIMINATING DUPLICATIVE PROJECT BIOSHIELD
                                                                        20                              REPORTS.
                                                                        21               Section 5 of the Project Bioshield Act of 2004 (42
                                                                        22 U.S.C. 247d–6c) is repealed.
                                      




                                                                                    •HR 307 RS

                                                                          1     TITLE III—ENHANCING MEDICAL                 144
                                                                          2       COUNTERMEASURE REVIEW
                                                                          3     SEC. 301. SPECIAL PROTOCOL ASSESSMENT.
                                                                          4              Section 505(b)(5)(B) of the Federal Food, Drug, and
                                                                          5 Cosmetic Act (21 U.S.C. 355(b)(5)(B)) is amended by strik-
                                                                          6 ing ‘‘size of clinical trials intended’’ and all that follows
                                                                          7 through ‘‘. The sponsor or applicant’’ and inserting the fol-
                                                                          8 lowing: ‘‘size—
                                                                          9                        ‘‘(i)(I) of clinical trials intended to form the pri-
                                                                        10               mary basis of an effectiveness claim; or
                                                                        11                         ‘‘(II) in the case where human efficacy studies
                                                                        12               are not ethical or feasible, of animal and any associ-
                                                                        13               ated clinical trials which, in combination, are in-
                                                                        14               tended to form the primary basis of an effectiveness
                                                                        15               claim; or
                                                                        16                         ‘‘(ii) with respect to an application for approval
                                                                        17               of a biological product under section 351(k) of the
                                                                        18               Public Health Service Act, of any necessary clinical
                                                                        19               study or studies.
                                                                        20 The sponsor or applicant’’.
                                                                        21      SEC. 302. AUTHORIZATION FOR MEDICAL PRODUCTS FOR
                                                                        22                              USE IN EMERGENCIES.
                                                                        23               (a) IN GENERAL.—Section 564 of the Federal Food,
                                      



                                                                        24 Drug, and Cosmetic Act (21 U.S.C. 360bbb–3) is amend-
                                                                        25 ed—


                                                                                    •HR 307 RS

                                                                                                                              145
                                                                          1                        (1) in subsection (a)—
                                                                          2                                 (A) in paragraph (1), by striking ‘‘sections
                                                                          3                        505, 510(k), and 515 of this Act’’ and inserting
                                                                          4                        ‘‘any provision of this Act’’;
                                                                          5                                 (B) in paragraph (2)(A), by striking
                                                                          6                        ‘‘under a provision of law referred to in such
                                                                          7                        paragraph’’ and inserting ‘‘under section 505,
                                                                          8                        510(k), or 515 of this Act or section 351 of the
                                                                          9                        Public Health Service Act’’; and
                                                                        10                                  (C) in paragraph (3), by striking ‘‘a provi-
                                                                        11                         sion of law referred to in such paragraph’’ and
                                                                        12                         inserting ‘‘a section of this Act or the Public
                                                                        13                         Health Service Act referred to in paragraph
                                                                        14                         (2)(A)’’;
                                                                        15                         (2) in subsection (b)—
                                                                        16                                  (A) in the subsection heading, by striking
                                                                        17                         ‘‘EMERGENCY’’ and inserting ‘‘EMERGENCY                               OR
                                                                        18                         THREAT JUSTIFYING EMERGENCY AUTHORIZED
                                                                        19                         USE’’;
                                                                        20                                  (B) in paragraph (1)—
                                                                        21                                         (i) in the matter preceding subpara-
                                                                        22                                  graph (A), by striking ‘‘may declare an
                                                                        23                                  emergency’’ and inserting ‘‘may make a
                                      



                                                                        24                                  declaration that the circumstances exist’’;
                                                                                    •HR 307 RS

                                                                                                                              146
                                                                          1                                        (ii) in subparagraph (A), by striking
                                                                          2                                 ‘‘specified’’;
                                                                          3                                        (iii) in subparagraph (B)—
                                                                          4                                                  (I) by striking ‘‘specified’’; and
                                                                          5                                                  (II) by striking ‘‘; or’’ and insert-
                                                                          6                                        ing a semicolon;
                                                                          7                                        (iv) by amending subparagraph (C) to
                                                                          8                                 read as follows:
                                                                          9                                 ‘‘(C) a determination by the Secretary that
                                                                        10                         there is a public health emergency, or a signifi-
                                                                        11                         cant potential for a public health emergency,
                                                                        12                         that affects, or has a significant potential to af-
                                                                        13                         fect, national security or the health and security
                                                                        14                         of United States citizens living abroad, and that
                                                                        15                         involves a biological, chemical, radiological, or
                                                                        16                         nuclear agent or agents, or a disease or condition
                                                                        17                         that may be attributable to such agent or agents;
                                                                        18                         or’’; and
                                                                        19                                         (v) by adding at the end the following:
                                                                        20                                  ‘‘(D) the identification of a material threat
                                                                        21                         pursuant to section 319F–2 of the Public Health
                                                                        22                         Service Act sufficient to affect national security
                                                                        23                         or the health and security of United States citi-
                                      



                                                                        24                         zens living abroad.’’;
                                                                        25                                  (C) in paragraph (2)—


                                                                                    •HR 307 RS

                                                                                                                              147
                                                                          1                                        (i) in subparagraph (A), by amending
                                                                          2                                 clause (ii) to read as follows:
                                                                          3                                        ‘‘(ii) a change in the approval status of
                                                                          4                                 the product such that the circumstances de-
                                                                          5                                 scribed in subsection (a)(2) have ceased to
                                                                          6                                 exist.’’;
                                                                          7                                        (ii) by striking subparagraph (B); and
                                                                          8                                        (iii) by redesignating subparagraph
                                                                          9                                 (C) as subparagraph (B);
                                                                        10                                  (D) in paragraph (4), by striking ‘‘advance
                                                                        11                         notice of termination, and renewal under this
                                                                        12                         subsection.’’ and inserting ‘‘, and advance notice
                                                                        13                         of termination under this subsection.’’; and
                                                                        14                                  (E) by adding at the end the following:
                                                                        15                         ‘‘(5) EXPLANATION                   BY SECRETARY.—If                  an au-
                                                                        16               thorization under this section with respect to an un-
                                                                        17               approved product or an unapproved use of an ap-
                                                                        18               proved product has been in effect for more than 1
                                                                        19               year, the Secretary shall provide in writing to the
                                                                        20               sponsor of such product an explanation of the sci-
                                                                        21               entific, regulatory, or other obstacles to approval, li-
                                                                        22               censure, or clearance of such product or use, including
                                                                        23               specific actions to be taken by the Secretary and the
                                      



                                                                        24               sponsor to overcome such obstacles.’’;
                                                                        25                         (3) in subsection (c)—


                                                                                    •HR 307 RS

                                                                                                                              148
                                                                          1                                 (A) in the matter preceding paragraph
                                                                          2                        (1)—
                                                                          3                                        (i) by inserting ‘‘the Assistant Sec-
                                                                          4                                 retary for Preparedness and Response,’’
                                                                          5                                 after ‘‘consultation with’’;
                                                                          6                                        (ii) by striking ‘‘Health and’’ and in-
                                                                          7                                 serting ‘‘Health, and’’; and
                                                                          8                                        (iii) by striking ‘‘circumstances of the
                                                                          9                                 emergency involved’’ and inserting ‘‘appli-
                                                                        10                                  cable circumstances described in subsection
                                                                        11                                  (b)(1)’’;
                                                                        12                                  (B) in paragraph (1), by striking ‘‘speci-
                                                                        13                         fied’’ and inserting ‘‘referred to’’; and
                                                                        14                                  (C) in paragraph (2)(B), by inserting ‘‘,
                                                                        15                         taking into consideration the material threat
                                                                        16                         posed by the agent or agents identified in a dec-
                                                                        17                         laration under subsection (b)(1)(D), if applica-
                                                                        18                         ble’’ after ‘‘risks of the product’’;
                                                                        19                         (4) in subsection (d)(3), by inserting ‘‘, to the ex-
                                                                        20               tent practicable given the circumstances of the emer-
                                                                        21               gency,’’ after ‘‘including’’;
                                                                        22                         (5) in subsection (e)—
                                                                        23                                  (A) in paragraph (1)(A), by striking ‘‘cir-
                                      



                                                                        24                         cumstances of the emergency’’ and inserting ‘‘ap-
                                                                                    •HR 307 RS

                                                                                                                              149
                                                                          1                        plicable circumstances described in subsection
                                                                          2                        (b)(1)’’;
                                                                          3                                 (B) in paragraph (1)(B), by amending
                                                                          4                        clause (iii) to read as follows:
                                                                          5                                        ‘‘(iii) Appropriate conditions with re-
                                                                          6                                 spect to collection and analysis of informa-
                                                                          7                                 tion concerning the safety and effectiveness
                                                                          8                                 of the product with respect to the use of such
                                                                          9                                 product during the period when the author-
                                                                        10                                  ization is in effect and a reasonable time
                                                                        11                                  following such period.’’;
                                                                        12                                  (C) in paragraph (2)—
                                                                        13                                         (i) in subparagraph (A)—
                                                                        14                                                   (I) by striking ‘‘manufacturer of
                                                                        15                                         the product’’ and inserting ‘‘person’’;
                                                                        16                                                   (II) by striking ‘‘circumstances of
                                                                        17                                         the emergency’’ and inserting ‘‘appli-
                                                                        18                                         cable circumstances described in sub-
                                                                        19                                         section (b)(1)’’; and
                                                                        20                                                   (III) by inserting at the end be-
                                                                        21                                         fore the period ‘‘or in paragraph
                                                                        22                                         (1)(B)’’;
                                                                        23                                         (ii) in subparagraph (B)(i), by insert-
                                      



                                                                        24                                  ing before the period at the end ‘‘, except as
                                                                        25                                  provided in section 564A with respect to au-


                                                                                    •HR 307 RS

                                                                                                                              150
                                                                          1                                 thorized changes to the product expiration
                                                                          2                                 date’’; and
                                                                          3                                        (iii) by amending subparagraph (C) to
                                                                          4                                 read as follows:
                                                                          5                                 ‘‘(C) In establishing conditions under this
                                                                          6                        paragraph with respect to the distribution and
                                                                          7                        administration of the product for the unap-
                                                                          8                        proved use, the Secretary shall not impose condi-
                                                                          9                        tions that would restrict distribution or adminis-
                                                                        10                         tration of the product when distributed or ad-
                                                                        11                         ministered for the approved use.’’; and
                                                                        12                                  (D) by amending paragraph (3) to read as
                                                                        13                         follows:
                                                                        14                         ‘‘(3) GOOD              MANUFACTURING                    PRACTICE;    PRE-
                                                                        15               SCRIPTION.—With                    respect to the emergency use of a
                                                                        16               product for which an authorization under this section
                                                                        17               is issued (whether an unapproved product or an un-
                                                                        18               approved use of an approved product), the Secretary
                                                                        19               may waive or limit, to the extent appropriate given
                                                                        20               the applicable circumstances described in subsection
                                                                        21               (b)(1)—
                                                                        22                                  ‘‘(A) requirements regarding current good
                                                                        23                         manufacturing practice otherwise applicable to
                                      



                                                                        24                         the manufacture, processing, packing, or holding
                                                                        25                         of products subject to regulation under this Act,


                                                                                    •HR 307 RS

                                                                                                                              151
                                                                          1                        including such requirements established under
                                                                          2                        section 501 or 520(f)(1), and including relevant
                                                                          3                        conditions prescribed with respect to the product
                                                                          4                        by an order under section 520(f)(2);
                                                                          5                                 ‘‘(B) requirements established under section
                                                                          6                        503(b); and
                                                                          7                                 ‘‘(C) requirements established under section
                                                                          8                        520(e).’’;
                                                                          9                        (6) in subsection (g)—
                                                                        10                                  (A) in the subsection heading, by inserting
                                                                        11                         ‘‘REVIEW         AND’’     before ‘‘REVOCATION’’;
                                                                        12                                  (B) in paragraph (1), by inserting after the
                                                                        13                         period at the end the following: ‘‘As part of such
                                                                        14                         review, the Secretary shall regularly review the
                                                                        15                         progress made with respect to the approval, li-
                                                                        16                         censure, or clearance of—
                                                                        17                                  ‘‘(A) an unapproved product for which an
                                                                        18                         authorization was issued under this section; or
                                                                        19                                  ‘‘(B) an unapproved use of an approved
                                                                        20                         product for which an authorization was issued
                                                                        21                         under this section.’’; and
                                                                        22                                  (C) by amending paragraph (2) to read as
                                                                        23                         follows:
                                      




                                                                                    •HR 307 RS

                                                                                                                              152
                                                                          1                        ‘‘(2) REVISION            AND REVOCATION.—The                         Secretary
                                                                          2              may revise or revoke an authorization under this sec-
                                                                          3              tion if—
                                                                          4                                 ‘‘(A) the circumstances described under sub-
                                                                          5                        section (b)(1) no longer exist;
                                                                          6                                 ‘‘(B) the criteria under subsection (c) for
                                                                          7                        issuance of such authorization are no longer met;
                                                                          8                        or
                                                                          9                                 ‘‘(C) other circumstances make such revision
                                                                        10                         or revocation appropriate to protect the public
                                                                        11                         health or safety.’’;
                                                                        12                         (7) in subsection (h)(1), by adding after the pe-
                                                                        13               riod at the end the following: ‘‘The Secretary shall
                                                                        14               make any revisions to an authorization under this
                                                                        15               section available on the Internet Web site of the Food
                                                                        16               and Drug Administration.’’;
                                                                        17                         (8) by adding at the end of subsection (j) the fol-
                                                                        18               lowing:
                                                                        19                         ‘‘(4) Nothing in this section shall be construed as
                                                                        20               authorizing a delay in the review or other consider-
                                                                        21               ation by the Secretary of any application or submis-
                                                                        22               sion pending before the Food and Drug Administra-
                                                                        23               tion for a product for which an authorization under
                                      



                                                                        24               this section is issued.’’; and
                                                                        25                         (9) by adding at the end the following:


                                                                                    •HR 307 RS

                                                                          1              ‘‘(m) CATEGORIZATION             153       OF    LABORATORY TESTS ASSO-
                                                                          2     CIATED           WITH DEVICES SUBJECT TO AUTHORIZATION.—
                                                                          3                        ‘‘(1) IN      GENERAL.—In                   issuing an authorization
                                                                          4              under this section with respect to a device, the Sec-
                                                                          5              retary may, subject to the provisions of this section,
                                                                          6              determine that a laboratory examination or procedure
                                                                          7              associated with such device shall be deemed, for pur-
                                                                          8              poses of section 353 of the Public Health Service Act,
                                                                          9              to be in a particular category of examinations and
                                                                        10               procedures (including the category described by sub-
                                                                        11               section (d)(3) of such section) if, based on the totality
                                                                        12               of scientific evidence available to the Secretary—
                                                                        13                                  ‘‘(A) such categorization would be beneficial
                                                                        14                         to protecting the public health; and
                                                                        15                                  ‘‘(B) the known and potential benefits of
                                                                        16                         such categorization under the circumstances of
                                                                        17                         the authorization outweigh the known and poten-
                                                                        18                         tial risks of the categorization.
                                                                        19                         ‘‘(2) CONDITIONS                OF DETERMINATION.—The                   Sec-
                                                                        20               retary may establish appropriate conditions on the
                                                                        21               performance of the examination or procedure pursu-
                                                                        22               ant to such determination.
                                                                        23                         ‘‘(3)      EFFECTIVE                PERIOD.—A                  determination
                                      



                                                                        24               under this subsection shall be effective for purposes of
                                                                        25               section 353 of the Public Health Service Act notwith-


                                                                                    •HR 307 RS

                                                                                                                              154
                                                                          1              standing any other provision of that section during
                                                                          2              the effective period of the relevant declaration under
                                                                          3              subsection (b).’’.
                                                                          4              (b) EMERGENCY USE                         OF   MEDICAL PRODUCTS.—Sub-
                                                                          5 chapter E of chapter V of the Federal Food, Drug, and Cos-
                                                                          6 metic Act (21 U.S.C. 360bbb et seq.) is amended by insert-
                                                                          7 ing after section 564 the following:
                                                                          8     ‘‘SEC. 564A. EMERGENCY USE OF MEDICAL PRODUCTS.

                                                                          9              ‘‘(a) DEFINITIONS.—In this section:
                                                                        10                         ‘‘(1) ELIGIBLE                  PRODUCT.—The                   term ‘eligible
                                                                        11               product’ means a product that—
                                                                        12                                  ‘‘(A) is approved or cleared under this
                                                                        13                         chapter or licensed under section 351 of the Pub-
                                                                        14                         lic Health Service Act;
                                                                        15                                  ‘‘(B)(i) is intended for use to prevent, diag-
                                                                        16                         nose, or treat a disease or condition involving a
                                                                        17                         biological, chemical, radiological, or nuclear
                                                                        18                         agent or agents; or
                                                                        19                                  ‘‘(ii) is intended for use to prevent, diag-
                                                                        20                         nose, or treat a serious or life-threatening disease
                                                                        21                         or condition caused by a product described in
                                                                        22                         clause (i); and
                                                                        23                                  ‘‘(C) is intended for use during the cir-
                                      



                                                                        24                         cumstances under which—
                                                                                    •HR 307 RS

                                                                                                                              155
                                                                          1                                        ‘‘(i) a determination described in sub-
                                                                          2                                 paragraph (A), (B), or (C) of section
                                                                          3                                 564(b)(1) has been made by the Secretary of
                                                                          4                                 Homeland Security, the Secretary of De-
                                                                          5                                 fense, or the Secretary, respectively; or
                                                                          6                                        ‘‘(ii) the identification of a material
                                                                          7                                 threat described in subparagraph (D) of sec-
                                                                          8                                 tion 564(b)(1) has been made pursuant to
                                                                          9                                 section 319F–2 of the Public Health Service
                                                                        10                                  Act.
                                                                        11                         ‘‘(2) PRODUCT.—The term ‘product’ means a
                                                                        12               drug, device, or biological product.
                                                                        13               ‘‘(b) EXPIRATION DATING.—
                                                                        14                         ‘‘(1) IN        GENERAL.—The                   Secretary may extend
                                                                        15               the expiration date and authorize the introduction or
                                                                        16               delivery for introduction into interstate commerce of
                                                                        17               an eligible product after the expiration date provided
                                                                        18               by the manufacturer if—
                                                                        19                                  ‘‘(A) the expiration date extension is in-
                                                                        20                         tended to support the United States ability to
                                                                        21                         protect—
                                                                        22                                         ‘‘(i) the public health; or
                                                                        23                                         ‘‘(ii) military preparedness and effec-
                                      



                                                                        24                                  tiveness; and
                                                                                    •HR 307 RS

                                                                                                                              156
                                                                          1                                 ‘‘(B) the expiration date extension is sup-
                                                                          2                        ported by an appropriate scientific evaluation
                                                                          3                        that is conducted or accepted by the Secretary.
                                                                          4                        ‘‘(2) REQUIREMENTS                    AND CONDITIONS.—Any             ex-
                                                                          5              tension of an expiration date under paragraph (1)
                                                                          6              shall, as part of the extension, identify—
                                                                          7                                 ‘‘(A) each specific lot, batch, or other unit
                                                                          8                        of the product for which extended expiration is
                                                                          9                        authorized;
                                                                        10                                  ‘‘(B) the duration of the extension; and
                                                                        11                                  ‘‘(C) any other requirements or conditions
                                                                        12                         as the Secretary may deem appropriate for the
                                                                        13                         protection of the public health, which may in-
                                                                        14                         clude requirements for, or conditions on, product
                                                                        15                         sampling, storage, packaging or repackaging,
                                                                        16                         transport, labeling, notice to product recipients,
                                                                        17                         recordkeeping, periodic testing or retesting, or
                                                                        18                         product disposition.
                                                                        19                         ‘‘(3) EFFECT.—Notwithstanding any other pro-
                                                                        20               vision of this Act or the Public Health Service Act,
                                                                        21               an eligible product shall not be considered an unap-
                                                                        22               proved product (as defined in section 564(a)(2)(A))
                                                                        23               and shall not be deemed adulterated or misbranded
                                      



                                                                        24               under this Act because, with respect to such product,
                                                                        25               the Secretary has, under paragraph (1), extended the


                                                                                    •HR 307 RS

                                                                                                                              157
                                                                          1              expiration date and authorized the introduction or
                                                                          2              delivery for introduction into interstate commerce of
                                                                          3              such product after the expiration date provided by the
                                                                          4              manufacturer.
                                                                          5                        ‘‘(4) EXPIRATION                  DATE.—For              purposes of this
                                                                          6              subsection, the term ‘expiration date’ means the date
                                                                          7              established through appropriate stability testing re-
                                                                          8              quired by the regulations issued by the Secretary to
                                                                          9              ensure that the product meets applicable standards of
                                                                        10               identity, strength, quality, and purity at the time of
                                                                        11               use.
                                                                        12               ‘‘(c) CURRENT GOOD MANUFACTURING PRACTICE.—
                                                                        13                         ‘‘(1) IN        GENERAL.—The                    Secretary may, when
                                                                        14               the circumstances of a domestic, military, or public
                                                                        15               health emergency or material threat described in sub-
                                                                        16               section (a)(1)(C) so warrant, authorize, with respect
                                                                        17               to an eligible product, deviations from current good
                                                                        18               manufacturing practice requirements otherwise appli-
                                                                        19               cable to the manufacture, processing, packing, or
                                                                        20               holding of products subject to regulation under this
                                                                        21               Act, including requirements under section 501 or
                                                                        22               520(f)(1) or applicable conditions prescribed with re-
                                                                        23               spect to the eligible product by an order under section
                                      



                                                                        24               520(f)(2).
                                                                                    •HR 307 RS

                                                                                                                              158
                                                                          1                        ‘‘(2) EFFECT.—Notwithstanding any other pro-
                                                                          2              vision of this Act or the Public Health Service Act,
                                                                          3              an eligible product shall not be considered an unap-
                                                                          4              proved product (as defined in section 564(a)(2)(A))
                                                                          5              and shall not be deemed adulterated or misbranded
                                                                          6              under this Act because, with respect to such product,
                                                                          7              the Secretary has authorized deviations from current
                                                                          8              good manufacturing practices under paragraph (1).
                                                                          9              ‘‘(d) EMERGENCY DISPENSING.—The requirements of
                                                                        10 sections 503(b) and 520(e) shall not apply to an eligible
                                                                        11 product, and the product shall not be considered an unap-
                                                                        12 proved product (as defined in section 564(a)(2)(A)) and
                                                                        13 shall not be deemed adulterated or misbranded under this
                                                                        14 Act because it is dispensed without an individual prescrip-
                                                                        15 tion, if—
                                                                        16                         ‘‘(1) the product is dispensed during the cir-
                                                                        17               cumstances described in subsection (a)(1)(C); and
                                                                        18                         ‘‘(2) such dispensing without an individual pre-
                                                                        19               scription occurs—
                                                                        20                                  ‘‘(A) as permitted under the law of the
                                                                        21                         State in which the product is dispensed; or
                                                                        22                                  ‘‘(B) in accordance with an order issued by
                                                                        23                         the Secretary, for the purposes and duration of
                                      



                                                                        24                         the       circumstances                 described              in     subsection
                                                                        25                         (a)(1)(C).


                                                                                    •HR 307 RS

                                                                                                                              159
                                                                          1              ‘‘(e) EMERGENCY USE INSTRUCTIONS.—
                                                                          2                        ‘‘(1)      IN        GENERAL.—The                     Secretary,      acting
                                                                          3              through an appropriate official within the Depart-
                                                                          4              ment of Health and Human Services, may create and
                                                                          5              issue emergency use instructions to inform health care
                                                                          6              providers or individuals to whom an eligible product
                                                                          7              is to be administered concerning such product’s ap-
                                                                          8              proved, licensed, or cleared conditions of use.
                                                                          9                        ‘‘(2) EFFECT.—Notwithstanding any other pro-
                                                                        10               visions of this Act or the Public Health Service Act,
                                                                        11               a product shall not be considered an unapproved
                                                                        12               product and shall not be deemed adulterated or mis-
                                                                        13               branded under this Act because of the issuance of
                                                                        14               emergency use instructions under paragraph (1) with
                                                                        15               respect to such product or the introduction or delivery
                                                                        16               for introduction of such product into interstate com-
                                                                        17               merce accompanied by such instructions—
                                                                        18                                  ‘‘(A) during an emergency response to an
                                                                        19                         actual emergency that is the basis for a deter-
                                                                        20                         mination described in subsection (a)(1)(C)(i); or
                                                                        21                                  ‘‘(B) by a government entity (including a
                                                                        22                         Federal, State, local, or tribal government enti-
                                                                        23                         ty), or a person acting on behalf of such a gov-
                                      



                                                                        24                         ernment entity, in preparation for an emergency
                                                                        25                         response.’’.


                                                                                    •HR 307 RS

                                                                          1              (c) RISK EVALUATION                  160       AND        MITIGATION STRATE-
                                                                          2     GIES.—Section                505–1 of the Federal Food, Drug, and Cos-
                                                                          3 metic Act (21 U.S.C. 355–1), is amended—
                                                                          4                        (1) in subsection (f), by striking paragraph (7);
                                                                          5              and
                                                                          6                        (2) by adding at the end the following:
                                                                          7              ‘‘(k) WAIVER              IN     PUBLIC HEALTH EMERGENCIES.—
                                                                          8 The Secretary may waive any requirement of this section
                                                                          9 with respect to a qualified countermeasure (as defined in
                                                                        10 section 319F–1(a)(2) of the Public Health Service Act) to
                                                                        11 which a requirement under this section has been applied,
                                                                        12 if the Secretary determines that such waiver is required to
                                                                        13 mitigate the effects of, or reduce the severity of, the cir-
                                                                        14 cumstances under which—
                                                                        15                         ‘‘(1) a determination described in subparagraph
                                                                        16               (A), (B), or (C) of section 564(b)(1) has been made
                                                                        17               by the Secretary of Homeland Security, the Secretary
                                                                        18               of Defense, or the Secretary, respectively; or
                                                                        19                         ‘‘(2) the identification of a material threat de-
                                                                        20               scribed in subparagraph (D) of section 564(b)(1) has
                                                                        21               been made pursuant to section 319F–2 of the Public
                                                                        22               Health Service Act.’’.
                                                                        23               (d) PRODUCTS HELD                           FOR       EMERGENCY USE.—The
                                      



                                                                        24 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et
                                                                                    •HR 307 RS

                                                                                                                              161
                                                                          1 seq.) is amended by inserting after section 564A, as added
                                                                          2 by subsection (b), the following:
                                                                          3     ‘‘SEC. 564B. PRODUCTS HELD FOR EMERGENCY USE.

                                                                          4              ‘‘It is not a violation of any section of this Act or of
                                                                          5 the Public Health Service Act for a government entity (in-
                                                                          6 cluding a Federal, State, local, or tribal government entity),
                                                                          7 or a person acting on behalf of such a government entity,
                                                                          8 to introduce into interstate commerce a product (as defined
                                                                          9 in section 564(a)(4)) intended for emergency use, if that
                                                                        10 product—
                                                                        11                         ‘‘(1) is intended to be held and not used; and
                                                                        12                         ‘‘(2) is held and not used, unless and until that
                                                                        13               product—
                                                                        14                                  ‘‘(A) is approved, cleared, or licensed under
                                                                        15                         section 505, 510(k), or 515 of this Act or section
                                                                        16                         351 of the Public Health Service Act;
                                                                        17                                  ‘‘(B) is authorized for investigational use
                                                                        18                         under section 505 or 520 of this Act or section
                                                                        19                         351 of the Public Health Service Act; or
                                                                        20                                  ‘‘(C) is authorized for use under section
                                                                        21                         564.’’.
                                                                        22      SEC. 303. DEFINITIONS.
                                                                        23               Section 565 of the Federal Food, Drug, and Cosmetic
                                      



                                                                        24 Act (21 U.S.C. 360bbb–4) is amended by striking ‘‘The Sec-
                                                                        25 retary, in consultation’’ and inserting the following:


                                                                                    •HR 307 RS

                                                                                                                              162
                                                                          1              ‘‘(a) DEFINITIONS.—In this section—
                                                                          2                        ‘‘(1) the term ‘countermeasure’ means a qualified
                                                                          3              countermeasure, a security countermeasure, and a
                                                                          4              qualified pandemic or epidemic product;
                                                                          5                        ‘‘(2) the term ‘qualified countermeasure’ has the
                                                                          6              meaning given such term in section 319F–1 of the
                                                                          7              Public Health Service Act;
                                                                          8                        ‘‘(3) the term ‘security countermeasure’ has the
                                                                          9              meaning given such term in section 319F–2 of such
                                                                        10               Act; and
                                                                        11                         ‘‘(4) the term ‘qualified pandemic or epidemic
                                                                        12               product’ means a product that meets the definition
                                                                        13               given such term in section 319F–3 of the Public
                                                                        14               Health Service Act and—
                                                                        15                                  ‘‘(A) that has been identified by the Depart-
                                                                        16                         ment of Health and Human Services or the De-
                                                                        17                         partment of Defense as receiving funding directly
                                                                        18                         related to addressing chemical, biological, radio-
                                                                        19                         logical, or nuclear threats, including pandemic
                                                                        20                         influenza; or
                                                                        21                                  ‘‘(B) is included under this paragraph pur-
                                                                        22                         suant to a determination by the Secretary.
                                                                        23               ‘‘(b) GENERAL DUTIES.—The Secretary, in consulta-
                                      



                                                                        24 tion’’.
                                                                                    •HR 307 RS

                                                                                                                              163
                                                                          1     SEC. 304. ENHANCING MEDICAL COUNTERMEASURE ACTIVI-
                                                                          2                             TIES.
                                                                          3              Section 565 of the Federal Food, Drug, and Cosmetic
                                                                          4 Act (21 U.S.C. 360bbb–4), as amended by section 303, is
                                                                          5 further amended—
                                                                          6                        (1) in the section heading, by striking ‘‘TECH-
                                                                          7              NICAL ASSISTANCE’’                            and inserting ‘‘COUNTER-
                                                                          8              MEASURE DEVELOPMENT, REVIEW, AND TECH-
                                                                          9              NICAL ASSISTANCE’’;
                                                                        10                         (2) in subsection (b), by striking the subsection
                                                                        11               enumerator and all that follows through ‘‘shall estab-
                                                                        12               lish’’ and inserting the following:
                                                                        13               ‘‘(b) GENERAL DUTIES.—In order to accelerate the de-
                                                                        14 velopment, stockpiling, approval, licensure, and clearance
                                                                        15 of qualified countermeasures, security countermeasures, and
                                                                        16 qualified pandemic or epidemic products, the Secretary, in
                                                                        17 consultation with the Assistant Secretary for Preparedness
                                                                        18 and Response, shall—
                                                                        19                         ‘‘(1) ensure the appropriate involvement of Food
                                                                        20               and Drug Administration personnel in interagency
                                                                        21               activities related to countermeasure advanced research
                                                                        22               and development, consistent with sections 319F,
                                                                        23               319F–1, 319F–2, 319F–3, 319L, and 2811 of the
                                                                        24               Public Health Service Act;
                                      




                                                                        25                         ‘‘(2) ensure the appropriate involvement and
                                                                        26               consultation of Food and Drug Administration per-
                                                                                    •HR 307 RS

                                                                                                                              164
                                                                          1              sonnel in any flexible manufacturing activities car-
                                                                          2              ried out under section 319L of the Public Health
                                                                          3              Service Act, including with respect to meeting regu-
                                                                          4              latory requirements set forth in this Act;
                                                                          5                        ‘‘(3) promote countermeasure expertise within
                                                                          6              the Food and Drug Administration by—
                                                                          7                                 ‘‘(A) ensuring that Food and Drug Admin-
                                                                          8                        istration personnel involved in reviewing coun-
                                                                          9                        termeasures for approval, licensure, or clearance
                                                                        10                         are informed by the Assistant Secretary for Pre-
                                                                        11                         paredness and Response on the material threat
                                                                        12                         assessment conducted under section 319F–2 of
                                                                        13                         the Public Health Service Act for the agent or
                                                                        14                         agents for which the countermeasure under re-
                                                                        15                         view is intended;
                                                                        16                                  ‘‘(B) training Food and Drug Administra-
                                                                        17                         tion personnel regarding review of counter-
                                                                        18                         measures for approval, licensure, or clearance;
                                                                        19                                  ‘‘(C) holding public meetings at least twice
                                                                        20                         annually to encourage the exchange of scientific
                                                                        21                         ideas; and
                                                                        22                                  ‘‘(D) establishing protocols to ensure that
                                                                        23                         countermeasure reviewers have sufficient train-
                                      



                                                                        24                         ing or experience with countermeasures;
                                                                                    •HR 307 RS

                                                                                                                              165
                                                                          1                        ‘‘(4) maintain teams, composed of Food and
                                                                          2              Drug Administration personnel with expertise on
                                                                          3              countermeasures, including specific countermeasures,
                                                                          4              populations with special clinical needs (including
                                                                          5              children and pregnant women that may use counter-
                                                                          6              measures, as applicable and appropriate), classes or
                                                                          7              groups of countermeasures, or other countermeasure-
                                                                          8              related technologies and capabilities, that shall—
                                                                          9                                 ‘‘(A) consult with countermeasure experts,
                                                                        10                         including countermeasure sponsors and appli-
                                                                        11                         cants, to identify and help resolve scientific
                                                                        12                         issues related to the approval, licensure, or clear-
                                                                        13                         ance of countermeasures, through workshops or
                                                                        14                         public meetings; and
                                                                        15                                  ‘‘(B) improve and advance the science relat-
                                                                        16                         ing to the development of new tools, standards,
                                                                        17                         and approaches to assessing and evaluating
                                                                        18                         countermeasures—
                                                                        19                                         ‘‘(i) in order to inform the process for
                                                                        20                                  countermeasure approval, clearance, and li-
                                                                        21                                  censure; and
                                                                        22                                         ‘‘(ii) with respect to the development of
                                                                        23                                  countermeasures for populations with spe-
                                      



                                                                        24                                  cial clinical needs, including children and
                                                                        25                                  pregnant women, in order to meet the needs


                                                                                    •HR 307 RS

                                                                                                                              166
                                                                          1                                 of such populations, as necessary and ap-
                                                                          2                                 propriate; and
                                                                          3                        ‘‘(5) establish’’; and
                                                                          4                        (3) by adding at the end the following:
                                                                          5              ‘‘(c) FINAL GUIDANCE                       ON    DEVELOPMENT                    OF   ANIMAL
                                                                          6 MODELS.—
                                                                          7                        ‘‘(1) IN      GENERAL.—Not                    later than 1 year after
                                                                          8              the date of the enactment of the Pandemic and All-
                                                                          9              Hazards Preparedness Reauthorization Act of 2013,
                                                                        10               the Secretary shall provide final guidance to industry
                                                                        11               regarding the development of animal models to sup-
                                                                        12               port approval, clearance, or licensure of counter-
                                                                        13               measures referred to in subsection (a) when human ef-
                                                                        14               ficacy studies are not ethical or feasible.
                                                                        15                         ‘‘(2) AUTHORITY                  TO EXTEND DEADLINE.—The
                                                                        16               Secretary may extend the deadline for providing final
                                                                        17               guidance under paragraph (1) by not more than 6
                                                                        18               months upon submission by the Secretary of a report
                                                                        19               on the status of such guidance to the Committee on
                                                                        20               Energy and Commerce of the House of Representa-
                                                                        21               tives and the Committee on Health, Education,
                                                                        22               Labor, and Pensions of the Senate.
                                                                        23               ‘‘(d) DEVELOPMENT                     AND       ANIMAL MODELING PROCE-
                                                                        24      DURES.—




                                                                                    •HR 307 RS

                                                                          1                        ‘‘(1) AVAILABILITY     167           OF ANIMAL MODEL MEET-
                                                                          2              INGS.—To            facilitate the timely development of animal
                                                                          3              models and support the development, stockpiling, li-
                                                                          4              censure, approval, and clearance of countermeasures,
                                                                          5              the Secretary shall, not later than 180 days after the
                                                                          6              enactment of this subsection, establish a procedure by
                                                                          7              which a sponsor or applicant that is developing a
                                                                          8              countermeasure for which human efficacy studies are
                                                                          9              not ethical or practicable, and that has an approved
                                                                        10               investigational new drug application or investiga-
                                                                        11               tional device exemption, may request and receive—
                                                                        12                                  ‘‘(A) a meeting to discuss proposed animal
                                                                        13                         model development activities; and
                                                                        14                                  ‘‘(B) a meeting prior to initiating pivotal
                                                                        15                         animal studies.
                                                                        16                         ‘‘(2) PEDIATRIC                 MODELS.—To               facilitate the de-
                                                                        17               velopment and selection of animal models that could
                                                                        18               translate to pediatric studies, any meeting conducted
                                                                        19               under paragraph (1) shall include discussion of ani-
                                                                        20               mal models for pediatric populations, as appropriate.
                                                                        21               ‘‘(e)        REVIEW              AND         APPROVAL                OF         COUNTER-
                                                                        22      MEASURES.—

                                                                        23                         ‘‘(1) MATERIAL                  THREAT.—When                   evaluating an
                                      



                                                                        24               application or submission for approval, licensure, or
                                                                        25               clearance of a countermeasure, the Secretary shall


                                                                                    •HR 307 RS

                                                                                                                              168
                                                                          1              take into account the material threat posed by the
                                                                          2              chemical, biological, radiological, or nuclear agent or
                                                                          3              agents identified under section 319F–2 of the Public
                                                                          4              Health Service Act for which the countermeasure
                                                                          5              under review is intended.
                                                                          6                        ‘‘(2) REVIEW                    EXPERTISE.—When                       practicable
                                                                          7              and appropriate, teams of Food and Drug Adminis-
                                                                          8              tration personnel reviewing applications or submis-
                                                                          9              sions described under paragraph (1) shall include a
                                                                        10               reviewer with sufficient training or experience with
                                                                        11               countermeasures pursuant to the protocols established
                                                                        12               under subsection (b)(3)(D).’’.
                                                                        13      SEC. 305. REGULATORY MANAGEMENT PLANS.
                                                                        14               Section 565 of the Federal Food, Drug, and Cosmetic
                                                                        15 Act (21 U.S.C. 360bbb–4), as amended by section 304, is
                                                                        16 further amended by adding at the end the following:
                                                                        17               ‘‘(f) REGULATORY MANAGEMENT PLAN.—
                                                                        18                         ‘‘(1) DEFINITION.—In this subsection, the term
                                                                        19               ‘eligible countermeasure’ means—
                                                                        20                                  ‘‘(A) a security countermeasure with respect
                                                                        21                         to which the Secretary has entered into a pro-
                                                                        22                         curement contract under section 319F–2(c) of the
                                                                        23                         Public Health Service Act; or
                                      




                                                                        24                                  ‘‘(B) a countermeasure with respect to
                                                                        25                         which the Biomedical Advanced Research and


                                                                                    •HR 307 RS

                                                                                                                              169
                                                                          1                        Development Authority has provided funding
                                                                          2                        under section 319L of the Public Health Service
                                                                          3                        Act for advanced research and development.
                                                                          4                        ‘‘(2) REGULATORY                     MANAGEMENT PLAN PROC-
                                                                          5              ESS.—The             Secretary, in consultation with the Assist-
                                                                          6              ant Secretary for Preparedness and Response and the
                                                                          7              Director of the Biomedical Advanced Research and
                                                                          8              Development Authority, shall establish a formal proc-
                                                                          9              ess for obtaining scientific feedback and interactions
                                                                        10               regarding the development and regulatory review of
                                                                        11               eligible countermeasures by facilitating the develop-
                                                                        12               ment of written regulatory management plans in ac-
                                                                        13               cordance with this subsection.
                                                                        14                         ‘‘(3) SUBMISSION                  OF REQUEST AND PROPOSED
                                                                        15               PLAN BY SPONSOR OR APPLICANT.—
                                                                        16                                  ‘‘(A) IN       GENERAL.—A                sponsor or applicant
                                                                        17                         of an eligible countermeasure may initiate the
                                                                        18                         process described under paragraph (2) upon sub-
                                                                        19                         mission of a written request to the Secretary.
                                                                        20                         Such request shall include a proposed regulatory
                                                                        21                         management plan.
                                                                        22                                  ‘‘(B) TIMING              OF SUBMISSION.—A                   sponsor
                                                                        23                         or applicant may submit a written request
                                      



                                                                        24                         under subparagraph (A) after the eligible coun-
                                                                                    •HR 307 RS

                                                                                                                              170
                                                                          1                        termeasure has an investigational new drug or
                                                                          2                        investigational device exemption in effect.
                                                                          3                                 ‘‘(C) RESPONSE                BY SECRETARY.—The              Sec-
                                                                          4                        retary shall direct the Food and Drug Adminis-
                                                                          5                        tration, upon submission of a written request by
                                                                          6                        a sponsor or applicant under subparagraph (A),
                                                                          7                        to work with the sponsor or applicant to agree
                                                                          8                        on a regulatory management plan within a rea-
                                                                          9                        sonable time not to exceed 90 days. If the Sec-
                                                                        10                         retary determines that no plan can be agreed
                                                                        11                         upon, the Secretary shall provide to the sponsor
                                                                        12                         or applicant, in writing, the scientific or regu-
                                                                        13                         latory rationale why such agreement cannot be
                                                                        14                         reached.
                                                                        15                         ‘‘(4) PLAN.—The content of a regulatory man-
                                                                        16               agement plan agreed to by the Secretary and a spon-
                                                                        17               sor or applicant shall include—
                                                                        18                                  ‘‘(A) an agreement between the Secretary
                                                                        19                         and the sponsor or applicant regarding develop-
                                                                        20                         mental milestones that will trigger responses by
                                                                        21                         the Secretary as described in subparagraph (B);
                                                                        22                                  ‘‘(B) performance targets and goals for
                                                                        23                         timely and appropriate responses by the Sec-
                                      



                                                                        24                         retary to the triggers described under subpara-
                                                                        25                         graph (A), including meetings between the Sec-


                                                                                    •HR 307 RS

                                                                                                                              171
                                                                          1                        retary and the sponsor or applicant, written
                                                                          2                        feedback, decisions by the Secretary, and other
                                                                          3                        activities carried out as part of the development
                                                                          4                        and review process; and
                                                                          5                                 ‘‘(C) an agreement on how the plan shall be
                                                                          6                        modified, if needed.
                                                                          7                        ‘‘(5) MILESTONES                      AND         PERFORMANCE         TAR-
                                                                          8              GETS.—The               developmental milestones described in
                                                                          9              paragraph (4)(A) and the performance targets and
                                                                        10               goals described in paragraph (4)(B) shall include—
                                                                        11                                  ‘‘(A) feedback from the Secretary regarding
                                                                        12                         the data required to support the approval, clear-
                                                                        13                         ance, or licensure of the eligible countermeasure
                                                                        14                         involved;
                                                                        15                                  ‘‘(B) feedback from the Secretary regarding
                                                                        16                         the data necessary to inform any authorization
                                                                        17                         under section 564;
                                                                        18                                  ‘‘(C) feedback from the Secretary regarding
                                                                        19                         the data necessary to support the positioning
                                                                        20                         and delivery of the eligible countermeasure, in-
                                                                        21                         cluding to the Strategic National Stockpile;
                                                                        22                                  ‘‘(D) feedback from the Secretary regarding
                                                                        23                         the data necessary to support the submission of
                                      



                                                                        24                         protocols for review under section 505(b)(5)(B);
                                                                                    •HR 307 RS

                                                                                                                              172
                                                                          1                                 ‘‘(E) feedback from the Secretary regarding
                                                                          2                        any gaps in scientific knowledge that will need
                                                                          3                        resolution prior to approval, licensure, or clear-
                                                                          4                        ance of the eligible countermeasure and plans for
                                                                          5                        conducting the necessary scientific research;
                                                                          6                                 ‘‘(F) identification of the population for
                                                                          7                        which the countermeasure sponsor or applicant
                                                                          8                        seeks approval, licensure, or clearance and the
                                                                          9                        population for which desired labeling would not
                                                                        10                         be appropriate, if known; and
                                                                        11                                  ‘‘(G) as necessary and appropriate, and to
                                                                        12                         the extent practicable, a plan for demonstrating
                                                                        13                         safety and effectiveness in pediatric populations,
                                                                        14                         and for developing pediatric dosing, formulation,
                                                                        15                         and administration with respect to the eligible
                                                                        16                         countermeasure, provided that such plan would
                                                                        17                         not delay authorization under section 564, ap-
                                                                        18                         proval, licensure, or clearance for adults.
                                                                        19                         ‘‘(6) PRIORITIZATION.—
                                                                        20                                  ‘‘(A)       PLANS           FOR        SECURITY              COUNTER-
                                                                        21                         MEASURES.—The                    Secretary shall establish regu-
                                                                        22                         latory management plans for all security coun-
                                                                        23                         termeasures for which a request is submitted
                                      



                                                                        24                         under paragraph (3)(A).
                                                                                    •HR 307 RS

                                                                          1                                 ‘‘(B) PLANS   173       FOR OTHER ELIGIBLE COUN-
                                                                          2                        TERMEASURES.—The                        Secretary shall determine
                                                                          3                        whether resources are available to establish regu-
                                                                          4                        latory management plans for eligible counter-
                                                                          5                        measures that are not security countermeasures.
                                                                          6                        If resources are available to establish regulatory
                                                                          7                        management plans for eligible countermeasures
                                                                          8                        that are not security countermeasures, and if re-
                                                                          9                        sources are not available to establish regulatory
                                                                        10                         management plans for all eligible counter-
                                                                        11                         measures for which requests have been submitted,
                                                                        12                         the Director of the Biomedical Advanced Re-
                                                                        13                         search and Development Authority, in consulta-
                                                                        14                         tion with the Commissioner, shall prioritize
                                                                        15                         which eligible countermeasures may receive regu-
                                                                        16                         latory management plans.’’.
                                                                        17      SEC. 306. REPORT.
                                                                        18               Section 565 of the Federal Food, Drug, and Cosmetic
                                                                        19 Act (21 U.S.C. 360bbb–4), as amended by section 305, is
                                                                        20 further amended by adding at the end the following:
                                                                        21               ‘‘(g) ANNUAL REPORT.—Not later than 180 days after
                                                                        22 the date of enactment of this subsection, and annually there-
                                                                        23 after, the Secretary shall make publicly available on the
                                      



                                                                        24 Web site of the Food and Drug Administration a report
                                                                                    •HR 307 RS

                                                                                                                              174
                                                                          1 that details the countermeasure development and review ac-
                                                                          2 tivities of the Food and Drug Administration, including—
                                                                          3                        ‘‘(1) with respect to the development of new tools,
                                                                          4              standards, and approaches to assess and evaluate
                                                                          5              countermeasures—
                                                                          6                                 ‘‘(A) the identification of the priorities of
                                                                          7                        the Food and Drug Administration and the
                                                                          8                        progress made on such priorities; and
                                                                          9                                 ‘‘(B) the identification of scientific gaps
                                                                        10                         that impede the development, approval, licensure,
                                                                        11                         or clearance of countermeasures for populations
                                                                        12                         with special clinical needs, including children
                                                                        13                         and pregnant women, and the progress made on
                                                                        14                         resolving these challenges;
                                                                        15                         ‘‘(2) with respect to countermeasures for which a
                                                                        16               regulatory management plan has been agreed upon
                                                                        17               under subsection (f), the extent to which the perform-
                                                                        18               ance targets and goals set forth in subsection (f)(4)(B)
                                                                        19               and the regulatory management plan have been met,
                                                                        20               including, for each such countermeasure—
                                                                        21                                  ‘‘(A) whether the regulatory management
                                                                        22                         plan was completed within the required time-
                                                                        23                         frame, and the length of time taken to complete
                                      



                                                                        24                         such plan;
                                                                                    •HR 307 RS

                                                                                                                              175
                                                                          1                                 ‘‘(B) whether the Secretary adhered to the
                                                                          2                        timely and appropriate response times set forth
                                                                          3                        in such plan; and
                                                                          4                                 ‘‘(C) explanations for any failure to meet
                                                                          5                        such performance targets and goals;
                                                                          6                        ‘‘(3) the number of regulatory teams established
                                                                          7              pursuant to subsection (b)(4), the number of products,
                                                                          8              classes of products, or technologies assigned to each
                                                                          9              such team, and the number of, type of, and any
                                                                        10               progress made as a result of consultations carried out
                                                                        11               under subsection (b)(4)(A);
                                                                        12                         ‘‘(4) an estimate of resources obligated to coun-
                                                                        13               termeasure development and regulatory assessment,
                                                                        14               including—
                                                                        15                                  ‘‘(A) Center-specific objectives and accom-
                                                                        16                         plishments; and
                                                                        17                                  ‘‘(B) the number of full-time equivalent em-
                                                                        18                         ployees of the Food and Drug Administration
                                                                        19                         who directly support the review of counter-
                                                                        20                         measures;
                                                                        21                         ‘‘(5) the number of countermeasure applications
                                                                        22               and submissions submitted, the number of counter-
                                                                        23               measures approved, licensed, or cleared, the status of
                                      



                                                                        24               remaining submitted applications and submissions,
                                                                                    •HR 307 RS

                                                                                                                              176
                                                                          1              and the number of each type of authorization issued
                                                                          2              pursuant to section 564;
                                                                          3                        ‘‘(6) the number of written requests for a regu-
                                                                          4              latory management plan submitted under subsection
                                                                          5              (f)(3)(A), the number of regulatory management plans
                                                                          6              developed, and the number of such plans developed for
                                                                          7              security countermeasures; and
                                                                          8                        ‘‘(7) the number, type, and frequency of meetings
                                                                          9              between the Food and Drug Administration and—
                                                                        10                                  ‘‘(A) sponsors of a countermeasure as de-
                                                                        11                         fined in subsection (a); or
                                                                        12                                  ‘‘(B) another agency engaged in develop-
                                                                        13                         ment or management of portfolios for such coun-
                                                                        14                         termeasures, including the Centers for Disease
                                                                        15                         Control and Prevention, the Biomedical Ad-
                                                                        16                         vanced Research and Development Authority, the
                                                                        17                         National Institutes of Health, and the appro-
                                                                        18                         priate agencies of the Department of Defense.’’.
                                                                        19      SEC. 307. PEDIATRIC MEDICAL COUNTERMEASURES.

                                                                        20               (a) PEDIATRIC STUDIES                        OF       DRUGS.—Section 505A of
                                                                        21 the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355a)
                                                                        22 is amended—
                                                                        23                         (1) in subsection (d), by adding at the end the
                                      



                                                                        24               following:
                                                                                    •HR 307 RS

                                                                                                                              177
                                                                          1                        ‘‘(5) CONSULTATION.—With respect to a drug
                                                                          2              that is a qualified countermeasure (as defined in sec-
                                                                          3              tion 319F–1 of the Public Health Service Act), a secu-
                                                                          4              rity countermeasure (as defined in section 319F–2 of
                                                                          5              the Public Health Service Act), or a qualified pan-
                                                                          6              demic or epidemic product (as defined in section
                                                                          7              319F–3 of the Public Health Service Act), the Sec-
                                                                          8              retary shall solicit input from the Assistant Secretary
                                                                          9              for Preparedness and Response regarding the need for
                                                                        10               and, from the Director of the Biomedical Advanced
                                                                        11               Research and Development Authority regarding the
                                                                        12               conduct of, pediatric studies under this section.’’; and
                                                                        13                         (2) in subsection (n)(1), by adding at the end the
                                                                        14               following:
                                                                        15                                  ‘‘(C) For a drug that is a qualified counter-
                                                                        16                         measure (as defined in section 319F–1 of the
                                                                        17                         Public Health Service Act), a security counter-
                                                                        18                         measure (as defined in section 319F–2 of the
                                                                        19                         Public Health Service Act), or a qualified pan-
                                                                        20                         demic or epidemic product (as defined in section
                                                                        21                         319F–3 of such Act), in addition to any action
                                                                        22                         with respect to such drug under subparagraph
                                                                        23                         (A) or (B), the Secretary shall notify the Assist-
                                      



                                                                        24                         ant Secretary for Preparedness and Response
                                                                        25                         and the Director of the Biomedical Advanced Re-


                                                                                    •HR 307 RS

                                                                                                                              178
                                                                          1                        search and Development Authority of all pedi-
                                                                          2                        atric studies in the written request issued by the
                                                                          3                        Commissioner of Food and Drugs.’’.
                                                                          4              (b) ADDITION              TO     PRIORITY LIST CONSIDERATIONS.—
                                                                          5 Section 409I of the Public Health Service Act (42 U.S.C.
                                                                          6 284m) is amended—
                                                                          7                        (1) by striking subsection (a)(2) and inserting
                                                                          8              the following:
                                                                          9                        ‘‘(2) CONSIDERATION                         OF AVAILABLE INFORMA-
                                                                        10               TION.—In            developing and prioritizing the list under
                                                                        11               paragraph (1), the Secretary—
                                                                        12                                  ‘‘(A) shall consider—
                                                                        13                                         ‘‘(i) therapeutic gaps in pediatrics that
                                                                        14                                  may include developmental pharmacology,
                                                                        15                                  pharmacogenetic determinants of drug re-
                                                                        16                                  sponse, metabolism of drugs and biologics in
                                                                        17                                  children, and pediatric clinical trials;
                                                                        18                                         ‘‘(ii) particular pediatric diseases, dis-
                                                                        19                                  orders or conditions where more complete
                                                                        20                                  knowledge and testing of therapeutics, in-
                                                                        21                                  cluding drugs and biologics, may be bene-
                                                                        22                                  ficial in pediatric populations; and
                                                                        23                                         ‘‘(iii) the adequacy of necessary infra-
                                      



                                                                        24                                  structure to conduct pediatric pharma-
                                                                        25                                  cological research, including research net-


                                                                                    •HR 307 RS

                                                                                                                              179
                                                                          1                                 works and trained pediatric investigators;
                                                                          2                                 and
                                                                          3                                 ‘‘(B) may consider the availability of quali-
                                                                          4                        fied countermeasures (as defined in section
                                                                          5                        319F–1), security countermeasures (as defined in
                                                                          6                        section 319F–2), and qualified pandemic or epi-
                                                                          7                        demic products (as defined in section 319F–3) to
                                                                          8                        address the needs of pediatric populations, in
                                                                          9                        consultation with the Assistant Secretary for
                                                                        10                         Preparedness and Response, consistent with the
                                                                        11                         purposes of this section.’’; and
                                                                        12                         (2) in subsection (b), by striking ‘‘subsection (a)’’
                                                                        13               and inserting ‘‘paragraphs (1) and (2)(A) of sub-
                                                                        14               section (a)’’.
                                                                        15               (c) ADVICE             AND       RECOMMENDATIONS                         OF THE   PEDI-
                                                                        16      ATRIC            ADVISORY COMMITTEE REGARDING COUNTER-
                                                                        17      MEASURES               FOR        PEDIATRIC POPULATIONS.—Subsection
                                                                        18 (b)(2) of section 14 of the Best Pharmaceuticals for Children
                                                                        19 Act (42 U.S.C. 284m note) is amended—
                                                                        20                         (1) in subparagraph (C), by striking the period
                                                                        21               and inserting ‘‘; and’’; and
                                                                        22                         (2) by adding at the end the following:
                                                                        23                                  ‘‘(D) the development of countermeasures
                                      




                                                                        24                         (as defined in section 565(a) of the Federal Food,




                                                                                    •HR 307 RS

                                                                                                                              180
                                                                          1                        Drug, and Cosmetic Act) for pediatric popu-
                                                                          2                        lations.’’.
                                                                          3     TITLE IV—ACCELERATING MED-
                                                                          4        ICAL COUNTERMEASURE AD-
                                                                          5        VANCED RESEARCH AND DE-
                                                                          6        VELOPMENT
                                                                          7     SEC. 401. BIOSHIELD.

                                                                          8              (a) PROCUREMENT                     OF     COUNTERMEASURES.—Section
                                                                          9 319F–2(c) of the Public Health Service Act (42 U.S.C.
                                                                        10 247d–6b(c)) is amended—
                                                                        11                         (1) in paragraph (1)(B)(i)(III)(bb), by striking
                                                                        12               ‘‘eight years’’ and inserting ‘‘10 years’’;
                                                                        13                         (2) in paragraph (2)(C), by striking ‘‘the des-
                                                                        14               ignated congressional committees (as defined in para-
                                                                        15               graph (10))’’ and inserting ‘‘the appropriate commit-
                                                                        16               tees of Congress’’;
                                                                        17                         (3) in paragraph (5)(B)(ii), by striking ‘‘eight
                                                                        18               years’’ and inserting ‘‘10 years’’;
                                                                        19                         (4) in subparagraph (C) of paragraph (6)—
                                                                        20                                  (A) in the subparagraph heading, by strik-
                                                                        21                         ing       ‘‘DESIGNATED                 CONGRESSIONAL                   COMMIT-
                                                                        22                         TEES’’       and inserting ‘‘APPROPRIATE                              CONGRES-
                                                                        23                         SIONAL COMMITTEES’’;                        and
                                      




                                                                                    •HR 307 RS

                                                                                                                              181
                                                                          1                                 (B) by striking ‘‘the designated congres-
                                                                          2                        sional committees’’ and inserting ‘‘the appro-
                                                                          3                        priate congressional committees’’; and
                                                                          4                        (5) in paragraph (7)(C)—
                                                                          5                                 (A) in clause (i)(I), by inserting ‘‘including
                                                                          6                        advanced research and development,’’ after ‘‘as
                                                                          7                        may reasonably be required,’’;
                                                                          8                                 (B) in clause (ii)—
                                                                          9                                        (i) in subclause (III), by striking
                                                                        10                                  ‘‘eight years’’ and inserting ‘‘10 years’’; and
                                                                        11                                         (ii) by striking subclause (IX) and in-
                                                                        12                                  serting the following:
                                                                        13                                                   ‘‘(IX)        CONTRACT                TERMS.—The
                                                                        14                                         Secretary, in any contract for procure-
                                                                        15                                         ment under this section—
                                                                        16                                                            ‘‘(aa) may specify—
                                                                        17                                                                     ‘‘(AA) the dosing and
                                                                        18                                                            administration requirements
                                                                        19                                                            for the countermeasure to be
                                                                        20                                                            developed and procured;
                                                                        21                                                                     ‘‘(BB) the amount of
                                                                        22                                                            funding that will be dedi-
                                                                        23                                                            cated by the Secretary for
                                      



                                                                        24                                                            advanced research, develop-
                                                                                    •HR 307 RS

                                                                                                                              182
                                                                          1                                                           ment, and procurement of the
                                                                          2                                                           countermeasure; and
                                                                          3                                                                    ‘‘(CC) the specifications
                                                                          4                                                           the        countermeasure          must
                                                                          5                                                           meet to qualify for procure-
                                                                          6                                                           ment under a contract under
                                                                          7                                                           this section; and
                                                                          8                                                           ‘‘(bb) shall provide a clear
                                                                          9                                                  statement of defined Government
                                                                        10                                                   purpose limited to uses related to
                                                                        11                                                   a security countermeasure, as de-
                                                                        12                                                   fined in paragraph (1)(B).’’; and
                                                                        13                                  (C) by adding at the end the following:
                                                                        14                                         ‘‘(viii) FLEXIBILITY.—In carrying out
                                                                        15                                  this section, the Secretary may, consistent
                                                                        16                                  with the applicable provisions of this sec-
                                                                        17                                  tion, enter into contracts and other agree-
                                                                        18                                  ments that are in the best interest of the
                                                                        19                                  Government in meeting identified security
                                                                        20                                  countermeasure needs, including with re-
                                                                        21                                  spect to reimbursement of the cost of ad-
                                                                        22                                  vanced research and development as a rea-
                                                                        23                                  sonable, allowable, and allocable direct cost
                                      



                                                                        24                                  of the contract involved.’’.
                                                                                    •HR 307 RS

                                                                          1              (b) REAUTHORIZATION                  183     OF THE            SPECIAL RESERVE
                                                                          2 FUND.—Section 319F–2 of the Public Health Service Act
                                                                          3 (42 U.S.C. 247d–6b) is amended—
                                                                          4                        (1) in subsection (c)—
                                                                          5                                 (A) by striking ‘‘special reserve fund under
                                                                          6                        paragraph (10)’’ each place it appears and in-
                                                                          7                        serting ‘‘special reserve fund as defined in sub-
                                                                          8                        section (h)’’; and
                                                                        109                        and      (B) by striking paragraphs (9) and (10);
                                                                        11                         (2) by adding at the end the following:
                                                                        12               ‘‘(g) SPECIAL RESERVE FUND.—
                                                                        13                         ‘‘(1) AUTHORIZATION                         OF APPROPRIATIONS.—In
                                                                        14               addition to amounts appropriated to the special re-
                                                                        15               serve fund prior to the date of the enactment of this
                                                                        16               subsection, there is authorized to be appropriated, for
                                                                        17               the procurement of security countermeasures under
                                                                        18               subsection (c) and for carrying out section 319L (re-
                                                                        19               lating to the Biomedical Advanced Research and De-
                                                                        20               velopment Authority), $2,800,000,000 for the period
                                                                        21               of fiscal years 2014 through 2018. Amounts appro-
                                                                        22               priated pursuant to the preceding sentence are au-
                                                                        23               thorized to remain available until September 30,
                                      



                                                                        24               2019.
                                                                                    •HR 307 RS

                                                                                                                              184
                                                                          1                        ‘‘(2) USE            OF SPECIAL RESERVE FUND FOR AD-
                                                                          2              VANCED RESEARCH AND DEVELOPMENT.—The                                                Sec-
                                                                          3              retary may utilize not more than 50 percent of the
                                                                          4              amounts authorized to be appropriated under para-
                                                                          5              graph (1) to carry out section 319L (related to the
                                                                          6              Biomedical Advanced Research and Development Au-
                                                                          7              thority). Amounts authorized to be appropriated
                                                                          8              under this subsection to carry out section 319L are in
                                                                          9              addition to amounts otherwise authorized to be ap-
                                                                        10               propriated to carry out such section.
                                                                        11                         ‘‘(3) RESTRICTIONS                          ON     USE         OF     FUNDS.—
                                                                        12               Amounts in the special reserve fund shall not be used
                                                                        13               to pay costs other than payments made by the Sec-
                                                                        14               retary to a vendor for advanced development (under
                                                                        15               section 319L) or for procurement of a security coun-
                                                                        16               termeasure under subsection (c)(7).
                                                                        17                         ‘‘(4) REPORT.—Not later than 30 days after any
                                                                        18               date on which the Secretary determines that the
                                                                        19               amount of funds in the special reserve fund available
                                                                        20               for procurement is less than $1,500,000,000, the Sec-
                                                                        21               retary shall submit to the appropriate committees of
                                                                        22               Congress a report detailing the amount of such funds
                                                                        23               available for procurement and the impact such reduc-
                                      



                                                                        24               tion in funding will have—
                                                                                    •HR 307 RS

                                                                                                                              185
                                                                          1                                 ‘‘(A) in meeting the security countermeasure
                                                                          2                        needs identified under this section; and
                                                                          3                                 ‘‘(B) on the annual Public Health Emer-
                                                                          4                        gency Medical Countermeasures Enterprise and
                                                                          5                        Strategy Implementation Plan (pursuant to sec-
                                                                          6                        tion 2811(d)).
                                                                          7              ‘‘(h) DEFINITIONS.—In this section:
                                                                          8                        ‘‘(1) The term ‘advanced research and develop-
                                                                          9              ment’ has the meaning given such term in section
                                                                        10               319L(a).
                                                                        11                         ‘‘(2) The term ‘special reserve fund’ means the
                                                                        12               ‘Biodefense Countermeasures’ appropriations account,
                                                                        13               any appropriation made available pursuant to sec-
                                                                        14               tion 521(a) of the Homeland Security Act of 2002,
                                                                        15               and any appropriation made available pursuant to
                                                                        16               subsection (g)(1).’’.
                                                                        17      SEC. 402. BIOMEDICAL ADVANCED RESEARCH AND DEVEL-
                                                                        18                              OPMENT AUTHORITY.
                                                                        19               (a) DUTIES.—Section 319L(c)(4) of the Public Health
                                                                        20 Service Act (42 U.S.C. 247d–7e(c)(4)) is amended—
                                                                        21                         (1) in subparagraph (B)(iii), by inserting
                                                                        22               ‘‘(which may include advanced research and develop-
                                                                        23               ment for purposes of fulfilling requirements under the
                                      



                                                                        24               Federal Food, Drug, and Cosmetic Act or section 351
                                                                        25               of this Act)’’ after ‘‘development’’; and


                                                                                    •HR 307 RS

                                                                                                                              186
                                                                          1                        (2) in subparagraph (D)(iii), by striking ‘‘and
                                                                          2              vaccine manufacturing technologies’’ and inserting
                                                                          3              ‘‘vaccine-manufacturing                          technologies,             dose-sparing
                                                                          4              technologies,             efficacy-increasing                    technologies,     and
                                                                          5              platform technologies’’.
                                                                          6              (b) TRANSACTION AUTHORITIES.—Section 319L(c)(5)
                                                                          7 of the Public Health Service Act (42 U.S.C. 247d–7e(c)(5))
                                                                          8 is amended by adding at the end the following:
                                                                          9                                 ‘‘(G) GOVERNMENT                      PURPOSE.—In            award-
                                                                        10                         ing contracts, grants, and cooperative agreements
                                                                        11                         under this section, the Secretary shall provide a
                                                                        12                         clear statement of defined Government purpose
                                                                        13                         related to activities included in subsection
                                                                        14                         (a)(6)(B) for a qualified countermeasure or
                                                                        15                         qualified pandemic or epidemic product.’’.
                                                                        16               (c) FUND.—Paragraph (2) of section 319L(d) of the
                                                                        17 Public Health Service Act (42 U.S.C. 247d–7e(d)(2)) is
                                                                        18 amended to read as follows:
                                                                        19                         ‘‘(2) FUNDING.—To carry out the purposes of
                                                                        20               this section, there is authorized to be appropriated to
                                                                        21               the Fund $415,000,000 for each of fiscal years 2014
                                                                        22               through 2018, such amounts to remain available until
                                                                        23               expended.’’.
                                      




                                                                        24               (d) CONTINUED INAPPLICABILITY                                 OF    CERTAIN PROVI-
                                                                        25      SIONS.—Section                 319L(e)(1)(C) of the Public Health Service


                                                                                    •HR 307 RS

                                                                                                                               187
                                                                          1 Act (42 U.S.C. 247d–7e(e)(1)(C)) is amended by striking
                                                                          2 ‘‘7 years’’ and inserting ‘‘12 years’’.
                                                                          3              (e) EXTENSION                    OF       LIMITED ANTITRUST EXEMP-
                                                                          4     TION.—

                                                                          5                        (1) IN        GENERAL.—Section                      405(b) of the Pan-
                                                                          6              demic and All-Hazards Preparedness Act (42 U.S.C.
                                                                          7              247d–6a note) is amended by striking ‘‘6-year’’ and
                                                                          8              inserting ‘‘12-year’’.
                                                                          9                        (2) EFFECTIVE               DATE.—This              subsection shall take
                                                                        10               effect as if enacted on December 17, 2012.
                                                                        11               (f) INDEPENDENT EVALUATION.—Section 319L of the
                                                                        12 Public Health Service Act (42 U.S.C. 247d–7e) is amended
                                                                        13 by adding at the end the following:
                                                                        14               ‘‘(f) INDEPENDENT EVALUATION.—
                                                                        15                         ‘‘(1) IN        GENERAL.—Not                    later than 180 days
                                                                        16               after the date of enactment of this subsection, the
                                                                        17               Comptroller General of the United States shall con-
                                                                        18               duct an independent evaluation of the activities car-
                                                                        19               ried out to facilitate flexible manufacturing capacity
                                                                        20               pursuant to this section.
                                                                        21                         ‘‘(2) REPORT.—Not later than 1 year after the
                                                                        22               date of enactment of this subsection, the Comptroller
                                                                        23               General of the United States shall submit to the ap-
                                      



                                                                        24               propriate committees of Congress a report concerning
                                                                                    •HR 307 RS

                                                                                                                              188
                                                                          1              the results of the evaluation conducted under para-
                                                                          2              graph (1). Such report shall review and assess—
                                                                          3                                 ‘‘(A) the extent to which flexible manufac-
                                                                          4                        turing capacity under this section is dedicated to
                                                                          5                        chemical, biological, radiological, and nuclear
                                                                          6                        threats;
                                                                          7                                 ‘‘(B) the activities supported by flexible
                                                                          8                        manufacturing initiatives; and
                                                                          9                                 ‘‘(C) the ability of flexible manufacturing
                                                                        10                         activities carried out under this section to—
                                                                        11                                         ‘‘(i) secure and leverage leading tech-
                                                                        12                                  nical expertise with respect to counter-
                                                                        13                                  measure advanced research, development,
                                                                        14                                  and manufacturing processes; and
                                                                        15                                         ‘‘(ii) meet the surge manufacturing ca-
                                                                        16                                  pacity needs presented by novel and emerg-
                                                                        17                                  ing threats, including chemical, biological,
                                                                        18                                  radiological, and nuclear agents.’’.
                                                                        19               (g) DEFINITIONS.—
                                                                        20                         (1)       QUALIFIED                 COUNTERMEASURE.—Section
                                                                        21               319F–1(a)(2)(A) of the Public Health Service Act (42
                                                                        22               U.S.C. 247d–6a(a)(2)(A)) is amended—
                                                                        23                                  (A) in the matter preceding clause (i), by
                                      



                                                                        24                         striking ‘‘to—’’ and inserting ‘‘—’’;
                                                                        25                                  (B) in clause (i)—


                                                                                    •HR 307 RS

                                                                                                                              189
                                                                          1                                        (i) by striking ‘‘diagnose’’ and insert-
                                                                          2                                 ing ‘‘to diagnose’’; and
                                                                          3                                        (ii) by striking ‘‘; or’’ and inserting a
                                                                          4                                 semicolon;
                                                                          5                                 (C) in clause (ii)—
                                                                          6                                        (i) by striking ‘‘diagnose’’ and insert-
                                                                          7                                 ing ‘‘to diagnose’’; and
                                                                          8                                        (ii) by striking the period at the end
                                                                          9                                 and inserting ‘‘; or’’; and
                                                                        10                                  (D) by adding at the end the following:
                                                                        11                                         ‘‘(iii) is a product or technology in-
                                                                        12                                  tended to enhance the use or effect of a drug,
                                                                        13                                  biological product, or device described in
                                                                        14                                  clause (i) or (ii).’’.
                                                                        15                         (2) QUALIFIED                   PANDEMIC OR EPIDEMIC PROD-
                                                                        16               UCT.—Section               319F–3(i)(7)(A) of the Public Health
                                                                        17               Service Act (42 U.S.C. 247d–6d(i)(7)(A)) is amend-
                                                                        18               ed—
                                                                        19                                  (A) in clause (i)(II), by striking ‘‘; or’’ and
                                                                        20                         inserting ‘‘;’’;
                                                                        21                                  (B) in clause (ii), by striking ‘‘; and’’ and
                                                                        22                         inserting ‘‘; or’’; and
                                                                        23                                  (C) by adding at the end the following:
                                      




                                                                        24                                         ‘‘(iii) a product or technology intended
                                                                        25                                  to enhance the use or effect of a drug, bio-


                                                                                    •HR 307 RS

                                                                                                                              190
                                                                          1                                 logical product, or device described in clause
                                                                          2                                 (i) or (ii); and’’.
                                                                          3                        (3) TECHNICAL                   AMENDMENTS.—Section                   319F–
                                                                          4              3(i) of the Public Health Service Act (42 U.S.C.
                                                                          5              247d–6d(i)) is amended—
                                                                          6                                 (A) in paragraph (1)(C), by inserting ‘‘,
                                                                          7                        564A, or 564B’’ after ‘‘564’’; and
                                                                          8                                 (B) in paragraph (7)(B)(iii), by inserting
                                                                          9                        ‘‘, 564A, or 564B’’ after ‘‘564’’.
                                                                        10      SEC. 403. STRATEGIC NATIONAL STOCKPILE.
                                                                        11               Section 319F–2 of the Public Health Service Act (42
                                                                        12 U.S.C. 247d–6b) is amended—
                                                                        13                         (1) in subsection (a)—
                                                                        14                                  (A) in paragraph (1)—
                                                                        15                                         (i) by inserting ‘‘consistent with sec-
                                                                        16                                  tion 2811’’ before ‘‘by the Secretary to be
                                                                        17                                  appropriate’’; and
                                                                        18                                         (ii) by inserting before the period at
                                                                        19                                  the end of the second sentence the following:
                                                                        20                                  ‘‘and shall submit such review annually to
                                                                        21                                  the appropriate congressional committees of
                                                                        22                                  jurisdiction to the extent that disclosure of
                                                                        23                                  such information does not compromise na-
                                      



                                                                        24                                  tional security’’; and
                                                                                    •HR 307 RS

                                                                                                                              191
                                                                          1                                 (B) in paragraph (2)(D), by inserting be-
                                                                          2                        fore the semicolon at the end the following: ‘‘and
                                                                          3                        that the potential depletion of countermeasures
                                                                          4                        currently in the stockpile is identified and ap-
                                                                          5                        propriately addressed, including through nec-
                                                                          6                        essary replenishment’’; and
                                                                          7                        (2)        in         subsection              (f)(1),          by     striking
                                                                          8              ‘‘$640,000,000 for fiscal year 2002, and such sums as
                                                                          9              may be necessary for each of fiscal years 2003 through
                                                                        10               2006. Such authorization is in addition to amounts
                                                                        11               in the special reserve fund referred to in subsection
                                                                        12               (c)(10)(A).’’ and inserting ‘‘$533,800,000 for each of
                                                                        13               fiscal years 2014 through 2018. Such authorization is
                                                                        14               in addition to amounts in the special reserve fund re-
                                                                        15               ferred to in subsection (h).’’.
                                                                        16      SEC. 404. NATIONAL BIODEFENSE SCIENCE BOARD.
                                                                        17               Section 319M(a) of the Public Health Service Act (42
                                                                        18 U.S.C. 247d–f(a)) is amended—
                                                                        19                         (1) in paragraph (2)—
                                                                        20                                  (A) in subparagraph (D)—
                                                                        21                                         (i) in clause (i), by striking ‘‘and’’ at
                                                                        22                                  the end;
                                                                        23                                         (ii) in clause (ii), by striking the pe-
                                      



                                                                        24                                  riod and inserting a semicolon; and
                                                                                    •HR 307 RS

                                                                                                                              192
                                                                          1                                        (iii) by adding at the end the fol-
                                                                          2                                 lowing:
                                                                          3                                        ‘‘(iii) one such member shall be an in-
                                                                          4                                 dividual with pediatric subject matter ex-
                                                                          5                                 pertise; and
                                                                          6                                        ‘‘(iv) one such member shall be a State,
                                                                          7                                 tribal, territorial, or local public health offi-
                                                                          8                                 cial.’’; and
                                                                        109                        sentence:(B) by adding at the end the following flush
                                                                        11               ‘‘Nothing in this paragraph shall preclude a member
                                                                        12               of the Board from satisfying two or more of the re-
                                                                        13               quirements described in subparagraph (D).’’; and
                                                                        14                         (2) in paragraph (5)—
                                                                        15                                  (A) in subparagraph (B), by striking ‘‘and’’
                                                                        16                         at the end;
                                                                        17                                  (B) in subparagraph (C), by striking the
                                                                        18                         period and inserting ‘‘; and’’; and
                                                                        19                                  (C) by adding at the end the following:
                                                                        20                                  ‘‘(D) provide any recommendation, finding,
                                                                        21                         or report provided to the Secretary under this
                                                                        22                         paragraph to the appropriate committees of Con-
                                                                        23                         gress.’’.
                                      




                                                                                    •HR 307 RS

                                      




                             Calendar No. 14
113TH CONGRESS
   1ST SESSION    H. R. 307




               AN ACT                                                                 H307
To reauthorize certain programs under the Public




  Health Service Act and the Federal Food, Drug,
  and Cosmetic Act with respect to public health
  security and all-hazards preparedness and re-
  sponse, and for other purposes.




                                                                                      Sfmt 6651
               FEBRUARY 14, 2013
           Reported with an amendment




                                                                                      Fmt 6651
                                                                                      Frm 00194
                                                                                      PO 00000
                                                                                      Jkt 029200
                                                                                      22:31 Feb 14, 2013
                                                                                      VerDate Mar 15 2010
                                                   srobinson on DSK4SPTVN1PROD with BILLS
